South African primary care clinical practice guidelines : exploratory study of guideline development, implementation and use by Kredo, Tamara
SOUTH AFRICAN PRIMARY CARE CLINICAL PRACTICE GUIDELINES: 
EXPLORATORY STUDY OF GUIDELINE DEVELOPMENT, 
IMPLEMENTATION AND USE 
Tamara Kredo
Dissertation presented for the degree of 
Doctor of Philosophy in Public Health 
Stellenbosch University, South Africa 
Supervisors: Professor Jimmy Volmink and Associate Professor Salla Atkins 
Date: December 2019 
ii 
Declaration 
By submitting this dissertation electronically, I declare that the entirety of the work contained therein is 
my own, original work, that I am the sole author thereof (save to the extent explicitly otherwise stated), 
that reproduction and publication thereof by Stellenbosch University will not infringe any third-party 
rights and that I have not previously in its entirety or in part submitted it for obtaining any qualification. 
This dissertation includes four original papers published or submitted for publication in peer-reviewed 
journals, and two policy briefs (summaries of the studies). In addition, there are several published papers 
to which I contributed and that are relevant to the doctoral research that have been included in the thesis 
as supplementary papers. The development and writing of the thesis papers (published and unpublished) 
and the thesis overall were the principal responsibility of myself and, where this is not the case, a 
declaration is included in the dissertation indicating the nature and extent of the contributions of co-
authors. 
Signature: 
Date: December 2019 
Copyright © 2019, Stellenbosch University 
All rights reserved 
Stellenbosch University https://scholar.sun.ac.za
iii 
Abstract 
Strong primary health care is indicative of a functioning health system and a necessary precursor to 
universal health coverage (UHC). The South African government aims to strengthen primary health care 
and implement UHC. Within the national UHC strategy, clinical practice guidelines are named tools to 
support evidence-informed, cost-effective practice.  However, if poorly developed, guidelines may hinder 
the quality of patient care; and, if not adequately implemented, they will have no impact. Against this 
backdrop, this dissertation aimed to explore the role-players, processes, barriers to and enablers of 
guideline development, implementation and use; and to suggest recommendations for improved 
guidelines for South African primary care. 
Qualitative methods were used to engage role-players contributing to primary care guidelines along the 
continuum from guideline development through implementation to use. In-depth interviews were 
conducted with national developers (n = 37) and provincial managers (n = 22); and seven focus group 
discussions were held with healthcare providers (n = 47) from June 2014 to August 2016. The four provinces 
selected represented diverse health systems and social conditions (KwaZulu Natal, Western Cape, Eastern 
Cape and Limpopo). All recorded data were transcribed verbatim. Thematic content analysis was used for 
data analysis. 
The initial phase engaged guideline developers who expressed the opinion that, overall, guidelines are an 
important means to ensure equitable and effective patient care and that the rigour of guideline 
development was improving. The study identified several factors which may negatively impact guideline 
credibility and implementability including inadequate human resources and funding for technical and 
methodological work; poor communication and coordination resulting in fragmentation between 
national, provincial, private and public sectors; lack of agreed development methods; poor management 
of potential conflicts of interest; and, insufficient consideration of implementation contexts. Participants 
felt these challenges could be mitigated by a committed guideline community working to reduce inequity. 
However, they thought improvements were currently being hampered by resource gaps which enable 
commercial or personal interests to drive development. Suggested solutions included national 
coordination of guideline activities which supports collaboration and transparency across sectors and 
disciplines.  
The next phase explored the experiences of guideline implementation.  Provincial and district managers, 
clinicians and trainers are supportive of guidelines as a tool for ensuring the delivery of quality healthcare 
services. They report having roles in guideline adaptation, implementation and evaluation but described 
feeling unsupported in these tasks.  Two significant themes arose in this study - health systems and socio-
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cultural-geographic factors. Health systems factors were financial constraints impacting access to 
guidelines and essential equipment/medicines; inadequate governance and audit capacity, and unclear 
accountability; insufficient skilled clinical staff; and, a need for interdisciplinary training and post-training 
mentorship. Socio-cultural-geographic factors considered to be important for improving guideline 
implementability were authentic consultation with end-users and implementers in the development 
stages to ensure feasible recommendations are made.  
The last phase explored perspectives of guideline use finding that healthcare providers, mostly nurses and 
allied healthcare providers, were knowledgeable about guidelines, generally trusted their credibility and 
were motivated to use them. Nurses reported that guidelines provide confidence and professional 
independence where doctors are scarce. Barriers to guideline use were inadequate hardcopy distribution 
and digital access; insufficient and substandard photocopies; linguistic challenges (e.g. complicated 
language, no summaries or local language versions); lack of support tools (e.g. posters); limited 
involvement in development impacting feasibility or acceptability of recommendations; and, patchy 
training and insufficient post-training supervision.  
Overall, the dissertation provides novel insights into the current state of primary care clinical guidelines in 
South Africa. The findings indicate that guidelines have the potential to strengthen primary health care in 
South Africa. The predominant view of guideline developers, implementers and users that guidelines add 
value to the health system creates a strong foundation from which to build. For further advancements the 
political environment needs to value and foster creativity, transparency and collaboration within and 
between guideline development and implementation groups to enhance guideline quality and 
acceptability.  
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Abstrakt 
Florerende primêre gesondheidsorg is een van die aanwysers van ’n funksionele gesondheidsorgstelsel en 
’n noodsaaklike voorloper van universele gesondheidsdekking (UGD). Die Suid-Afrikaanse regering het dit 
as ’n doelwit gestel om primêre gesondheidsorg te versterk en UGD in te voer. Binne die nasionale UGD-
strategie word riglyne vir kliniese praktyk beskou as instrumente waarmee bewysgebaseerde, 
kostedoeltreffende praktyk ondersteun word. Swak uitgewerkte riglyne kan egter juis die gehalte van 
pasiëntesorg belemmer; en indien dit nie behoorlik deurgevoer word nie, het dit geen uitwerking nie. Dit 
is die agtergrond waarteen hierdie proefskrif die rolspelers, prosesse, hindernisse en instaatstellers wat 
met die ontwikkeling, deurvoering en toepassing van riglyne verband hou, wil ondersoek en aanbevelings 
vir verbeterde riglyne vir Suid-Afrikaanse primêre sorg wil aanbied. 
Kwalitatiewe metodes is gevolg om rolspelers wat tot riglyne vir primêre sorg bydra, te betrek, vanoor die 
hele spektrum heen – vanaf die ontwikkeling tot die deurvoering en toepassing daarvan. Diepgaande 
onderhoude is met 37 nasionale ontwikkelaars en 22 provinsiale bestuurders gevoer, en sewe 
fokusgroepbesprekings is tussen Junie 2014 en Augustus 2016 met 47 gesondheidsorgverskaffers gehou. 
Die vier provinsies waaroor die navorsing gedoen is – KwaZulu-Natal, Wes-Kaap, Oos-Kaap en Limpopo – 
verteenwoordig uiteenlopende gesondheidsorgstelsels en sosiale omstandighede. Alle data op rekord is 
woordeliks oorgeskryf, en data-ontleding is aan die hand van tematiese inhoudsontleding gedoen. 
Die riglynontwikkelaars wat in die aanvangsfase betrek is, was wat van mening dat riglyne, in die geheel 
gesien, ’n belangrike manier is om gelyke en doeltreffende pasiëntesorg te verseker en dat die standaarde 
in riglynontwikkeling besig is om strenger te raak. Die navorsing het verskeie faktore uitgewys wat die 
geloofwaardigheid en uitvoerbaarheid van riglyne nadelig kan beïnvloed, byvoorbeeld onvoldoende 
menslike hulpbronne en befondsing vir tegniese en metodologiese werk; swak kommunikasie en 
koördinering, wat fragmentasie in nasionale, provinsiale, privaat en openbare sektore veroorsaak; ’n 
gebrek aan ooreengekome ontwikkelingsmetodes; swak bestuur van moontlike belangebotsings; en 
onvoldoende oorweging van die kontekste waarin deurvoering moet plaasvind. Volgens die deelnemers 
kan hierdie uitdagings getemper word deur ’n toegewyde riglyngemeenskap wat daaraan werk om 
ongelykheid uit te skakel. Nietemin reken hulle dat verbeterings tans deur gebrekkige bronne gekortwiek 
word, wat ’n gaping vir kommersiële of persoonlike belange laat om die gang van ontwikkeling te bepaal. 
Voorgestelde oplossings is onder meer nasionale koördinering van werksaamhede in verband met riglyne, 
wat samewerking sal ondersteun, en deursigtigheid en geloofwaardigheid oor alle sektore en vakgebiede 
heen. 
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Die volgende navorsingsfase het ondersoek hoe mense die deurvoering van riglyne ervaar. Provinsiale en 
distriksbestuurders, klinici en opleiers is ten gunste van riglyne as ’n instrument om te verseker dat 
gesondheidsorgdienste van gehalte gelewer word. Hulle rolbeskrywings sluit die aanpassing, deurvoering 
en evaluering van riglyne in, maar hulle voel dat hulle nie in hierdie take ondersteun word nie. Hierdie 
navorsing het twee duidelike temas opgelewer: faktore rakende gesondheidsorgstelsels en sosio-geo-
kulturele faktore. Faktore rakende gesondheidsorgstelsels is finansiële beperkings wat toegang tot riglyne 
en noodsaaklike toerusting of medikasie beïnvloed; ontoereikende bestuursbeheer- en ouditkapasiteit en 
onduidelikheid oor verantwoordbaarheid; onvoldoende opgeleide kliniese personeel; en ’n behoefte aan 
interdissiplinêre opleiding en post-opleiding-mentorskap. Onder die sosio-geo-kulturele faktore wat as 
belangrik vir verbeterde deurvoerbaarheid van riglyne beskou word, is egte beraadslaging met 
eindpuntgebruikers en deurvoerders, alreeds in die ontwikkelingstadiums, om te verseker dat die 
uiteindelik aanbevelings uitvoerbaar is. 
 
Die laaste navorsingsfase het perspektiewe op riglyntoepassing ondersoek en bevind dat 
gesondheidsorgwerkers, meestal verpleegkundiges en verskaffers van verwante gesondheidsorg, goed 
ingelig is oor riglyne, gewoonlik die geloofwaardigheid daarvan vertrou en gedrewe is om dit toe te pas. 
Verpleegkundiges was van mening dat riglyne vertroue en professionele onafhanklikheid bring waar 
dokters skaars is. Hindernisse wat riglyne betref is onvoldoende verspreiding van gedrukte weergawes 
sowel as onvoldoende digitale toegang; onvoldoende en minderwaardige fotokopieë; taalkundige 
uitdagings (bv. ingewikkelde taalgebruik en ’n gebrek aan opsommings en weergawes in die plaaslike 
taal); gebrek aan steunmateriaal (bv. plakkate); beperkte betrokkenheid by die ontwikkelingsfase, wat ’n 
uitwerking op die uitvoerbaarheid of aanvaarbaarheid van die aanbevelings het; en ongereelde opleiding 
en gebrekkige post-opleiding-toesig. 
 
In die geheel gesien, verskaf die proefskrif insig in die huidige stand van kliniese riglyne vir primêre sorg in 
Suid-Afrika. Die bevindings toon dat riglyne die potensiaal het om primêre gesondheidsorg in die land te 
versterk. Die oorheersende beskouing onder persone wat riglyne ontwikkel, deurvoer en toepas is dat 
riglyne waarde tot die gesondheidsorgstelsel toevoeg en ’n stewige grondslag vorm waarop voortgebou 
kan word. Met die oog op verdere vooruitgang moet die politieke omgewing die waarde van kreatiewe 
denke, deursigtigheid en samewerking binne en onderling tussen groepe wat riglyne ontwikkel en dié wat 
dit deurvoer, insien en dit bevorder ten einde die gehalte en aanvaarbaarheid van riglyne te bevorder.   
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Definition of terms 
Clinical practice 
guidelines (CPGs) 
CPGs are statements that include recommendations intended to optimise 
patient care that are informed by a systematic review of evidence and an 
assessment of the benefits and harms of alternative care options (Institute of 
Medicine, 2011). There are many synonyms for CPGs – in South Africa, we often 
use the term ‘Standard Treatment Guidelines’. 
Primary health care Primary health care is centred on the individual, the family and the community. 
The support they receive for treating and preventing disease, and for 
protecting, maintaining and improving their health is integrated across health 
and health-related sectors. These include housing, water, sanitation, 
agriculture, education, social welfare, environment, trade and commerce, etc. 
Within the health system, the health services provide the principal and most 
direct support to the community (National Department of Health, South 
Africa). 
Primary care  Primary care is first point of contact with, or the entry point into, the health 
system. Primary care constitutes the first level of care in a continuing 
healthcare process and would commonly be delivered at a clinic, health post 
or a private practitioner’s surgery. Primary care focuses on personal health or 
individual healthcare and is predominantly curative (or therapeutic), 
preventive and rehabilitative in nature (Health Systems Trust, Health Review 
2008). 
Universal health 
coverage (UHC) 
UHC is defined as ensuring that all people have access to needed health 
services (including prevention, promotion, treatment, rehabilitation and 
palliation) of sufficient quality to be effective while also ensuring that the use 
of these services does not expose the user to financial hardship (World Health 
Organization, accessed 21 April 2019, 
https://www.who.int/healthsystems/universal_health_coverage/en/).  
Primary health care 
re-engineering 
Enhancing primary health care through strengthening district managers. In 
addition to the district-management strengthening, this includes increasing 
ward-based outreach teams (community workers); integrated school health 
services and district clinical specialist teams (specialists that provide clinical 
governance including training). 
National Health 
Insurance (NHI) 
NHI is a health-financing system that is designed to pool funds to provide 
access to quality, affordable personal health services for all South Africans 
based on their health needs, irrespective of their socioeconomic status 
(National Department of Health, South Africa). 
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Essential medicines Essential medicines are those that satisfy the priority healthcare needs of the 
population. Essential medicines are selected with due regard to disease 
prevalence and public-health relevance, evidence of clinical efficacy and 
safety, and comparative costs and cost-effectiveness. 
(World Health Organization, accessed 21 April 2019, 
https://www.who.int/medicines/services/essmedicines_def/en/). 
Professional society A professional association (also called a professional body, professional 
organisation, or professional society) seeks to further a particular profession, 
the interests of individuals engaged in that profession and the public interest 
(Wikipedia, accessed 21 April 2019). 
Health-services 
research 
Health-services research is the multidisciplinary field of scientific investigation 
that studies how social factors, financing systems, organisational structures 
and processes, health technologies, and personal behaviours affect access to 
healthcare, the quality and cost of healthcare, and ultimately our health and 
well-being. Its research domains are individuals, families, organisations, 
institutions, communities, and populations (Lohr, Academy for Health Services 
Research and Health Policy, 2002). 
Health-systems 
research 
Health policy and systems research (HPSR) is a field that seeks to understand 
and improve how societies organise themselves in achieving collective health 
goals, and how different actors interact in the policy and implementation 
processes to contribute to policy outcomes. The objective is to promote the 
coverage, quality, efficiency and equity of health systems.  
(World Health Organization, accessed 21 April 2019, 
https://www.who.int/alliance-hpsr/about/hpsr/en/). 
Policy brief A policy brief is a concise summary of a particular issue, the policy options to 
deal with it, and some recommendations on the best option. It is aimed at 
government policy-makers and others who are interested in formulating or 
influencing policy (International Development Research Centre, accessed 21 
April 2019, https://www.idrc.ca/en/resources/research-tools). 
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Chapter 1.  Introduction and scope of work 
Background  
World Health Organization (WHO) member countries endorsed the 1978 Primary Health Care Alma Ata 
Declaration committing to developing primary health care as core national health policy (1). Primary 
health care, usually the first contact for people with the health system, aims to provide comprehensive, 
accessible, cost-effective care throughout a person’s life (1, 2). A functioning primary health care system is 
considered indicative of a strong health system and a necessary precursor to achieving Universal Health 
Coverage (UHC)(2, 3). The UHC definition aligns with that of primary health care as it aims to ensure that 
‘all people have access to needed health services, including prevention, promotion, treatment, 
rehabilitation and palliation, of sufficient quality to be effective while also ensuring that the use of these 
services does not expose the user to financial hardship’ (2-4). Ambitions for more countries to achieve UHC 
was re-iterated in the 2015 United Nations’ Sustainable Development Goals (SDGs) agenda for 2030 in 
which Goal 3, dedicated to ‘health and wellbeing’, specifies targets for UHC as one of the indicators of 
success (5).  Further, in 2018, the Alma Ata and SDG agenda for UHC were re-affirmed in the WHO and 
United Nations Children’s Fund (UNICEF) led Primary Health Care Declaration of Astana (6).  
 
However, despite clear  goals and several multi-national agreements over several decades, a 2017 World 
Bank and WHO report measuring UHC success stated that at least half of the global population does not 
yet access basic health services (7). Furthermore, in 2019, the WHO included ‘weak primary health care’ in 
their list of top-ten threats to global public health (8). How best to address this gap between the aspirations 
for healthcare excellence and the current reality is complex. It is likely that the effect of politics, power and 
the social determinants of health play a part (9-11).  In this complex situation, health-systems and services 
research on and about UHC is essential for taking the health agenda forward and stimulating the uptake 
of evidence-informed strategies (12). 
 
In South Africa, like other under-resourced settings, there is an urgent need to improve the quality of 
primary health care to ensure good use of the limited funds, equity of access, and better patient outcomes 
(13, 14). The National Department of Health (NDoH) has indicated that patient outcomes in South Africa 
are poor relative to other middle-income countries with a similar health spend of 8.5% of the GDP (15, 16). 
In addition, South Africa has an entrenched two-tiered health system, including a private health sector 
catering for less than 20% of the population, alongside a faltering public-health system responsible for the 
remaining, mostly poor, South Africans (3, 17).  
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In line with the global agenda, primary health care strengthening in South African is a political imperative. 
The national government has introduced several programmes to improve health-service delivery over the 
past two decades including ‘primary health care re-engineering’ which aligns with global views about 
district health strengthening by empowering district managers; district outreach teams (community 
workers); integrated school health services and district clinical specialists (specialists that provide clinical 
governance including training) (18). More recently, South African government policies have committed to 
a major re-structuring of the current health system through their UHC policy which will be funded through 
a National Health Insurance (NHI) mechanism (3, 18-20).  
 
Despite these strategies, primary health care in South Africa is faltering in its progress to achieve the goal 
of quality, integrated, patient-centred, accessible, affordable care and strategies are needed to aid 
progress (21, 22). In South Africa the new NHI policy outlines the challenges in the current health system 
and proposes overarching strategies to achieve UHC, but clarity on the specific steps to reach UHC is still 
a matter of debate.  What is emphasised is the importance of enhanced clinical governance and  treatment 
guidelines, also known as clinical practice guidelines (CPGs), are named tools for supporting evidence-
informed, cost-effective patient care (3, 23).  
 
High-quality CPGs bridge the gap between synthesised evidence, policy, context and patient choice . They 
are recognised as essential quality-improvement tools with a range of purposes including standardisation 
of care, informing funding decisions and improving access to care (24-28). CPG development and 
implementation activities have been evolving globally over decades. In order to understand the history, 
research and innovation in the CPG field, we published a literature review entitled Guide to clinical practice 
guidelines: the current state of play (25) [Appendix 1].  The review ‘collates findings from an extensive 
document search, to provide a guide describing standards, methods and systems reported in the current 
CPG methodology and implementation literature’. This narrative review informed my understanding of 
CPG research globally and re-iterated the evidence gap in research and methods development emanating 
from low- and middle-income country (LMIC) settings.  
 
Furthermore, understanding the landscape of CPGs globally, regionally and in South Africa has been 
informed by other CPG-related research in which I have participated. This includes the conduct of 
systematic reviews to inform WHO CPGs which provided insight into the process of CPG development 
undertaken by WHO (29-31). In 2010 we conducted an evaluation of WHO guideline processes and quality, 
a follow on from an earlier study in 2007 which criticised the WHO for their expert opinion based CPGs, and 
found improvements since the introduction of their Guidelines Review Committee and guidance manual 
(32, 33). We also evaluated CPG development quality using the AGREE II tool and assessed the credibility 
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of the content for five priority conditions in 14 countries of the Southern African Development Community 
(34) [Appendix 2]. We found that South Africa is a node of technical expertise in this field, with the number 
and quality of our CPGs exceeding that of our regional neighbours. Further, we identified the difficulty in 
the region and that a repository would be helpful for policy-makers, health managers and users (34). These 
findings were reflected in another cross-sectional analysis we conducted in which we mapped all of the 
CPGs in South Africa (35) [Appendix 3]. We found 171 CPGs had been disseminated since 2012 developed 
by many CPG contributors from both the private and public sectors, and at all levels of the health system, 
including Professional Association CPGs for specialists, hospital-level CPGs addressing specific contextual 
requirements, and the many NDoH CPGs  (35). In addition to contributions to CPG development, South 
African researchers are global leaders in CPG implementation research, conducting studies evaluating 
CPG uptake for common primary care conditions such as HIV, asthma and tuberculosis (36-41). 
 
Overall what is known in the field of CPG in South Africa is that South African policy-makers, academics 
and managers have been contributing to CPG development and implementation activities nationally, 
regionally and internationally for many decades. From a historical perspective, in South Africa’s new 
democracy in the 1990s, CPGs were perceived to be important vehicles to address inequity entrenched 
during the apartheid era. Taking a lead from the WHO, the Essential Medicine List and Standard Treatment 
Guidelines committees were established to enhance equitable access to medicines and other technology 
throughout the country, particularly in previously disadvantaged provinces (42). Through Essential 
Medicine List-informed CPGs, government aims to increase their national purchasing power, decrease 
costs and increase access to essential care (42, 43). This becomes increasingly important in the context of 
UHC and the need to have CPGs that are credible and integrated across sectors and levels of care.   
 
Therefore, despite innovative South African activities into CPG development and implementation for 
primary health care, there is room for improvement to reach global CPG standards (44, 45). In addition, 
information is lacking regarding the context and processes of CPG development, adherence to CPGs, and 
factors that improve their implementation, accessibility and use. This is particularly concerning when one 
considers the diverse contexts of care found across the country, and the limited resources available to 
underwrite South Africa’s commitment to the WHO’s call for ‘health for all’ (5, 46). Local research is 
therefore needed to better understand the continuum of CPGs from development, adaptation or 
contextualisation through to effective implementation and evaluation. Such knowledge may pave the way 
for better-focused and more effective and efficient interventions to improve healthcare outcomes. 
 
It was against this backdrop that a broader project was established - the South African Guidelines 
Excellence (SAGE) project (http://www.mrc.ac.za/cochrane/sage.htm) funded as a Flagship Awards 
Stellenbosch University https://scholar.sun.ac.za
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Project by the South African Medical Research Council (SAMRC-RFA-IFSP-01-2013/ SAGE). The overarching 
goal of the Flagship funding was to support large-scale, innovative, interdisciplinary research projects to 
address health problems in South Africa. I was the project principal investigator, and my doctoral research 
comprised a component of the overall SAGE Project research. 
 
SAGE was a multi-partner initiative to contribute to both understanding and improving standards and 
capacity for national CPG development, adaptation and implementation for primary health care (PHC). An 
outline of the project purpose is provided in an editorial we wrote (47) [Appendix 4]. The project consisted 
of several components. The five goals were: 
Goal 1: Mapping primary care CPG development players and processes 
Goal 2: Identifying and evaluating local CPG quality  
Goal 3: Exploring barriers to and facilitators for CPG implementation and use  
Goal 4: Development of an online CPG toolkit 
Goal 5: Capacity building for CPG developers and implementers 
 
Each Goal was led by a different research team. I was responsible for Goals 1 and 3 which used qualitative 
research methods and included my PhD research, alongside other research led by other researchers; Goal 
2, 4 and 5 (led by colleagues at the University of South Australia and Stellenbosch University) used a variety 
of research methods including systematic reviews, cross-sectional designs and qualitative research 
methods to address their research questions and capacity-building deliverables. The protocol included 
several research components for the overall SAGE project, including research which formed part of this 
thesis. Full details of the protocol are provided in Appendix 5. For more information on the project see the 
website: www.mrc.ac.za/intramural-research-units/Cochrane-SAGE 
Outline of doctoral research  
Aims 
To examine the players, context, processes, barriers to and enablers of South African primary care clinical 
practice guideline development, implementation and use; and to develop recommendations for 
enhancing primary care guideline development and implementation. 
Research question 
What are the current contexts, processes, barriers to and enablers of clinical practice guideline 
development, implementation and use for South African primary care? 
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Sub-questions 
• Who are the stakeholders involved with South African primary care CPG development and 
implementation; what is the context in which this is done; what are the processes used; and what are 
drivers for and barriers to CPG development and implementation?  
• What is the role of provincial government officials and district managers in receiving, adapting, 
disseminating and implementing primary care clinical practice guidelines in four provinces in South 
Africa? 
• What are the perspectives of primary health care providers regarding the barriers to and potential 
solutions for increasing use of primary care CPGs in South Africa? 
• What are the implications for policy and practice based on the findings of the research? 
 
The thesis includes three published manuscripts, one submitted manuscript and two online policy briefs 
summarising the findings.  An overview of the chapters as they relate to the research aim and sub-
questions is provided in Table 1.  
 
Table 1. Outline of the PhD thesis chapters 
Chapter No. Outline of research sub-questions and contents 
Chapter 1 Introduction and scope of work - this chapter outlines the background to the 
research including primary health care, universal health coverage and the role of 
guidelines in this policy context. It also expands on the current status of guidelines 
in primary health care service delivery and the health system in South Africa. 
Chapter 2 Paper 1 addresses the sub-question ‘who are the roleplayers in primary care CPG 
development and what is their perspective about the context, barriers to and 
drivers of CPG development and implementation?’  
Chapter 3 Paper 2 addresses the sub-question ‘what are national primary care CPG 
developer’s perceptions of the processes that should inform national CPG 
development, and their view of what is occurring in practice?’ 
Chapter 4 Paper 3 addresses the sub-question ‘what are the barriers to and enablers of 
primary care CPG implementation from the perspective of provincial and district 
implementers in four provinces in South Africa?’ 
Chapter 5 Paper 4 addresses the sub-question ‘what are the perspectives of CPG users 
working in primary care facilities in four provinces in South Africa about the 
barriers to and enablers of CPG use?’ 
Chapter 6 The policy briefs address the sub-question ‘what are the implications for policy 
and practice based on the findings of the research?’ 
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They are summaries of the evidence from the manuscripts. 
- CPG development: evidence summary about the perspectives of primary care 
CPG developers and their suggested actions to enhance CPG development.  
- CPG implementation and use: evidence summary about the perspectives of 
provincial, district health managers and primary care providers and their 
suggested actions to enhance CPG uptake. 
Chapter 7 Discussion and conclusion - this chapter reflects on the findings from all the 
studies and suggests key learnings, strengths, limitations and research gaps. 
Overview of methods 
The research was conducted using qualitative research methods. This approach enabled us to learn about 
the perspectives of the range of role-players involved with primary care CPGs from development to use 
(48-50). Using in-depth interviews with national developers and provincial managers provided insights 
into their individual views of the field of CPG development and implementation; whereas the focus group 
method used when meeting CPG users in primary care ensured that we could gather their joint stories and 
experiences, reflected in a clinic team where CPGs are part of patient care. Details about the methods and 
analysis are provided within the four manuscripts reported in Chapters 2 to 5. Reporting of the methods 
and analysis followed the Consolidated Criteria for Reporting Qualitative research (COREQ) (51).  
Study setting  
South African primary care and the health system 
The research is embedded within South Africa’s primary health care system, and specifically explores 
primary care (first point of contact) CPGs, rather than primary health care CPGs which address broader 
issues of infrastructure or planning for health-service delivery.  Details about South Africa’s primary health 
care system are given above and within each publication.  
Sample population 
We engaged 107 role-players involved with national primary care CPG development; provincial and district 
CPG implementation; and primary care health care providers involved with CPG use (Table 2). After initial 
interviews with national CPG contributors, we learned that there are discrete groups, with differing roles 
and responsibilities for primary care CPG activities, hence the sample includes three sub-groups:   
developers of national primary care guidelines; implementers in provinces and districts; and, guideline 
users/ healthcare providers in primary care facilities.   
 
Development: National CPG development role-players included the public, private sector and 
pharmaceutical industry representatives, however, we interviewed relatively few of the latter two groups. 
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Sampling was done purposefully starting with individuals known to be involved with national CPG 
development.  We then used a snowballing approach asking those we interviewed for suggestions of who 
else we should speak to. Following the initial 25 interviews, the research team suggested that our sample 
was weighted towards medical doctors and pharmacists and was not representative of all clinical 
disciplines involved with primary care service delivery who are likely to have CPGs. We therefore 
proceeded to purposefully identify and interview additional role-players to ensure a representative 
sample including all primary care disciplines (dentistry, nutrition, nursing, rehabilitation/allied health, 
pharmacists, medical doctors). It is notable that we interviewed more developers in richer provinces, 
which likely reflects the position of the largest academic centres that dominate policy formulation and 
research. 
 
Implementation and use: When exploring CPG implementation and use, four provinces were visited, 
KwaZulu Natal, Western Cape, Eastern Cape and Limpopo.  These provinces were chosen as they differ in 
population size and density, economic development, healthcare spend and resources, and health 
outcomes. While the Western Cape, Eastern Cape and Limpopo have similar population sizes, the Western 
Cape is better funded, and has higher educational levels, lower poverty levels and higher life expectancy. 
KwaZulu-Natal has the largest population size, a high poverty prevalence and poor life expectancy, despite 
health expenditure approaching that of the Western Cape. Other factors besides available funds, are likely 
to play a role in this regard, including a high prevalence of infectious diseases,  such as HIV and the urban 
to rural distribution of health services (52).  
 
Within each province we visited provincial offices and two districts representing rural and peri-urban or 
urban primary care facilities. We aimed to interview two to five managers in the provincial office, two 
district managers or trainers in each of the two districts visited and to facilitate two focus groups with 
primary care healthcare providers in the districts where we had spoken to the district managers. We used 
both purposeful and convenience sampling based on who was available for interviews and on 
recommendations of relevant role-players by the Provincial Research Management Offices. As the 
individual papers only present the specific sample population, to give an overall perspective, we report on 
the overall sample briefly described in the table below (Table 2).  
 
Table 2. Overview of sample population in the PhD thesis 
Stakeholder group Description of sample  
Developers: National  37 interviews 
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- Disciplines represented included medicine (19), pharmacy (5), nursing 
(4), allied health (3), dentistry (1), nutrition (2), non-clinical managers (3) 
- Provinces included Eastern Cape (1); Gauteng (16); KwaZulu-Natal (3); 
Western Cape (17) 
- Roles or sectors included National (10) and Provincial Department of 
Health (2); Professional Societies (6); private sector (pharmaceutical 
industry 1; and medical schemes 2) (3); academia (14); non-
governmental organisations (2) 
Implementers: 
Provincial and district  
20 interviews (22 participants) 
Previous clinical disciplines: nurses = 15, doctors = 7 
KwaZulu-Natal: 4 interviews (1 in province, 3 in district offices) 
Limpopo: 4 interviews (2 in province and 2 in district offices) 
Eastern Cape: 6 interviews (2 in province, 4 in district offices) 
Western Cape: 6 interviews (5 in province, 1 in district offices) 
Users: Healthcare 
providers 
7 focus group discussions (48 participants) 
KwaZulu-Natal: Doctor, nurses, quality assurance officer, dentist, 
physiotherapist, counsellors (n = 12) 
Limpopo: Dentists, oral hygienist, occupational therapists, physiotherapists, 
dieticians, counsellors, database administrator (n = 17) 
Eastern Cape: Nurses (n = 12) 
Western Cape: Nurses, dentists, health promotions officer (n = 6) 
Data collection and management  
Negotiating access 
Data collection took place between June 2014 – August 2016, starting with national developers, and 
proceeding with several trips to the provinces and districts. National developers generally had more 
autonomy to agree to participate than those in provincial roles. Provincial research is managed and 
monitored through the National Health Research Database (https://nhrd.hst.org.za/), and each province 
has their own Research Management Office. The processes and requirements of these offices delayed 
access in some cases. Provincial and district offices in the provinces had varying responses to requests for 
interviews. Some individuals were more familiar and comfortable with the process and value of research, 
while others were reluctant or, at times, suspicious of the purpose of the research, requiring multiple 
submissions of approval documents to gain access to them or their teams. We anticipated that the 
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province with greater research experience, the Western Cape, would be the most accessible, however, this 
was the last province to provide approval. Due to changes in job roles in their Research Management 
Office, we were only able to complete one focus group, rather than two in this province. 
 
Preparation for interviews and analysis 
To build relevant skills to conduct the planned qualitative research, SAGE hosted an in-house workshop 
on qualitative interviewing skills prior to recruiting participants. Furthermore, I completed a course 
offered for doctoral students on Qualitative research methods: Practical approaches to qualitative research 
in 2014 through a jointly offered Stellenbosch University and Karolinska University programme. I also 
attended the University College London’s Centre for Behaviour Change Summer School 2015: Behaviour 
Change – Principles and Practice. At the outset of interviews, I received mentoring from experienced 
qualitative researchers. All interviews were attended by two researchers. I was the observer on initial 
interviews progressing to lead most of the remaining interviews. There was peer feedback following 
interviews to improve practice and reflect on skills and learning. 
 
Interviews and focus group discussions 
In-depth interviews 
In-depth interviews were conducted in English with national developers and provincial health managers 
all linked with CPGs for primary care (Table 1). Data were collected using the semi-structured questions 
framework to elicit free-flowing information and ideas. Although guided by the discussion schedule, this 
was adapted iteratively as I discovered more about the research field and could therefore verify or clarify 
points made in previous interviews. The main intention was to elicit views regarding processes and context 
for CPG development, enablers of and barriers to CPG development and implementation, and to identify 
additional relevant role-players. The discussion schedule is provided in an appendix of the protocol 
[Appendix 5]. Interviews were usually conducted face-to-face, at the workplace or another convenient 
venue at the request of participants. Three interviews were conducted via skype or phone due to 
scheduling challenges or the participant’s preference.   
 
Focus group discussions 
Focus groups, with primary care healthcare providers, followed a similar approach to interviews in that 
they were held in English and included two trained researchers, a lead facilitator and observer (Table 1). 
Focus groups included more diverse participants, and although we held these in English, at times, some 
of the junior staff chose to answer in their mother tongue.  The few sections of non-English language text 
were translated by members of the research team. A focus-group discussion schedule is shown in the SAGE 
protocol [Appendix 5]. The guide was used initially, but adapted iteratively to reflect learning from earlier 
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focus groups and, ultimately, aimed to elicit the following from healthcare providers: What is your 
understanding of a guideline? What is process of guideline use? What are potential enablers of and barriers 
to using guidelines?  
Ethical considerations 
The Ethics Committees at the South African Medical Research Council (SAMRC) and Stellenbosch 
University provided approval (SAMRC ethics approval EC 002-2/2014; Stellenbosch University ethics 
approval N14/02/008). As the SAGE Project principal investigator, I was responsible for drafting the 
protocol with input and final approval from co-investigators. All participants provided signed consent 
prior to participation. 
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Chapter 2: Primary care guideline development: role-players, context, 
barriers and enablers   
 
Summary: This qualitative study explored perspectives of national guideline developers regarding the 
prominent role-players in national guideline development and the context for development and 
implementation of primary care guidelines in South Africa. Furthermore, the interviews explored the 
possible barriers to and enablers of guideline development and implementation.  We found that South 
African guideline development is led by national government but there is an active community of guideline 
developers spanning the private and public sectors. We found guideline development and implementation 
were hampered by a lack of financial resources for technical and methodological work; fragmentation 
between groups, and between national and provincial health sectors; and, a lack of agreed systems for 
CPG development and implementation. Some CPG contributors steadfastly work to improve processes 
aiming to enhance communication, use of evidence, and transparency to ensure credible guidance is 
produced. Many interviewed had shared values, and were driven to address inequity, however, resource 
gaps were perceived to create an enabling environment for commercial interests or personal agendas to 
drive the CPG development process. 
 
Publication citation: Kredo T, Abrams A, Young T, Louw Q, Volmink J, Daniels K. Primary care clinical 
practice guidelines in South Africa: qualitative study exploring perspectives of national stakeholders. BMC 
Health Serv Res. 2017;17(1):608. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575947/pdf/12913_2017_Article_2546.pdf  
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processes and contexts of clinical guideline development for South African primary care Health Systems 
Trust Conference 2016, Boksburg, Gauteng. 4-6 May 2016 (poster). 
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Abstract
Background: Clinical practice guidelines (CPGs) are common tools in policy and clinical practice informing clinical
decisions at the bedside, governance of health facilities, health insurer and government spending, and patient
choices. South Africa’s health sector is transitioning to a national health insurance system, aiming to build on other
primary health care initiatives to transform the previously segregated, inequitable services. Within these plans CPGs
are an integral tool for delivering standardised and cost effective care. Currently, there is no accepted standard
approach to developing, adapting or implementing CPGs efficiently or effectively in South Africa. We explored the
current players; drivers; and the context and processes of primary care CPG development from the perspective of
stakeholders operating at national level.
Methods: We used a qualitative approach. Sampling was initially purposeful, followed by snowballing and further
sampling to reach representivity of primary care service providers. Individual in-depth interviews were recorded and
transcribed verbatim. We used thematic content analysis to analyse the data.
Results: We conducted 37 in-depth interviews from June 2014–July 2015. We found CPG development and
implementation were hampered by lack of human and funding resources for technical and methodological work;
fragmentation between groups, and between national and provincial health sectors; and lack of agreed systems for
CPG development and implementation. Some CPG contributors steadfastly work to improve processes aiming to
enhance communication, use of evidence, and transparency to ensure credible guidance is produced. Many
interviewed had shared values, and were driven to address inequity, however, resource gaps were perceived to create
an enabling environment for commercial interests or personal agendas to drive the CPG development process.
Conclusions: Our findings identified strengths and gaps in CPG development processes, and a need for national
standards to guide CPG development and implementation. Based on our findings and suggestions from participants, a
possible way forward would be for South Africa to have a centrally coordinated CPG unit to address these needs and
aspects of fragmentation by devising processes that support collaboration, transparency and credibility across sectors
and disciplines. Such an initiative will require adequate resourcing to build capacity and ensure support for the delivery
of high quality CPGs for South African primary care.
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Background
Since the first democratic elections in South Africa in
1994, there have been many initiatives aiming to trans-
form the previously segregated and fragmented health
sector [1, 2]. These include integrating the public
health system at national level, shifting from racialised
to integrated health departments; introducing a re-
engineered primary health care (PHC) approach deliv-
ered through health districts; and, refocusing funding
to priority programmes such as immunisation and HIV
care [3]. Despite this, and the allocation of 8.5% of
gross domestic product (GDP) to health care provision;
South Africa’s health outcomes are relatively poor when
compared to other middle-income countries with simi-
lar GDP percentage expenditure on health [1, 3, 4]. In
the public sector, inequalities in healthcare delivery and
outcomes persist between urban and rural settings and
within and between provinces [5]. In response to this
inequality and the high burden of disease from commu-
nicable and non-communicable causes, and violence
and injury; the Minister of Health is driving forward
plans for universal health coverage (UHC), as described
in the National Health Insurance (NHI) White Paper
[6–9].
Quality of health service delivery must be of high
standard for UHC to achieve its intended goal [10–12].
Clinical practice guidelines (CPGs) are a common
knowledge translation tool in policy and practice, cov-
ering clinical decisions at the bedside, governance of
health facilities, health insurer and government spend-
ing, and patient choices. CPGs summarise rigorously
gathered evidence, distilled for use by healthcare pro-
viders to standardise and provide best-available care
[13, 14]. Within the range of operational tools available
for policy implementation, CPGs are recognised as cen-
tral to clinical service delivery [15, 16].
The South African government has introduced sev-
eral PHC quality improvement programmes, including
appointing District Specialist Clinical Teams (DSCTs)
to support services within health districts. The ‘Ideal
Clinic’ programme was initiated in 2013 to systematic-
ally consider and ensure adequate infrastructure, hu-
man resources, good governance and equipment for
primary care [8, 17]. This programme is governed by
specific clinical policies, protocols and CPGs, and aims
to involve stakeholders across government depart-
ments, the private sector and non-governmental orga-
nisations (NGOs) to address health and social needs. In
part, the intention is to integrate the preventative and
curative health services in a patient-centred manner
[18]. The ‘Ideal Clinic’, based on PHC principles, in-
cludes the Integrated Clinical Services Management
programme, which focuses on efficient, cost-effective
chronic disease management [17, 19]. In this context,
CPGs are specifically used as clinical training tools for
the DCSTs, and as part of clinical audit criteria to as-
sess a facility’s attainment of ‘Ideal Clinic’ status [17].
South Africa has long contributed to CPG develop-
ment with key players such as the National Depart-
ment of Health (NDoH), clinical professional
societies and NGOs producing guidance for their
respective constituents. In particular, the NDoH’s
Essential Drugs Programme has been producing guid-
ance documents since the mid-1990s to support
equitable use of medicines in the public sector.
Other research on CPG development has been con-
ducted in South Africa, in particular, exploration of
policy development processes for maternal health and
there has also been a quantitative evaluation of the
quality of CPGs for PHC [20–23]. What is lacking,
however, is comprehensive information on the pro-
cesses, context and challenges for PHC CPG develop-
ment and implementation in South Africa. The NHI
system will require agreement and integration across
sectors and jurisdictions, and national CPGs will
need to speak to healthcare needs of all to ensure
equal service delivery and redress of ongoing ‘fault
lines’ in the system [5]. This transition from the
current health system arrangement to NHI provides
a window of opportunity to explore the current ‘state
of play’ of CPG development and implementation in
order to inform NHI processes.
Currently, there is no available guidance on standard
approaches to developing, adapting or implementing
CPGs efficiently or effectively in South Africa. To ad-
dress this gap, the South African Guidelines Excellence
(SAGE) project was established as a multi-partner re-
search initiative aimed at setting in motion a
stakeholder-driven process to contribute to the under-
standing of standards of national CPG development,
adaptation and implementation [24]. The project con-
sists of several components, including a mapping phase,
development of an online CPG resource, and capacity
building opportunities for those involved in CPG devel-
opment, implementation and research. During the
mapping phase, a cross-sectional analysis of a sample of
16 PHC CPGs was completed, identifying the strengths
and gaps, in relation to global standards for CPG
reporting [23, 25]. We found that overall AGREE II
scores were poor to moderate, mostly due to poor
reporting of rigour of methodological approaches; ap-
plicability; and, editorial independence. These findings
are of concern as they may impact on the credibility of
South African CPGs. In this paper we examine these is-
sues in more depth by identifying the current role
players; drivers; and the context and processes of PHC
CPG development from the perspective of national
stakeholders [26].
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Methods
This research makes use of qualitative methods, drawing
on an interpretivist paradigm to explore national role
players’ experiences in the processes of developing and
implementing CPGs [26–28].
Research context
South Africa has a population approaching 55 million,
with a health system invested in primary healthcare and
district level ownership [8]. Fiscal federalism is in place
in which national government designs strategies, policies
and clinical CPGs; and provincial governments imple-
ment CPGs, sometimes after adaptation, to the levels of
healthcare from regional, district to community based
health centres [2]. Although government is responsible
for CPG development and implementation, many role
players contribute to CPG activities to fill clinical guid-
ance gaps, possibly duplicating, and possibly omitting
key health areas.
Sampling
Purposeful sampling began with consultations between
the research team and CPG developers known to have a
role in national CPGs [28]. Stakeholder groups included
the NDoH, academics and researchers, specialist profes-
sional associations, medical schemes, NGOs, and the
pharmaceutical industry. In addition, the five core
NDoH-endorsed primary care CPGs were identified:
Basic Antenatal Care, Integrated Management of Child-
hood Illness, the Essential Drug List (EDL) Standard
Treatment Guidelines for primary care and Primary
Care 101 (PC101), as well as a recently completed CPG
for Health Promotion and these were used to guide sam-
pling. We used a ‘snowballing’ approach in which a core
group of individuals actively involved with CPG develop-
ment or implementation in South Africa for primary
care were invited to participate; these individuals were
then asked to identify other ‘key role players’ for inclu-
sion in the sample [28]. During the course of the study
we recognised that some groups known to be involved
with PHC service delivery or linked with the endorsed
PHC CPGs had not been identified through snowballing.
At interim analysis, the sample was dominated by doc-
tors and pharmacists, thus, additional groups including
allied health, dentistry, nursing, and nutrition were pur-
posefully sought to fill gaps and achieve a satisfactory
degree of representivity [28]. Those interviewed occu-
pied senior managerial positions within government,
academic or organisations.
Data collection and management
Interviewers received training in semi-structured inter-
viewing techniques from a senior social scientist re-
searcher. All but one of the interviews were conducted
in pairs. Interviewers were all female and included vari-
ous professions including clinicians (medical doctors, al-
lied health professionals), social scientists and basic
scientists, all with previous interviewing experience, and
in analysis of qualitative data. The lead researcher,
present at most interviews, has experience, as a doctor
and specialist clinical pharmacologist, in using and
teaching CPGs. She is also known to some of those
interviewed and is involved with CPG activities at aca-
demic institutions and government which may have fa-
cilitated access to some interviewees, but could also
introduce response bias. For this reason, it was consid-
ered important to have two interviewers per interviewee,
one of whom who was not engaged in CPG activity, and
thus would have more distance so as to ensure
objectivity.
Invitations were emailed to potential participants
requesting a suitable time and venue for conducting
interviews. Participants were provided with informa-
tion sheets and consent forms prior to their interview.
We aimed to interview everyone in person, but four
participants requested telephonic interviews. Most par-
ticipants chose to be interviewed at their place of
work, with one exception who opted to do the inter-
view at home. Two of those invited referred us to other
colleagues to interview. None of those invited dropped
out or requested to withdraw once we started. Inter-
views lasted 60 min on average (ranging from 40 to
90 min). One interview was spread over two sessions
due to time constraints during the first meeting. Before
commencing, the focus of the project and purpose of
the interview were discussed, and consent was re-
affirmed, thereby ensuring that participants under-
stood clearly why they were selected, what the
interview was about and what their rights were. The
semi-structured interview guide (see Additional file 1)
was tailored to the experiences of each interviewee and
each interview built on the findings of previous inter-
views. In other words, as the interviews progressed, as-
sumptions, queries, and gaps in the evolving data set
were clarified through further data collection. Data sat-
uration was achieved prior to final interviews. The
additional 10 interviews were conducted to ensure a
representative sample and that no new themes
emerged.
Interviews were recorded using a digital recorder. All
interviews were transcribed by a third party, blind to
the aims of the study. Transcriptions were reviewed
for accuracy by members of the research team, but not
by those interviewed, making changes as needed based
on the audio files. Data is stored electronically on
password-protected computers; a masterlist and the
consent forms are stored in a locked cabinet to which
the study lead has access.
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Analysis
An iterative, thematic content analysis approach was used
[29]. A team of four, initially deductively, read the first 24
transcripts to develop a coding list, maintaining a focus on
the key research objectives, that is: players, process, con-
text, drivers and barriers to CPG development or imple-
mentation [26]. Once this coding list was developed, a
single researcher coded the remaining 13 transcripts inde-
pendently. Coding lists were categorised by identifying
common themes within the broad research question. All
preliminary findings were presented and discussed with
the team to verify further emergent themes at regular in-
tervals until all interviews and analysis were completed
(Additional file 2). A summary of the findings and emer-
ging themes were presented to the larger project team –
consisting of people who have experience in CPG develop-
ment, PHC service delivery, and the South African health-
care context - for validation.
Rigour
To ensure rigour [27], we initiated the project ensuring
the question was relevant. Our study may be of inter-
est to the national policymakers or other researchers,
and given the paucity of information on CPG activities
in middle or lower income settings generally, this may
have global relevance. We ensured validity through de-
tailed description of our approach to sampling, data
collection, data management, analysis. We considered
reflexivity as described in the methods and limitations
of the manuscript. The results are most transferable to
the South African context – where history and politics
have impacted on policy development. However, some
findings may be transferable to other developing coun-
try settings where transparency and CPG processes are
also in transition. There may also be transferability
within South Africa and learning from primary care
CPGs to other CPG development.
Ethics and reporting
The study was approved by the Research Ethics Com-
mittees of the South African Medical Research Council
(EC002–2/2014) and Stellenbosch University (N14/02/
008). All participants provided written informed con-
sent. Names of participants were anonymised, however,
it was explained to participants that despite efforts to
maintain anonymity, their opinions might be recognisable
in the reporting process. An opportunity for them to with-
draw before or during the interview was provided (none
took this opportunity), and to review how their opinions
were conveyed in the final manuscript (some took this op-
portunity). We referred to the Consolidated criteria for
reporting qualitative research (COREQ) reporting guide-
lines to ensure comprehensive reporting [30].
Results
Overall, CPG development is a complex web of interac-
tions between players and organisations, informed by
values, politics and power. Values reported include dis-
tributive justice, standardising care and equitable access
to medicines. The process for CPG production differs by
setting and group and is often poorly articulated. Silos of
guideline activity, both nationally and provincially, po-
tentially result in duplicated efforts for the often volun-
teer teams of technical experts. There is recognition of a
transition to more robust processes in some CPG devel-
opment groups. There is also recognition and accept-
ance of the need to improve further to align with
international standards; however, the financial and hu-
man resources are lacking.
We conducted 37 in-depth interviews with high-level
policymakers and CPG contributors from national and
provincial Departments of Health; professional societies;
for-profit groups including pharmaceutical industry and
medical schemes; university academics; funders and
technical advisors (Table 1).
Role players in CPG development
Public sector players
Those interviewed agreed that NDoH plays the central
role driving and developing guidance documents
through their various directorates, supported by part-
ners, including academic institutions, funders and tech-
nical advisors from multi-lateral organisations such as
the WHO and UNICEF.
Guidelines is a big national Department of Health role
… [INT06].
It’s the government who is pushing, the government
which defined the date, the approach and so on and
Table 1 Description of stakeholders sampled (37 total)
Background discipline Medicine (19), pharmacy (5), nursing (4), allied health (3),
dentistry (1), nutrition (2), non-clinical managers (3)
Provinces represented Eastern Cape (1); Gauteng (16); Kwazulu-Natal (3); Western Cape (17)
Sectors and stakeholder
groups
National (10) and Provincial Department of Health (2); Professional Societies (6);
Private sector (pharmaceutical 1; and medical Schemes 2) (3); academia (14);
non-governmental organisations (2)
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as part of development partners, we go there to help.
[INT23]
Within government there is a central programme devel-
oping CPGs particular oriented to the essential medi-
cines list which is linked with streamlining national
medicine and device procurement; and in parallel there
are disease or topic specific programmes, such as HIV,
tuberculosis, rehabilitation and nutrition, developing
CPGs, with potentially overlapping content.
In addition to the NDoH CPG development efforts,
medical schemes, professional societies, at times with
pharmaceutical industry support, NGOs, provincial hos-
pital or clinic level initiatives all develop CPGs where no
or limited guidance exists. Participants, generally aca-
demics from outside of government, suggested that their
role in CPG development emerged to address gaps in
clinical guidance, not covered by NDoH.
But then some of the smaller, neglected diseases don’t
have a directorate at the Department of Health or
whatever ... And so often those are undertaken by
professional societies [INT06]
Organisations like the TAC [Treatment Action
Campaign] that has driven the engagement and
enabled professionals to actually engage with
government and get good policies in place and develop
good guidelines [INT18]
Furthermore, while PHC providers such as nurses play
the central role in service delivery at PHC they are not
seen to be driving CPG activities nationally, and were
described as noticeably absent in leading roles except
perhaps in consultation processes or external review of
documents.
Private sector players
Private health insurance is an important player in clin-
ical care in South Africa. Funding of medicines and de-
vices is decided through advanced systems and
committees within each scheme. Insurers are governed
by the Council for Medical Schemes who develop the
prescribed minimum benefit packages - however, up-
dates to these have not been promulgated for more
than a decade. Some participants described how the
essential medicines programme should form the basis
of the prescribed minimum benefit and ideally, align-
ing private sector with national government.
Ultimately the view is to change the legislation with
regard to private health care to make sure that this
essential medicines list forms the basis of this
minimum benefit package and then you remove a
whole bunch of inequity out of this private health
insurance [INT11]
At the end of the day, as we go into an NHI, this
divide should not exist [INT14]
The pharmaceutical industry, another private player,
may contribute evidence to medical schemes, profes-
sional societies and government to encourage invest-
ment in their health technology. They provide grants to
support some professional society guideline develop-
ment. Beyond the guideline development they impact
pricing of medicines, and influence practice of clinicians.
We have over the years been very conscious of the role
and the influence of industry in shaping decision-
making, even within the various well-respected na-
tional societies [INT18]
Consulting end-users and external groups
Although NDoH aims to involve various sectors and
interest groups through workshops and consultation
during CPG development, the need for tangible engage-
ment from stakeholders was described as a key area for
improvement.
we had people from facilities, we had nurses at
different strata, you had unions and you had nurses
from facility level giving input to that scale-up plan
which is very specific and thus you can say a guideline
for getting your clinic to function optimally … we also
involve the civil society organisations, our donor part-
ners and the NGO’s that, we call them implementation
partners funded by the donor partners, and then other
government departments and also private sector orga-
nisations [INT27]
We tried, really tried by all means to involve all the
stakeholders because with just us alone we won’t be
able to, to reach you know everybody who really needs
to be involved in addressing that particular problem
… I do not think we have really found a better, you
know, a better mechanism of really, you know,
engaging the people who are, who are at the frontline
of implementation on how do you really want us to
package some of this document [INT37]
Values and drivers for CPG development
The dominant view expressed by participants was that
CPGs are valued for supporting delivery of standardised,
equitable healthcare, especially in the post-apartheid
South African context to ensure access for all to PHC.
CPG development was driven by the same complex in-
fluences as other health policies [31], despite different
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disciplinary and ideological backgrounds. According to
our participants the values included commitment to the
NDoH’s tagline “health for all” [INT04]; addressing his-
torical inequalities; and standardisation of quality and
cost-effective healthcare.
Driver: equity
The need for greater equity was raised in both public
and private sector interviews. As a function of govern-
ment, the NDoH’s Essential Drugs Programme, was
viewed as promoting change from the earlier fragmented
health systems arrangements and the principles of equity
of access to medicines [32].
the essential drugs programme basically brought
together all the formularies from the different
homelands throughout South Africa, and tried to
level the playing fields to make sure that there is
equity in the way medicines are made available and
accessible … So we don’t want that disparity between
provinces [INT16]
Contrary to this, the medical schemes legislative envir-
onment was reported to encourage competition rather
than collaboration which raised concerns regarding
how this may perpetuate inequity and inappropriate
spending.
And we need to make sure our policy is fair, transparent
and equitable within the context of the benefit designs
that are … there are a lot of anomalies in private
healthcare because it is hopelessly inequitable. Even the
legislation with regard to private health care coverage is
inequitable but we are sort of constrained within the
sort of legislative environment that we operate in. And
so we need to find a mechanism to be able to operate
properly within that [INT11]
Drivers: personal, fiscal or political interests
Although equity was a dominant driver, participants dis-
cussed the prevalence of personal, fiscal or political
values or agendas amongst academics, the pharmaceut-
ical industry or other commercial enterprises and inter-
national organisations. In addition, CPG development
was described as being driven by priorities of funders in-
cluding NGOs, international donors or industry for new
research or products.
One of the big issues … is who is driving its development
and why. And if you think about why people develop
guidelines, it’s actually the fact that a massive amount is
driven by industry, and then it’s driven by the needs to
some extent and personal interest to another extent.
[INT20]
Everybody brings a bias to the table and WHO is a
really sore point with a lot of our experts because
they’re writing policy for …. Africa right, they’re
writing public health policy ... If anybody should be,
we should be telling WHO what to do [INT08]
As CPG development is poorly funded, participants per-
ceived this as an opportunity for the pharmaceutical in-
dustry to fund development through unrestricted
educational grants, which in turn may undermine the in-
dependence and credibility of a CPG. However, this view
was not shared by all within academia and professional
societies, as in some cases limited funding and the needs
of constituents were valued above potential conflicts of
interest. It was also suggested bias was perceived as the
norm rather than the exception in CPG groups within
professional societies.
we are critically dependent on drug companies. No one
else is willing to fund guidelines. I mean, theoretically,
if one looked at it in its purest form, the department of
health should be funding all of this. They should be
intricately involved – we should all be doing it
together – but they don’t. They don’t at all [INT19]
Processes in place for CPG development
As we explored the deductive categories of players,
drivers, context and process of CPG development, sev-
eral sub-themes emerged including the perceived chal-
lenge of fragmentation of CPG development and
implementation processes; human skills and resource
shortages; and, gaps in standardised systematic methods.
Fragmentation: socio-political environment impacts CPG
processes
So all are little silos inside other silos [INT20]
Participants described fragmentation affecting both
CPG development and implementation, with most
expressing concern regarding inefficient use of lim-
ited human and funding resources. Fragmentation oc-
curred between national departments, between the
private and public sectors, between national and pro-
vincial departments of health, between provinces and
within provinces and districts.
Fragmentation impacts development
The fragmentation within government programmes,
and between the public and private sectors is de-
scribed as predominantly affecting CPGs production.
Silos within NDoH processes, where individuals work
in closed teams, not communicating effectively across
departments, teams or working groups, were thought
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to result in duplication, poor resource use and gaps
in recommendations. For example participants ex-
plained that directorates may produce parallel guid-
ance to that produced by another group or
professional society. Some participants described im-
proving coordination of CPG development processes,
however, not consistently or universally. The slow
progress in addressing known issues of fragmentation
was attributed to the limited capacity (administrative,
organisational) and inadequate financial resources
from central government.
There is nothing in the department of health that
will take on community acquired pneumonia
guidelines. Where does it fall? It doesn’t fall into any
directorate. So the societies have traditionally done
this [INT06]
Poorly coordinated national CPG development is per-
ceived to have knock-on effects as healthcare providers
receive conflicting guidance, in turn hampering
implementation.
Fragmentation impacts implementation
Participants described a disconnection between na-
tional and provincial government, suggesting this re-
sulted in CPGs which lacked legislative power to
enforce standardised implementation and impact ser-
vice delivery. These responses reflects South Africa’s
fiscal federal-oversight system, in which national gov-
ernment develops policies and provinces have inde-
pendence to implement [33]. This form of governance
may perpetuate disparity between provinces, however,
there is recognised complexity given that each prov-
ince has different infrastructure, governance strengths
and capacity to adapt and implement policies.
the whole national - provincial problem is a huge
issue that this country has to kind of sort out …
There is incredible frustration in that they [National
Department of Health] don’t have the power and the
provinces can kind of, they may say sort of set this
policy but they can’t enforce it and no one is
reporting, there’s no accountability [INT08]
Despite concerns about differences between provinces,
global best practice suggests that CPGs should be
adapted to local contexts. South African provinces have
vastly different contexts, including resources, cultures,
and infrastructure that require context-specific adapta-
tions. Thus, as expressed by some, there is an inherent
tension in trying to develop CPGs as national standards,
when needs might demand different regional or district
approaches.
Resource shortages: human capacity and time
Most participants expressed anxiety about lack of tech-
nical skills, dedicated time and funding for quality CPG
development. This perceived ‘insurmountable task’ was
thought to have a knock-on effects resulting in chal-
lenges with transparency and falling short of inter-
national standards.
I sympathize with the department on a lot of levels
because they don’t have the resources, they’re
constantly fighting fires but now it’s just not
appropriate anymore to have this, policy making
should be transparent, it should be thought through, it
should not be something done hurriedly [INT08]
As soon as you look at this process it becomes almost
insurmountable. Essentially, what is international
consensus on how it should be done, and then the reality
is that there’s just a mass of work to be done to combat
that load to be correct, even if you were just to perhaps
redevelop from scratch, which is something you should
probably do. And there probably isn’t the resources
either in-house, or even if you were to spread it out, to
get everything up and running at the same time [INT20]
Human capacity shortages
Of the limited human resources, medical doctors ap-
peared to dominate the national primary care CPG de-
velopment groups, followed by pharmacists; with other
disciplines working in parallel within different govern-
ment directorates. Nurses were generally not part of na-
tional guideline groups.
You know, there are very few people who can actually
develop the guidelines from nursing. Very few people
have that expertise – almost no one [INT18]
Many individuals interviewed mentioned that volunteer
clinical experts and members of guideline groups had
multiple roles over and above their usual positions. They
were often tasked with methodological work of search-
ing for, appraising and synthesising evidence. The same
experts may also be involved with CPG design and
implementations. Some recognised this as a weakness,
while others accepted this as the reality of low-resource
environments.
So they go through a lot of, it’s a lot of work, first of
all, people who are doing other jobs [INT06]
Lack of skills transfer in guideline groups
CPG development was seen by some as being dominated
by the same individuals often included in CPG panels
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over many years. Limited capacity was felt to be, in part,
a consequence of poor succession planning within
government.
I mean, you know, some of these folks have been
involved forever [INT08]
Some participants suggested that this hampered a hand-
over of skills. More inclusive CPG panels were desired
as an opportunity for ‘on the job’ capacity building, but
at times, experienced members were lost prior to new
members being adequately capacitated. Some partici-
pants were encouraged by the addition of new panel
members – which they viewed positively as allowing the
development of more transparent, inclusive processes.
Conflicts of interest: funding drives agenda
Participants suggested that when skills to conduct the
necessary technical work are deficient, groups with fi-
nancial or other vested interests, often linked with
pharmaceutical industry, may use the opportunity to
drive their interests for marketing their health technolo-
gies. A lack of capacity to synthesise evidence could re-
sult in a reliance on the industry for support.
Pharmaceutical players have resources to package evi-
dence or fund CPG activities. The implication is due to
the resource shortages described the industry may exer-
cise their influence.
Now that process is terrible because a lot of the
clinical colleagues do not have the skills to put an
evidence based discussion together, so that’s where a
lot of the conflict comes in. They get the industry to
write them [INT01]
Gaps: lack of systems for CPG development
No standardised processes for development
CPG development is not uniformly organised within the
different NDoH programmes.
It’s chaotic, it’s uncoordinated, it’s opaque [INT08]
Participants suggested some programmes had structured
systems while other programmes’ processes were per-
ceived as “ad-hoc” or “chaotic” or in the case of private
sector, guided by outdated protocols.
Well, I don’t know what happens. They seem to be like
a complete black box [INT03]
told by the minister, you know, like we need these
guidelines out immediately. And then you’ll get stuck
into it, and then there will be a new HoD [head of
department], and then there will be a new this and
there will be a new that. You know, the process is just
very, very chaotic locally [INT14]
For instance, like the PMB [prescribed minimum
benefit] guidelines, the algorithms are really a mess at
the moment. They were published 15 years ago or
whatever, and they are just a little one-pager with a few
little lines. And they were extensively updated five years
ago…. and they are still not promulgated. The private
sector is sitting in a vacuum because the medical aids
by law only have to fund to that level [INT18]
Some CPG development groups such as the NDoH
Essential Drugs Programme, established with good
intentions during the post-apartheid period, were
described as improving their processes over time; having
put in place rigorous CPG development approaches.
They were also criticised for poor communication and
lack of transparency in decision-making. This group has
explicit documents for ensuring interests are declared
and confidentiality respected [34]. What is not apparent
in the available documents is how transparency can be
improved and processes shared to build public trust.
Participants from outside government tended to have
less trust in the government processes due to unsatisfac-
tory experiences with trying to contribute to the CPGs
which seemed to lead to reluctance to buy-in from some
individuals and groups.
I mean the EDL seems like a very well-run process.
Now I mean I have issues with the EDL not being
transparent, I mean I think I would like to see mi-
nutes, I think as public sectors, you know, public funds
and that sort of thing, we’re entitled … [INT08]
And I think we have to really consider what the best
means is of documenting evidence and then sharing
that evidence in order to get buy-in [INT21]
Managing conflicts of interest
Our academic participants often held multiple roles,
both for government and their institutions. Those in-
volved with professional societies reported their desire
to collaborate with or be endorsed by government. Some
societies seemed to be successful in working with gov-
ernment or identifying independent funding to develop
CPGs, however, most were described to rely on pharma-
ceutical companies. Some members of professional soci-
eties were described as receiving funding from many
industry sources, but the processes for reporting or
managing these potential conflicts differed.
Everyone is going to have a conflict of interest, because
everyone is going to have to have received funding
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from someone for something ... So the answer is
probably yes, we should, but I think at the end of the
day it’s probably not practical [INT19]
Transition to better processes
Participants indicated that improvements are needed for
CPG development to meet global standards, however,
some reported that over the past 20 years there has been
slow but persistent progress and a shift to increasingly
transparent systems and methods for CPG development.
I think guidelines have come a long way, I think they’re
much more evidence based [INT06]
There’s a keen awareness that it could be done better
and that there should be some sort of debate [INT21]
The commitment of CPG developers to advance CPG
processes is an influential enabler of continued progress.
Implementation processes lag behind
Several participants complained that CPG implementa-
tion is lagging and requires additional specific skills and
adequate funding to ensure recommendations reach
end-users and contribute to improved patient outcomes.
in terms of guideline development there’s still a lot of
work that needs to be done, but in terms of
implementation there’s more work that needs to be
done [INT16]
For the most part, national CPG developers, had fewer
responses to questions regarding implementation, and
referred us to provincial players to explore this further.
Discussion
Global reporting for CPGs requires adherence to several
quality standards including a description of a clear scope
for the CPG; inclusion of all relevant stakeholders in de-
velopment; rigorous methods for finding and assimilat-
ing evidence; and ensuring conflicts of interest and
funders interests are recognised and managed [14, 35].
Yet there is evidence that South African CPGs fall short
of quality reporting standards [23, 36]. We sought to ex-
plore the reasons behind this through the perspectives
of national stakeholders regarding current processes,
drivers, enablers and barriers for primary care CPG de-
velopment. Our analysis suggests that the context and
processes for CPG development represent a complex
network of interactions, informed by values and power.
There are multiple stakeholders, across government de-
partments, healthcare disciplines, and sectors contribut-
ing to CPGs with varying skills and intentions. The
NDoH is the key role player in CPG development for
the public sector, with professional societies and other
organisations filling in gaps (i.e., topics where guidelines
do not exist, or in situations where guideline updates
have not been undertaken for a number of years). Des-
pite the common view that CPGs are valued for support-
ing delivery of standardised, equitable healthcare, there
is also a belief that CPGs may in some instances be
manipulated by commercial, personal or other interests.
CPGs aim to address health inequity as reflected in
the national policies and plans for PHC reform. CPGs
are specifically mentioned as useful tools to assist several
key programmes including the NHI and the ‘Ideal Clinic’
[15]. In light of the intended transition to UHC through
the proposed NHI funding system, private and public-
sector CPGs will need to be aligned to ensure equitable
access to quality healthcare services [7, 9]. In this con-
text, concerns were raised regarding the parallel private
and public healthcare system wherein private insurers
operate independently from national government. The
out-dated clinical protocols and Prescribed Minimum
Benefits packages mean that private sector funders have
freedom to drive healthcare decisions based on criteria
other than best evidence or cost-effectiveness. The
current proposal for NHI recognises this deficiency, and
proposes revision of the medical schemes Prescribed
Minimum Benefits and for health technology assessment
to underpin clinical recommendations [9].
Processes for CPG development in SA
The slow progress experienced in improvements in the
health system and the fact that issues like fragmentation
still persist has been highlighted in other health systems
research [5]. Despite the introduction of key health pol-
icy reforms [5, 37], historical issues like fragmentation,
human resource challenges and paucity of standardised
systems continue to hamper progress in all areas of
healthcare delivery [38]. Interviewees consistently re-
ported concerns about the fragmented health system
and its impact on CPG development and implementa-
tion. Fragmentation of CPG development may be under-
stood to reflect these longstanding weaknesses in
available systems resulting in opaque methods for CPG
development; possible duplication due to lack of central
oversight and communication between national CPG de-
velopment groups; under-resourcing of people with
specific skills to develop and implement CPGs; and, gaps
in feedback and communication systems between
stakeholders.
Several well-credentialed international groups have
developed standardised methods outlining key steps to
ensure trustworthiness of the final CPG [13, 39, 40]. We
found that no such guidance exists in South Africa, and
most interviewees described ad hoc processes, including
inadequate consultation, and poorly managed conflicts
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of interest which may result in biased CPG recommen-
dations, and diminished buy-in for CPGs [41]. These
deficits may, in turn, impact on implementation. Imple-
mentation particularly was an issue of the national-
provincial disconnect, however, only few of those
interviewed were closely involved with implementation
as this is largely the responsibility of provincial
government.
Lack of adequate Human Resources for Health is a
commonly reported problem in South Africa, particu-
larly in rural districts [2, 5, 42]. For CPGs, we found that
there is a limited pool of skilled contributors to CPG de-
velopment, who are often working voluntarily or for lim-
ited remuneration and are overburdened. The specific
technical skills gap identified includes capacity to syn-
thesise and incorporate evidence; regular communica-
tion on CPG processes with stakeholders; and design
and implementation for CPGs.
Limitations and strengths
Limitations of our study include potential for sampling
bias. Our sample is dominated by medical professionals,
many from Gauteng and Western Cape Provinces. Our
sample probably reflects the reality of skewed power dy-
namics in CPG development in South Africa, where
many who lead national knowledge production, and
therefore are able to contribute their voluntary time to
the process, may be based in the Western Cape and
Gauteng. To minimise and mitigate this potential bias,
we allowed for snowballing for any and all national con-
tributors to CPG processes; in addition, we purposively
sampled across all primary care disciplines. The skew
sample suggests that CPG development needs to become
more inclusive of different disciplines in different prov-
inces throughout South Africa. Another possible limita-
tion is response bias as those interviewed are all active
members in CPG development and likely to be positively
inclined towards the value of the work. Therefore, we
explored the players, drivers, processes and context ra-
ther than the perceived value of CPGs. Another potential
limitation is the impact of where researcher team mem-
bers are ‘situated’, their institutional affiliation, and per-
ceived credibility also called ‘positionality’ [31].
Positionality may facilitate gaining access to policy-
makers and discussion of sensitive issues and it may
allow for interpretation of nuanced cues, but may also
skew responses, similar to the Hawthorn effect [28, 31].
Generally one of the interviewers was from Cochrane
South Africa, a recognised specialist unit for evidence
synthesis. However, the senior experienced policymakers
and CPG contributors interviewed were thought to be
peer level to the interviewers and less likely to be influ-
enced by power dynamics commonly ascribed to inter-
viewer/interviewee relationships [28].
Our study also had several strengths such as the
teams’ prior training in qualitative interviewing; pre-
knowledge of the CPG context, augmented by speaking
to experts; the inclusion of members from different dis-
ciplines who could point to gaps in the process, thus en-
hancing rigour; and, reaching a range of participants,
including senior members of the NDoH.
What does it mean for SA CPG developers and development?
We found overwhelming commitment by those involved
and slow but consistent transition to improving systems
and processes. Commonly shared values regarding ad-
dressing inequitable clinical service through improved ac-
cess to medicines and care defined by good quality CPGs
may serve as an enabler to further processual improve-
ments. Based on our findings, we feel that the key areas
requiring attention include the need to reduce fragmenta-
tion by considering central coordination of CPG activities
with buy-in from public-private stakeholders and ongoing
communication between stakeholders already involved.
We recommend that this be underpinned by agreed na-
tional standards and processes for CPG development and
implementation, considering different provincial contexts.
Finally, we feel that resourcing of activities is key to de-
velop capacity to conduct methodological work, support
clinical recommendation decision-making using transpar-
ent processes and improve communication, dissemination
and implementation.
Conclusion
As South Africa transitions towards the NHI system and
the ideal of “health for all” there is an opportunity to re-
flect on lessons learned from PHC CPG contributors,
and build on global experience and knowledge. WHO’s
PHC Alma Alta Declaration states that PHC is a funda-
mental right and that ‘primary health care is essential
health care based on practical, scientifically sound, so-
cially acceptable methods and technology’ – in our con-
text, CPGs provide the bridge and process through
which this may happen [19]. However, South Africa is
among many countries with faltering progress in advan-
cing principles of WHO’s Alma-Ata for universal access
to PHC [19, 38]. The data suggests that the current par-
allel private-public health systems pose a substantial
challenge to uniform healthcare access. Participants de-
scribe commitment on the part of government, and
those who support government in their CPG endeav-
ours, to build collaborative, transparent, adequately
funded and staffed systems that foster communication
and encourage efficient use of the country’s scarce re-
sources. A national CPG coordination unit could assist
to develop credible, efficient structures to address the
challenges identified.
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Chapter 3: Primary care guideline development: processes for development 
 
Summary: This qualitative study was an in-depth exploration of the processes that underpin primary care 
guideline development including perceptions from national contributors regarding what they think should 
be happening and their descriptions of what the processes currently are.  
 
We identified six specific processes that should be strengthened to more effectively develop national 
primary care guidelines, these include: 1) use of evidence; 2) enhanced stakeholder consultation; 3) 
processes for transparency; 4) better management of interests; 5) enhanced communication/co-
ordination between guideline development groups; and, 6) consideration of the need for ‘fit-for-context’ 
guidelines applicable in provinces. 
 
Publication citation: Kredo T, Cooper S, Abrams A, Daniels K, Volmink J, Atkins S. National stakeholders' 
perceptions of the processes that inform the development of national clinical practice guidelines for 
primary healthcare in South Africa. Health Res Policy Syst. 2018;16(1):68. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069850/pdf/12961_2018_Article_348.pdf 
Related publications and presentations: 
At the SAGE Project start, we planned an editorial series for the South African Medical Journal outlining 
different aspects of guidelines and an overview of the project purpose: Kredo T, Machingaidze S, Louw Q, 
Young T, Grimmer K. South African Guideline Excellence (SAGE): What's in a name? S Afr Med J. 
2016;106(1):18-20. [Appendix 4] 
The remaining papers are available at: http://www.mrc.ac.za/intramural-research-units/Cochrane-SAGE    
 
Kredo T, Abrams A, Machingaidze S, Young T, Louw Q, Daniels K. Exploring current players, practices, 
processes and contexts of clinical guideline development for South African primary care Health Systems 
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Abstract
Background: There is increased international focus on improving the rigour of clinical practice guideline (CPG)
development practices. However, few empirical studies on CPG development have been conducted in low- and
middle-income countries. This paper explores national stakeholders’ perceptions of processes informing CPG
development for primary healthcare in South Africa, focusing on both their aspirations and views of what is
actually occurring.
Methods: A qualitative study design was employed including individual interviews with 37 South African
primary care CPG development role-players. Participants represented various disciplines, sectors and provinces.
The data were analysed through thematic analysis and an interpretivist conceptual framework.
Results: Strongly reflecting current international standards, participants identified six ‘aspirational’ processes that they
thought should inform South African CPG development, as follows: (1) evidence; (2) stakeholder consultation; (3)
transparency; (4) management of interests; (5) communication/co-ordination between CPG development groups; and
(6) fit-for-context. While perceptions of a transition towards more robust processes was common, CPG development
was seen to face ongoing challenges with regards to all six aspirational processes. Many challenges were attributed
to inadequate financial and human resources, which were perceived to hinder capacity to undertake the necessary
methodological work, respond to stakeholders’ feedback, and document and share decision-making processes.
Challenges were also linked to a complex web of politics, power and interests. The CPG development arena was
described as saturated with personal and financial interests, groups competing for authority over specific territories
and unequal power dynamics which favour those with the time, resources and authority to make contributions. These
were all perceived to affect efforts for transparency, collaboration and inclusivity in CPG development.
Conclusion: While there is strong commitment amongst national stakeholders to advance CPG development processes,
a mix of values, politics, power and capacity constraints pose significant challenges. Contrasting perspectives regarding
managing interests and how best to adapt to within-country contexts requires further exploration. Dedicated resources
for CPG development, standardised systems for managing conflicting interests, and the development of a political
environment that fosters collaboration and more equitable inclusion within and between CPG development groups are
needed. These initiatives may enhance CPG quality and acceptability, with associated positive impact on patient care.
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Background
Clinical practice guidelines (CPGs) have become a famil-
iar tool in policy and clinical practice. CPGs have a
range of purposes, intended to improve the efficiency
and cost-effectiveness of health system utilisation and to
decrease preventable mistakes [1]. They generally in-
clude statements of expected practice, benchmarks
against which individuals may audit and potentially im-
prove their practices, and guidance regarding undertak-
ing given tasks [1]. CPGs were historically built mostly
on expert opinion, which included variable (and often
selective) reference to research evidence [2–4]. However,
over the last decade there has been increased focus on
improving the quality of CPGs and the methodological
rigour of their development [5]. Globally, health system
pressures are increasingly demanding that resources are
effectively allocated and based on research evidence of
‘what works’ [6]. Within this context, there is growing
recognition that high quality, evidence-informed CPGs
can serve as practical vehicles for meeting these de-
mands and reducing the gap between evidence, policy
and best practice [1, 7].
This maturing CPG development culture is evidenced
by the various recent attempts made by well-credentialed
international collaborations to standardise and improve
the credibility of CPG development practices [8]. Between
2011 and 2013, three sets of standards were independently
proposed to assist CPG developers in addressing key is-
sues of quality, as follows: the Institute of Medicine intro-
duced 8 standards for guideline development [9], the
Guidelines International Network produced 11 relatively
similar standards [10], and McMaster University compiled
a checklist of 18 topics and 146 items to guide devel-
opers [1]. Concurrently, two checklists (the AGREE II
instrument [11] and iCAHE guideline quality checklist
[12]) were developed, both providing tools to evaluate
the process of CPG development and the quality of
its reporting. While there are differences between
these standards, they are unified in advocating for
CPG development to be guided by transparently con-
structed and evidence-informed approaches that have
a clear and applicable scope and are integrated with
stakeholder consultation [8].
Despite a growing knowledge industry centred on
CPG development, little is currently known about this
topic in low-resource settings generally and in
sub-Saharan Africa (SSA) in particular [13–15]. While
numerous studies in high-income countries (HICs) have
investigated the quality of CPGs and their development
methodologies in a variety of settings [16], very few of
these studies have been conducted in SSA. For example,
a systematic review evaluating 42 guideline appraisal
studies, including 626 guidelines published between
1988 and 2007, found only 6 guidelines across the
studies were from Africa [17]. Nevertheless, the situation
is beginning to change, with the topic receiving more
empirical attention in SSA over the last 5 years. For ex-
ample, recent quantitative reviews have evaluated the
quality of CPGs for priority diseases in SSA generally
[13] and in South Africa specifically [18]. Similarly, cer-
tain qualitative studies have provided analyses of the de-
velopment processes of guidelines for eclampsia
treatment and malaria control in 3 SSA countries [19,
20], as well as for maternal health [21], lay health
workers [22] and primary care [23] in South Africa.
This body of research in SSA has revealed many simi-
lar shortcomings in the quality of CPGs and their devel-
opment as those identified in studies in HICs, including
with regards to their methodological rigour, editorial in-
dependence and applicability to local practice [13, 18].
However, it has also shed light on certain unique,
context-specific challenges facing CPG development in
the region. For example, complex political environments
and interests, bureaucratic processes and budget strug-
gles, a lack of locally relevant evidence, and limited skills
have all been shown to hinder CPG development in SSA
[19–23]. Taken together, the findings from this small
body of research suggests that more knowledge is
needed on the specific circumstances, processes and pri-
orities underpinning CPG development in different SSA
settings, and the factors that could improve their con-
struction. This knowledge will help pave the way for bet-
ter focused, locally tailored and effective interventions to
improve CPG quality and development, and associated
positive impact on healthcare practices and outcomes in
the region.
Against this backdrop, the aim of the current study
was to explore national stakeholders’ perceptions of
current CPG development activity for primary health-
care (PHC) in South Africa. More specifically, it sought
to investigate their perceptions of the processes that
should inform national CPG development, and their
sense of what is actually occurring. This study is a
sub-study of a broader qualitative study that provided an
overview of the current landscape of PHC CPG activity
in the country [23]. This sub-study explores the issue of
CPG development in more depth, with a focus on the
perspectives of stakeholders operating at the national
level. Both the larger study and this sub-study form part
of the South African Guidelines Excellence (SAGE) pro-
ject, which aims to understand and improve the develop-
ment, adaptation, implementation and use of PHC CPGs
in South Africa [24].
Research context
CPGs have been part of South African clinical practice
for many decades. Formal national CPG processes were
put in place in the mid-90s in a bid to address historical
Kredo et al. Health Research Policy and Systems  (2018) 16:68 Page 2 of 14
Stellenbosch University https://scholar.sun.ac.za
inequity in health service delivery in the nine provinces.
South Africa’s National Department of Health (NDoH)
currently spearheads several primary care guideline pro-
grammes, including condition-specific guidelines (e.g.
malaria, HIV, tuberculosis) and the Essential Medicines
Programme, which develops comprehensive Standard
Treatment Guidelines for rational prescription at all
levels of care in an equitable, cost-effective manner.
Additionally, academic departments and professional so-
cieties develop CPGs, addressing gaps in what is avail-
able from NDoH.
Methods
This study adopted a qualitative approach to understand
the phenomena under investigation as experienced and
perceived by the actors involved. The methods have
been described in detail elsewhere [23], and thus a brief
summary is provided here, together with a more detailed
description of the analysis methods used in this paper.
Participants and data collection
The sample included 37 participants from a range of
disciplines, stakeholder groups and provinces in the
country (Table 1). Participants were approached in
their capacity as contributing to national South Afri-
can CPG development. Most were from academic
contexts and providing expert input to guideline
panels, many had been involved with this for more
than 15 years. Besides the government players, the
other participants usually held multiple roles, such
that, in addition to CPG development, some were re-
sponsible for research, clinical teaching and senior
management roles in academic or private sector con-
texts. Only one government member had a specific
role in CPG implementation. Data collection com-
prised in-depth individual interviews, conducted to-
gether by two interviewers per interview. The
interviews were based on a semi-structured interview
guide, including open-ended questions and tailoring
to the experiences of each specific interviewee. Key
themes explored included players involved in CPG ac-
tivity, CPG nomenclature and terminology, as well as
the processes, contexts and values underpinning CPG
development, adaption, contextualisation, implementa-
tion and use in South Africa.
Data analysis
The data for this paper were analysed through thematic
analysis [25] and the lens of an interpretivist conceptual
framework [26].
The larger SAGE project previously developed a list of
conceptual components (‘open coding’), guided by the re-
search objectives of the SAGE project. After immersion in
the transcripts, codes related to ‘CPG development’ within
the SAGE coding framework were used to code the tran-
scripts through multiple line-by-line readings and with the
aid of Nvivo10, a software programme that aids in the
management of qualitative data. Additional or revised
codes were developed iteratively as determined by the data
and added to the coding framework. Initial and revised
codes were then collated into potential themes and pro-
duced into an overall ‘thematic map’ to guide further ana-
lyses. Using the thematic map, the themes related to the
processes of developing CPGs were identified, named and
extracted. For each theme, the focus was on capturing
how the participants were making sense of CPG develop-
ment, and the values and concerns they attached to this
issue. While we focused on identifying common themes,
we also paid attention to the presence of potential diver-
sities in participants’ perspectives. Further analyses were
then undertaken to check if these ‘fitted’ in relation to the
coded extracts, to refine the specifics of each theme and
their relationships with each other, and to contextualise
these themes within the other emerging topics in the
dataset.
Throughout the analysis process, we attempted to ad-
here to the methodological principle of reflexivity [27].
At regular intervals SC, TK and KD jointly discussed
and further unpacked the emergent themes. Along with
facilitating verification, validation and refinement of
ideas, these discussions also provided opportunities for
the researchers’ interests and taken-for-granted assump-
tions to surface and subsequently be examined. Such re-
flexivity was facilitated further by the different roles the
researchers occupied in relation to the research, an
awareness of which provided for an illuminating inter-
play of emic–etic viewpoints. TK, KD and AA had
jointly conducted most interviews, both had prior know-
ledge of many participants and TK is involved with CPG
activities within academic and government settings. KD
and AA are social scientists, and had been involved from
project inception with planning, interviews and initial
analysis. KD has been involved with health policy
Table 1 Description of stakeholders sampled (n = 37) [23]
Background discipline Medicine (n = 19), pharmacy (n = 5), nursing (n = 4), allied health (n = 3), dentistry (n = 1), nutrition (n = 2), non-
clinical managers (n = 3)
Sectors and stakeholder groups National (n = 10) and Provincial Department of Health (n = 2), Professional Societies (n = 6), Private sector
(pharmaceutical n = 1 and medical schemes n = 2), academia (n = 14), non-governmental organisations (n = 2)
Provinces represented Eastern Cape (n = 1), Gauteng (n = 16), Kwazulu-Natal (n = 3), Western Cape (n = 17)
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analysis in another project. AA straddles social science
and quantitative research in her role at the Cochrane
Centre. SC became involved in the research only at the
analysis stage and had little prior knowledge of the local
CPG landscape. SC’s a priori unfamiliarity with the inter-
view content enabled the data to be explored openly and
with a ‘fresh’ perspective. Moreover, the interaction be-
tween researchers with both ‘distance’ and ‘closeness’
allowed for previous understandings to be opened-up
and questioned, and for our own positioning and associ-
ated shaping of the research process and outcomes to be
critically reflected upon.
Results
The analysis revealed six ‘aspirational’ processes that
participants perceived to be most important when devel-
oping CPGs for PHC in South Africa, namely (1) evi-
dence, (2) stakeholder consultation, (3) transparency, (4)
management of interests, (5) communication/co-ordin-
ation between different CPG development groups, and
(6) fit-for-context. We describe each process separately,
unpacking both participants’ aspirations and their views
of the extent to which each process is, in reality, under-
pinning the development of CPGs. To preserve anonym-
ity, certain phrases have been removed from quotations
and replaced with alternative text in square brackets.
Evidence
The concept of an ‘evidence-based approach’ featured
prominently in participants’ narratives. An overwhelm-
ing majority of participants, across stakeholder groups,
strongly emphasised that CPGs should be driven by sci-
entific evidence on the effectiveness, safety and
cost-efficiency of a clinical process or treatment. The no-
tion that CPGs “should be evidence-informed” (INT33),
“scientifically rigorous” (INT14) and “guided by the
current evidence-base” (INT25) was widespread, or as
one government participant succinctly stated: “The de-
partment stand is that whatever policies or guidelines we
develop are evidence based” (INT22).
A common sentiment, particularly amongst academic
and government participants, was that the development
processes of many national CPGs have evolved over
time, increasingly being informed by a more robust
evidence-informed approach. Many CPGs were de-
scribed as “coming a long way” (INT06) or having “over
time, become more and more evidence based” (INT4).
Whilst perceptions of progress were common, the need
for further improvement was also communicated. More
specifically, many participants expressed reservations
about certain CPGs in the country, and the extent to
which they are being guided by an evidence-based
approach.
Various reasons were provided for the inadequacies
participants saw with regards to the certain CPGs’ use of
evidence. Here, a lack of dedicated time and funding, as
well a scarcity of skills for quality CPG development
emerged as overriding themes. The interviews were satu-
rated with accounts of how those involved with CPG de-
velopment are often doing it voluntarily and afterhours,
and there is thus limited capacity to undertake the ne-
cessary methodological work:
“People are stretched… we all have full time jobs and
we’re doing it, not for money, not for kudos… so you
can’t expect the kind of rigor that you’d like to see”
(INT04, Academic)
Along with limited time and funding, many partici-
pants also highlighted how there is a dearth of skills in
the country for synthesising and incorporating evidence
in CPGs. Many spoke about the “lack of competent
people who are able to do this kind of work at a national
level” (INT03) and that “the distribution of people with
skills in evidence-based medicine… is quite a problem in
the country” (INT15).
The shortages of skills in evidence-based medicine
within the NDoH, in particular, emerged as a key issue
amongst government participants. Many attributed this
deficiency to what they perceived as inadequate, or even
non-existent, in-house training. As one participant put it
succinctly:
“We have also not been trained on the processes that
need to be followed”
(INT37, NDoH)
Similarly, another government official replied, when
asked whether he received training in evidence-based
medicine:
“No training, no training! You learn on the job… when
you see courses being offered… in most cases it’s out
of your own pocket because it’s outside of the HR
development planning process”
(INT22, NDoH)
Stakeholder consultation
There was considerable agreement amongst participants
and across stakeholder groups that widespread stake-
holder consultation also needs to form an essential part
of CPG development. Many participants spoke at length
about why this is critical. Along with serving as an
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important peer-review mechanism, widespread consult-
ation was seen as essential for facilitating ‘buy-in’:
“I think a key for any guideline is inclusivity. Because
if you want people to embrace your guideline, it’s
much easier if they were part of it than if you just
thrust it upon them”
(IN19, Professional society member)
Several participants felt that it is particularly important
to include the end-users of CPGs in consultation pro-
cesses to ensure that guidelines are “practical… at imple-
mentation level” (IN32), are “acceptable to those
implementing them” (INT22) and “so nurses understand
what you want to say” (INT05).
Many participants spoke about their own CPG devel-
opment processes as involving stakeholder consultation,
one which they perceived to be fairly wide and extensive.
Participants spoke about “our strategy of wide consult-
ation” (IN22), that “we are fairly meticulous about circu-
lating our guidelines to all organisations concerned”
(INT17) and that, ultimately, “Anybody who is on the
ground, who feel they have something to contribute here,
they will” (INT16).
While there was a tendency amongst participants to
describe their own consultation processes in relatively
positive terms, a more complex picture of stakeholder
engagement in CPG development also surfaced. This
emerged most prominently when participants talked
about their experiences with the development processes
of other CPG development groups. This also materia-
lised in certain participants’ narratives of their own con-
sultation processes, where certain reservations were
revealed.
Many participants spoke about various other CPG de-
velopment groups as comprising “a very non-consultative
process” (INT18) or as being “an authoritative entity, who
never… considers clinicians’ input” (INT17). Others de-
scribed the inherent unresponsiveness of certain CPG
groups, and their inadequacies in responding to people’s
input. As one participant said:
“The sense that we’ve had with all the people we’ve
engaged with is that you will send a lot of feedback to
the [particular CPG development group] but you’ll get
no formal response to any of your feedback”
(INT03, Academic)
This failure to provide adequate feedback was recognised
by certain participants with regards to their own consult-
ation processes. Many explained how there actually is a
very rigorous process for considering and incorporating
stakeholder feedback, and yet due to capacity constraints,
they are limited in their ability to adequately respond. As
one participant indicated, acknowledging that this is a
problem:
“People will give a comment, but when the book is
published they see that their comment hasn’t been
incorporated… it’s not that the committee didn’t
consider the comment… but because of capacity
constraints, we can’t respond to each and every
comment… but we’ve got to ask ourselves: how do we
make it more publicly available that we have looked
at your comment… without responding to each and
every person on each and every point?”
(INT16, NDoH)
Certain participants conveyed other reservations with
regards to their own consultation processes. Some ques-
tioned the level of inclusivity of their engagement pro-
cesses, highlighting the problems they have engaging
with particular groups. For example, many professional
society participants alluded to the struggles they encoun-
ter consulting with government:
“I think the process should be more inclusive… that
is certainly the weakness of our current situation.
But engaging with government is an extremely
difficult process… there are very, serious barriers of
communication with government”
(INT18, Professional society member)
Many other professional society participants shared
this participant’s view, providing similar accounts of how
“communication with the DoH has been shocking”
(INT19), and how “there should be an easier way for us
to engage government” (INT14).
Certain government participants alluded to the dif-
ficulties they experience around engaging with vari-
ous groups. Some felt that particular provinces,
other than the Western Cape and Gauteng, are hard
to engage with and ultimately remain weak in their
participation:
“I think there are weaknesses within the consultations
at provincial level… in a province like Western Cape,
it is done widely, but in other provinces, not really that
much”
(INT22, NDoH)
Other government officials felt that the end-users of
CPGs are another specific group that they have found
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hard to reach and are unsatisfactorily consulted, as
reflected by this participant’s comment:
“I don’t think we have found a better… mechanism of
really engaging the people who are… at the frontline of
implementation… I think a lot of programmes struggle
with what will be the best way of engaging the end users”
(INT36, NDoH)
Those participants who expressed uncertainties about
their own stakeholder consultations suggested various
aspects of the engagement process that might limit its
inclusivity. For example, some indicated that the process
tends to favour those who have the capacity to provide
written feedback and the ability to use the internet, as
depicted in the following two statements:
“So [a particular CPG development group] have…
collated a whole lot of emails and they send it
out and also make it available on the website…
but it just depends sometimes though, like nurses
in rural areas do not have the capacity to connect
online”
(INT33, Academic)
“The same usual suspects will give their comments
because that’s their comfortable way of engaging… but
there are other people who engage differently… maybe
they don’t want to write something so they may need a
different strategy”
(INT16, NDoH)
Relatedly, other participants suggested that the time
given to stakeholders to provide feedback is insufficient,
and may be an additional barrier to more widespread
and inclusive consultation:
“The consultation process doesn’t always look valid
because there wasn’t given time to comment”
(INT14, Professional society member)
Transparency
It was widely suggested that CPG development also
needs to be guided by a clear, transparent process so
people can understand decision-making processes. Many
participants spoke about the fact that “people need to see
the validity of the process” (INT01) and that “fair trans-
parency is a critical component of guideline develop-
ment” (INT23), or as one participant stated:
“I think the most important thing is that… we have to
have a very transparent, clear process… a level of
transparency that… someone can understand why
decision were made”
(INT08, Professional society member)
The dominant view expressed by participants in all the
stakeholder groups was that CPG development in the
country tends to lack sufficient transparency. Descrip-
tions were commonplace about how CPG construction
processes are “very untransparent… completely opaque
to everybody” (INT14), “a complete mystery” (INT3), or
as described by one participant:
“I have issues with the [particular CPG development
group] not being transparent… what we need is to
make that process visible, because it’s actually, they
have terms of reference, they have criteria, they go
through a very evidence-based process”
(INT30, Academic)
Like this participant, many other participants conveyed
a sense of trust in the rigour of various CPG develop-
ment processes, and yet perceived there to be a signifi-
cant gap in the documentation and sharing of the logic
behind the decisions. Many suggested that there is a
need for greater communication about exactly how the
process unfolded, so that people can better appreciate
the credibility of CPGs:
“I think the communication… there’s a lot of
misconceptions… but just talking to people and telling
them, okay, this is how we do it, then they get the
insights… that there’s a rigorous process”
(INT16, NDoH)
Not many participants provided reasons for why the
process is not as transparent as it should be, despite
probing by interviewers. The few that did reflect on this
issue suggested, once again, that limited time and fund-
ing was the cause, with stakeholders lacking the capacity
to adequately record and elucidate decision-making
processes:
“So there is an awful lot of work going on… but not a
lot of capacity to engage in a very clearly documented
and open process… but we do need to consider what
the best means is of documenting evidence and then
sharing that evidence in order to get more buy-in”
(INT21, Academic)
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Given that few participants provided details on why
transparency is an issue, it is unclear whether this view
is shared by others.
Management of interests
A few participants stated explicitly that the declaration
and management of interests need to form a key aspect
of CPG development, so that decision-making processes
are not influenced by inappropriate forces:
“Your governance has to be clear… people have to
know… what interest they need to declare, what
information they need to keep confidential… and the
reason… is because we don’t want undue influence on
our decision-making processes”
(INT16, NDoH)
Although not overtly stated in most cases, many par-
ticipants clearly conveyed the view that vested interests
need to be considered and managed when producing
CPGs. The interviews were replete with descriptions of
people’s conflicts of interests and the role these are play-
ing in CPG development. Participants spoke about these
interests as being both personal/intellectual and finan-
cial. In terms of the former, many described in detail the
“personal agendas” (INT5), “little hobby horses” (INT6)
and “vested interests” (INT14) people involved with CPG
development across the board have:
“There’s a whole lot of politics… we have all these
competing interests… even us sitting at the university…
we have these different groups that have their own
agenda… to defend their turf”
(INT25, Academic)
More specifically, many participants described how in-
dividuals developing CPGs may be involved with specific
programmes or research projects, and often push for
guidelines to incorporate these. As articulated by this
participant:
“There’s a lot of individuals or research institutions
pushing their own agendas… like those on drug
development, clinical trials… the expectation is that
you would change your policy based on that… and it
creates problems for us in terms of determining what
should be in the guidelines… we’re put under pressure”
(INT22, NDoH)
Numerous participants provided analogous ac-
counts, similarly highlighting the problems they have
around managing personal interests. Certain partici-
pants also expressed uncertainty about how these
agendas can and should be managed, as communi-
cated by this participant:
“We talked about this… how we probably need to also
disclose grant conflicts of interest because if you’re
sitting on a study that is, you know, if you change [the
policy], your study is not going to continue, right?…
But, then everybody has some sort of bias, so I don’t
know what the ultimate answer is, like how do you
make this so completely transparent”
(INT08, Professional society member)
In addition to interests of a personal or intellectual na-
ture, many participants were also particularly concerned
about financial interests and the fact that a “massive
amount” of guidelines are “driven by industry” (INT20).
As aptly revealed by this remark:
“My colleagues… they don’t see the harm if industry
comes and does this. You know, it’s so insidious…
they’re doing subliminal advertising, and people don’t
get how that can influence how you make a decision”
(INT16, NDoH)
When talking about the pervasiveness of financial in-
terests, many participants were particularly worried
about professional society groups in this regard. Com-
ments about such groups having “lots of apparent influ-
ence of industry” (INT21) and “being influenced
tremendously by industry” (INT18) were ubiquitous,
along with descriptions of how professional society
CPGs are “essentially drug company driven” (INT19).
Many participants also questioned the sufficiency of the
extent to which the financial interests operating amongst
professional societies are being managed:
“In many instances, if not most instances, there is no
process to deal with potential conflicts of interest”
(INT15, NDoH)
Certain professional society participants themselves
expressed analogous concerns, with some conveying
similar apprehensions about the presence and inad-
equate management of financial interests within their
own societies. As one member acknowledged:
“It depends on the integrity of the individual… you
know, I think it’s very glib now, the declaration of
conflict of interest. It goes up in the first slide and you
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don’t even see it. Here’s my title and here’s my conflict
of interest. It’s very glib”
(INT18, Professional society member)
In a similar manner, when asked directly about his ex-
periences of conflict of interests within his own society,
another participant explained:
“I’m trying to remember… whether we actually had to
declare a conflict of interest. I don’t think we did”
(INT19, Professional society member)
This participant went on to articulate why conflicts
were not declared within his society, outlining some
of the difficulties in this regard. According to him, it
would be “too numerous” as “everyone is going to have
to have received funding from someone for something”.
He explained that “all those would all have to be de-
clared … which would take the first four pages of the
guideline”. He indicated further that “if you try and
put too many rules in place”, you will ultimately cre-
ate a hindrance to CPG development, or as he put it:
“It then trumps people’s desire to actually do the
guidelines”.
Thus, while most participants felt that management of
interests is a key activity for CPG development, certain
stakeholders had a different perspective. As with the par-
ticipant above, some questioned the value as well as the
practicality of declaring and managing conflicts of
interests.
Communication and co-ordination between CPG
development groups
Various participants stressed the importance of commu-
nication and co-ordination between different CPG devel-
opment groups, suggesting that “those writing guidelines
must speak to each other” (INT37) and that “there’s got
to be absolute linkage between programme guidelines”
(INT27). This was identified as essential for ensuring
“harmony between guidelines” (INT03) and that “we
don’t give confusing messages to practitioners” (INT15).
Many participants felt that it is particularly important
for CPG developers to communicate with the Essential
Drug List (EDL) committee, as exemplified by this
comment:
“If I was redesigning the system, I would have a…
process for guideline development that has a clearing
house effect that goes through the EDL, who then
issues it”
(INT14, Professional society member)
There was much consensus amongst the participants
that, in reality, communication and coordination be-
tween different CPG development groups is noticeably
absent. The general picture that emerged was one of
fragmentation, whereby a diverse range of groups are de-
veloping CPGs relatively independently of each other.
Many described this disconnect as occurring between
the private and public sectors:
“Private, they do their own thing, only… where they
don’t have a choice… or where they absolutely
don’t know, only then do they then refer to the other
guidelines”
(INT06, NDoH)
Other participants spoke about divisions within the
NDoH and the lack of communication across govern-
ment departments. CPG development processes within
the NDoH were referred to as “siloed in a way that
there’s not really good communication” (INT08), “dis-
jointed pockets of activities” (INT15), or as one partici-
pant proposed:
“There is a two-parallel process from the department
of health, and the one side is the formal process and
on the other side you’ve got stroke management,
malaria management, HIV management… so all are
little silos inside other silos”
(INT20, NDoH)
At the same time, many participants felt that some,
but not all, CPG development groups are communicat-
ing with the EDL, or as two participants put it “commu-
nication is stronger with some programmes than with
others” (INT37) and “often programmes haven’t checked
the EDL” (INT20). This view was shared by a member of
the EDL committee who, when asked whether CPGs are
being circulated through the EDL, responded:
“It doesn’t happen with all national departments. So
[particular government department], yes, but I’m still
struggling to get [particular government department]
to send their guidelines to us for peer review”
(INT17, Academic)
This lack of communication between CPG developers
was perceived to result in the replication of guidelines
and a duplication of work, or in the words of one par-
ticipant: “discrete pockets of people reviewing the same
data” (INT11). It was thought to also give rise to contra-
dictions between CPGs, with “a whole host of conflicting
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recommendations across the different guidelines”
(INT03) and guidelines that “don’t fit together… to make
a coherent whole” (INT02).
Some participants attributed this situation to a matter
of timing, suggesting that CPG inconsistencies are re-
lated to the fact that different CPGs are developed and
updated “according to different schedules” (INT37) that
are “not always in sync” (INT15). However, other partici-
pants conceived the problem to be of a more political
nature. That is, it was suggested that the difficulties stem
from the complex relations of power and control that
exist within the CPG development arena in the country,
as one participant proposed:
“There are lots of interest groups competing for control
of this, and that’s why partly it hasn’t been cohesive…
The department of health, because they are in the HIV
field, I think wants to keep some of that to themselves.
The TB people wanted the TB to themselves… there’s
just lots of competing interests around these things.”
(INT14, Professional society member)
Fit-for-context
A final issue that featured prominently in the interviews
was the need for CPGs to be contextually relevant, and
thus the necessity that CPG developers think about
“what is suitable for our context” (INT01) and “is this
relevant to our situation” (INT37), or as specifically
stated:
“We feel guidelines need to be relevant to South Africa,
I mean, our situations are different and our cost
constraints are different, and it has to be relevant”
(INT18, Professional society member)
When describing CPG development processes, there
was considerable agreement amongst participant groups
that most CPGs in the country draw heavily on inter-
national guidelines and what is being recommended glo-
bally, particularly by WHO:
“In most cases guidelines are guided by the WHO
recommendations”
(INT22, NDoH)
Although there was widespread consensus that CPGs
in South Africa are usually based on what is being done
and advocated for internationally, there were divergent
views amongst the participants about the use of this ap-
proach. Some were critical of this tendency, suggesting
that we should not be relying on other sources to do the
methodological work of CPG development:
“I would say there’s an over reliance on other
guidelines without looking at the primary evidence”
(INT37, NDoH)
Other participants expressed frustration with the dom-
inance of global discourse, and the pressures they feel to
conform to these. This was aptly conveyed by one par-
ticipant who lamented:
“WHO is a really sore point with a lot of our experts
because they’re writing policy for Africa… I mean we
do not lack technical expertise… and we have the
evidence… I think our experts should be the ones
driving the decisions”
(INT14, Professional society member)
In contrast to these perspectives, other participants
supported the widespread use of international guidelines
when developing local CPGs. Here, the common view
was that it is unwarranted to repeat the work already
done by other, well-respected organisations:
“It’s not necessarily developing all the guidelines from
scratch… because if it’s there, why reinvent the wheel”
(INT25, Academic)
Many participants shared this view, yet suggested fur-
ther that international CPGs should be used but a process
of contextualisation should ensure the “critical appraisal
of international guideline” and “local adaptation” of these
so they suit out local circumstances (INT37). As two pro-
fessional society participants explained:
“What I have been pushing for a lot is to say, take
the WHO guidelines… and then adapt them to South
Africa”
(INT14, Professional society member)
“What we want to do, [which] we haven’t always
historically done… is we need to take WHO as the
starting point, the baseline and then adapt from there”
(INT08, Professional society member)
As suggested by these two participants, and sharing
the views of other participants, the process of adapting
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international CPGs is currently limited, something which
was perceived to be a key area for improvement. How-
ever, there were some participants who indicated that
they do undertake such a process, stating, for example,
that “we use international ones and then adapt for this
context” (INT25) or that “a lot of it is based on WHO
recommendations and then we decide whether it is suit-
able for our context” (INT30). Despite considerable
probing, details of exactly how this process of appraisal
and adaptation is undertaken was difficult to gage, with
participants providing little information in this regard.
While the importance of local relevance was widely
emphasised, the majority of participants indicated, sim-
ultaneously, that CPGs should not be adapted for con-
textual difference within South Africa. With one
exception, all participants emphasised strongly that “we
don’t want disparity between provinces” (NT16) and that
“you can’t have a different standard for Limpopo [poorly
resourced province] and for the Western Cape [well-re-
sourced province]” (INT04). In justifying this view, many
participants explained how the overriding objective of
post-1994 CPGs is to promote justice and ensure every-
one has access to the same standard of care, so as to re-
dress the historical inequities instigated by the apartheid
regime. Thus, according to them, adapting CPGs for
inter-provincial contextual differences would be going
against the very socio-political role CPGs are meant to
play in the country. However, one participant, a govern-
ment official from Kwa-Zulu Natal, had a contrasting
perspective, explaining how South African provinces
have vastly different resources, cultures and infrastruc-
ture, and that a failure to accommodate these diversities
could have dire consequences:
“Our needs might not necessarily be the exact same
as other provinces… and sometimes you find that a
national guideline is… not tailored for the province…
and the moment you say you must without considering
the situation in the province it will make a situation
worse, it won’t help us”
(INT32, NDoH)
Discussion
This paper explored national stakeholder participants’
perceptions of the processes informing CPG develop-
ment for PHC in South Africa, focusing on both their
aspirations and sense of what is occurring ‘in reality’.
While the analysis sought to identify common themes, it
also paid careful attention to potential divergences in
perspective.
The findings revealed considerable agreement amongst
participants about the processes that should inform CPG
development in the country. While there were differences
in the relative importance given to each of the six aspir-
ational processes identified, all were highlighted as import-
ant by the 37 participants. These processes strongly reflect
current global standards regarding guideline development,
and their emphasis on inter alia use of evidence, stake-
holder involvement, transparency, applicability and editor-
ial independence/managing conflict of interest [1, 9, 10].
The importance of ‘evidence’ was a particularly prominent
theme. This widespread culture of evidence-based medi-
cine amongst our respondents, and similarly revealed in
other policy development studies in South Africa [21, 28],
stands in sharp contrast to the literature describing a lack
of access to and awareness of evidence in many low- and
middle-income countries [29, 30].
Another theme that featured strongly in the partici-
pants’ narratives was the importance of CPGs to be ‘fit
for context’. While there were divergent views about the
pervasive use of international guidelines, and evident
tensions around whether CPGs should accommodate
provincial differences, the imperative to consider ‘con-
text’ when developing CPGs was a common viewpoint.
There is growing interest within the international CPG
methodology literature in ‘contextualisation’, with various
frameworks recently developed to guide the adaption of
CPGs developed in one country to other settings [31,
32]. However, these approaches tend to be designed for
the reconfiguration of CPGs to new, but contextually
similar, settings [5, 33]. They thus provide little guidance
on how CPGs might be transferred across settings with
different healthcare policies and contexts. The Filipino
CPG implementation project [33] and Practical Ap-
proach to Lung Health in South Africa initiative [34] are
examples of the few attempts that have been made to
develop practical approaches for contextualising CPGs
developed in HICs to low- and middle-income countries.
More of these kinds of initiatives are clearly needed, as
evidenced by participants’ uncertainty in this present
study around how to adapt CPGs developed in HICs for
effective use in South Africa.
A particularly noteworthy finding from this study was
the chasm between participants’ aspirations of how
things ‘should be’ and their views of how things are ‘in
reality’. While many spoke about a transition towards
more robust processes, the general view was that CPG
development still faces significant challenges with
regards to all six aspirational processes highlighted.
Across all six thematic areas, there were suggestions for
how best to bridge the gap between what is, and what
should be happening, in CPG development processes;
we explore these suggestions in another paper [23]. Con-
curring with other guideline development research in in
SSA [19–23], many of the problems identified were at-
tributed to a lack of financial and human capacity. More
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specifically, the paucity of dedicated time, funding and
skills for CPG development was perceived to hinder the
methodological work of synthesising evidence, effectively
responding to stakeholders’ feedback, and transparently
documenting and sharing decision-making processes. A
lack of resources is not a unique issue affecting CPG de-
velopment in South Africa. Despite the introduction of
key health policy reforms, human and financial resource
challenges continue to hamper progress in all areas of
healthcare delivery [35]. The findings in this paper sug-
gest that, like in other areas of healthcare, there is a
need for greater dedicated resources for CPG develop-
ment to build capacity and support for the delivery of
high quality CPGs in South Africa.
In addition to resource limitations, our findings sug-
gested that current challenges facing CPG development
are also intimately linked with the complex web of polit-
ics and power operating within the CPG arena in the
country. For example, the fragmentation within govern-
ment programmes and between public and private sec-
tors was attributed, in part, to issues of control and
ownership. Different groups were described as interested
in maintaining their authority over specific territories,
thus sabotaging efforts for collaborative CPG develop-
ment work. As proposed elsewhere [23] and supported
by this study, a possible way forward would be for South
Africa to have a centrally coordinated CPG unit with
buy-in from and communication between public and
private stakeholders. It would be important for this unit
to help foster a political environment that promotes col-
laboration and integration between different CPG devel-
opment groups.
Simultaneously, the CPG arena was seen to be satu-
rated with personal, financial and political vested inter-
ests, and lacking processes for reporting and managing
these. The issue of conflicting interests is not unique to
South Africa. Globally, many guideline development
groups fail to adequately disclose and manage conflicts
of interests [36, 37]. Most certainly, guideline develop-
ment is never neutral, and is inevitably “a social as well
as technical process” that “necessarily reflect[s] value
judgments” [38]. However, clear procedures for the
documentation and management of interests, including
financial relationships and sources, are essential. The
varying perspectives participants in this study conveyed
around if and how conflicting interests can and should
be managed suggests that this is a complex issue in the
country. Further research on this topic in South Africa is
therefore needed, and substantial stakeholder input and
buy-in will be required if we are to move from how in-
terests have been managed to how they should be.
Finally, challenges pertaining to stakeholder engage-
ment were also described as related to power dynamics
in the country. The nature of CPG consultation was
perceived to favour those individuals and groups who
have the time, resources and capacity to provide input.
As such, and as reported in other studies in South Africa
[22, 39], the views of end-users of CPGs, ‘at the coal face’
of service delivery remain inadequately incorporated. As
suggested by participants in this present study, and simi-
larly highlighted elsewhere [40, 41], a failure to include
the perspectives of those who will be implementing
CPGs could have a dire impact on their effective uptake
and use. A noticeable absence in the stakeholders’ narra-
tives in this study pertains to the issue of patient in-
volvement. Internationally, patient engagement is now
recognised as an important component of CPG develop-
ment to ensure the production of more patient-centred
and trustworthy guidelines [42, 43]. The silence around
this topic in this study suggests that the involvement of
patients in CPG development clearly requires more at-
tention in South Africa.
Additionally, it emerged that the process of stakeholder
engagement tends to marginalise the opinions of individ-
uals and groups located in the more resource-limited
provinces in the country. This is indeed further supported
by the fact that, despite our attempts to include national
stakeholders from all provinces in the country in this
study, our final sample was dominated by participants
from Gauteng and Western Cape Provinces, two of the
country’s most well-resourced provinces. Read in conjunc-
tion with the study findings, this sample bias is likely to
reflect the reality of skewed power dynamics in CPG de-
velopment in South Africa, where many who lead national
knowledge production, and are therefore able to contrib-
ute their time to the process, may be based in the Western
Cape and Gauteng. Ultimately, all of this suggests that
CPG development in South Africa needs to develop more
innovative strategies for better reaching and including the
voices of those across professional hierarchies and
provinces in the country, as well patients and healthcare
consumers.
Study strengths and limitations
The strengths and limitations of the broader study in
which this sub-study is embedded, have been described
in detail elsewhere [23]. With regards to this sub-study
specifically, we have focused on the personal accounts
and experiences of respondents. A strength of this ap-
proach is that the data represents the perspectives of ac-
tors engaged directly with CPG activity in South Africa
and therefore provide valuable insights into the thinking
behind CPG development processes. However, we
recognise that such accounts are inevitably influenced
by respondents’ position at time of event, their position
at the time of being interviewed, their relationship with
the researchers and their memory of particular events
and processes [44]. Our final sample was dominated by
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participants from Gauteng and Western Cape Provinces,
and thus the views and perspectives of stakeholders who
may be involved in CPG development from other Prov-
inces in the country might not have been sufficiently
reflected. At the same time, we did not speak to patient
representative groups or patients, as it emerged during
our stakeholder ‘mapping exercise’ that these individuals
and groups are currently limited in their involvement
with CPG development in the country. Further research
in CPG development in South Africa, which tries to
reach more ‘marginalised’ stakeholders, including pa-
tients and patient representative groups, is needed.
Furthermore, and as noted in the previous paper [23],
the lead researcher, who was present at most interviews,
has experience in evidence synthesis for CPGs and
teaching about CPGs. As she may be known to some in-
terviewees as an advocate for evidence-based healthcare,
this may introduce response bias. Therefore, we ensured
that at least two interviewers were present, including
one who was not engaged in CPG activities, with the
intention to create more distance and, as much as pos-
sible, objectivity. In addition, and as described in the
methods section, the researchers discussed the findings
at regular intervals during the analysis process. This
helped to verify and refine the emerging themes and
provided an opportunity for our presuppositions (and
how they may be shaping the analysis) to be identified
and critically examined.
While the results of this study need to be generalised
with caution, as all qualitative research, we have suc-
ceeded in providing in-depth insight into CPG develop-
ment in South Africa. The results corroborate with and
extend the findings from other studies on this topic in
SSA and South Africa more specifically. The results also
shed light on key factors that might help to improve the
development of high-quality CPGs in South Africa, and
potentially other countries in the region.
Many of the findings in this study are similar to those
previously reported. However, two unique issues that
emerged, which have not received much discussion else-
where, were the complexities around managing conflicting
interests and adapting CPGs to within-country contextual
differences. Participants in this study held contrasting per-
spectives about these issues, suggesting the need for fur-
ther research into these factors and greater discussion
regarding how they should be addressed.
Conclusion
Growing awareness of the important role CPGs can play
in healthcare systems in SSA demands increased know-
ledge about CPG development activity in the region. Fo-
cusing on South Africa, this study has shown that, while
there is strong commitment amongst national stake-
holders to advance guideline development processes, a
complex mix of values, politics, power and capacity con-
straints pose significant challenges in this regard. More
dedicated resources for CPG development, together with
standardised conflict of interest policies and greater
guidance for trans-contextual CPG adaption will help
enhance the quality and credibility of CPGs for PHC
and have an associated positive impact on patient care
in the country. Cultivating a political environment that
fosters collaboration, reciprocity and more equitable in-
clusion within and between different CPG development
groups and stakeholders could help reduce duplication
of efforts, make better use of limited resources and
skills, and help redress historical inequities within the
South African healthcare context.
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Chapter 4: Primary care guideline implementation: barriers and enablers 
 
Summary: In this qualitative study, we conducted in-depth interviews with 22 provincial and district 
health managers, district clinical specialists and trainers involved with guideline implementation in four 
provinces in South Africa. Two main themes arose that pose barriers to guideline implementation in the 
provinces: a) health-system factors; and, b) socio-cultural and geographic context factors.  
 
The health-system factors included financial constraints that impact access to guidelines and necessary 
equipment and medicines to do their jobs as well as the importance of and need for strengthening 
governance, leadership and accountability. Participants suggested that the health workforce needs 
support and bolstering including increasing the numbers of skilled nursing and other clinical services; 
quality assurance of training programmes for primary-care clinicians, particularly nurses; interdisciplinary 
training to ensure all staff are adhering to current guidelines; and, strengthening of post-training 
mentorship.   
 
Socio-cultural and geographic contextual considerations resulted in recommendations that guidelines 
should be fit for the context through consultation with end-users and implementers in the development 
stages; and, adjusting provincial indicators to match the cultural preferences and values and to ensure 
recommendations are acceptable and feasible to implement. 
 
Publication citation: Kredo T, Cooper S, Abrams A, Muller J, Schmidt BM, Volmink J, Atkins S. ‘Building on 
shaky ground’ - Primary care guideline implementation - perspectives of provincial and district 
implementers in four South African provinces. BMJ Open (submitted 5 May 2019). 
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Kredo T. Mapping the needs of guideline implementers for South African primary care. African Cochrane 
Indaba 2019, Cape Town, 25-26 March 2019 (Plenary). 
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Abstract 
Background
Clinical practice guidelines are important tools supporting evidence-informed patient care. In South 
Africa, although guidelines are usually developed at national level, responsibility for implementation lies 
with provincial government. This study explored perspectives of provincial and district health managers 
stakeholders regarding barriers to and enablers for primary care guideline implementation.
Methods
We used qualitative research methods, comprising in-depth interviews with twenty-two participants in 
four provinces in South Africa (Eastern Cape, Western Cape, Kwazulu-Natal, Limpopo). We interviewed 
provincial and district health managers responsible for implementation and/or training. Analysis 
proceeded with inductive thematic content analysis to develop categories and themes; followed by 
discussion of results and finalization of themes with a multidisciplinary team. 
Results
Participants recommended urgent consideration of health system challenges, particularly financial 
constraints impacting on access to both guidelines themselves and to the basic medical equipment and 
supplies to adhere to the guidelines. They suggested that to overcome health service gaps, leadership 
should be strengthened, roles clarified and accountability measures, such as audit and feedback, be 
improved. Participants suggested that the inadequate numbers of skilled nursing and other clinical staff 
hampered guideline use and ultimately patient care. Quality assurance of training programmes for 
clinicians, particularly nurses; interdisciplinary training to ensure all staff are included; and 
strengthening post-training mentorship was recommended. Furthermore, fit for purpose guideline 
implementation needs to consider the unique settings in each province and district, including local 
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culture and geography. This should start from guideline development stages by including guideline end-
users.
Conclusions
Universal health coverage is planned for the coming decade and guidelines are one of the named tools 
to achieve evidence-informed, effective healthcare. Increasing access to guidelines and enhancing 
training and clinical supervision may enable short to medium term benefits. However, investing in 
health system strengthening is a pre-requisite to evidence-informed practice.   
Key words: qualitative research, clinical practice guidelines, implementation, primary care, quality of 
care, health systems research, health services research, policy implementation, quality improvement
Article summary
Strengths and limitations of this study
 Clinical practice guidelines are named tools for bridging the gap between policy and 
practice to support implementation of equitable and cost-effective health services. Yet, 
there is a paucity of research on clinical guidelines from low- and middle-income 
countries.
 Strengths of the study are that we report interviews with provincial and district health 
managers in four culturally and geographically diverse South African provinces. 
 The qualitative research methods enable us to explore perspectives of those involved 
with guideline implementation who shared their views regarding what is working and 
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what can be improved. The research identified two themes impacting guideline 
implementation: Health system factors and socio-cultural and geographic context.  
o According to participants, several insights emerged for how these factors might be 
addressed: Strengthening the health system through adequate financial 
investment and ensuring availability of medical equipment and supplies are 
necessary for guideline adherence.
o Strengthening leadership and putting in place constructive accountability 
measures, including appropriate use of audit and feedback.
o Quality assurance of training programmes for primary health care providers, 
particularly nurses, and facilitating interdisciplinary training to ensure all staff are 
adhering to guidelines. 
o Mentorship and clinical support are provided through District Clinical Specialists 
but requires further strengthening. 
o Consideration of the unique settings in each province, including culture, 
geography and social needs is required to ensure effective implementation.
 Limitations of the study include that there are many primary care guidelines available in 
South Africa with different target users. Further interviews may elucidate additional 
specific barriers to and enablers of guideline implementation. Furthermore, the health 
system is an evolving environment, and continuous research of this kind is likely 
necessary to keep abreast of developments to inform guideline implementation.
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Background 
Primary health care (PHC) remains an important focus globally and part of the foundation for Universal 
Health Coverage (UHC)(1). The South African government, like other lower- and middle-income 
countries, have indicated a commitment to enhancing in primary care for UHC (2-4). However, PHC has 
had faltering progress at best, and despite political will, investment has not been sufficient to overcome 
challenges posed by colliding communicable and non-communicable epidemics alongside recognized 
health system deficiencies (5, 6). Health outcomes remain poor relative to other middle-income 
countries with similar health spend; and healthcare remains inequitably distributed within a two tiered 
public and private system where 40% of the health budget is consumed by the private sector, despite 
serving 17% of the population (7-9).  
In South Africa, several strategic initiatives aim to address health system fragmentation, including PHC 
re-engineering, with emphasis on district health system strengthening; and advancing policy planning 
for National Health Insurance (6, 10, 11). These initiatives place importance on clinical governance, with 
clinical practice guidelines (CPGs) one named strategy for healthcare strengthening. 
CPGs are recognized tools for health policy implementation and quality improvement (12-14). Evidence-
informed CPGs aim to recommend effective diagnostic, prevention and management interventions, 
while minimising harm, within the limits of what a health system can afford. In South Africa, at least 175 
CPGs have been developed since 2012, largely for management of non-communicable diseases and 
mostly by the Department of Health (15). While the number of CPGs available may be substantial, they 
provide no benefit if inadequately implemented.  Studies in South Africa and elsewhere have found 
potential implementation gaps where, despite the availability of CPGs, clinical care does not meet 
required standards (16-21). 
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Evidence-to-practice gaps pose a substantial challenge and the how best to overcome them has been a 
longstanding debate (22-25). There are checklists available that outline potential approaches for best -
practice CPG implementation (26-28). However, which strategies work, under which conditions, remains 
a complex and evolving research field. Generally, tailored, multifaceted interventions addressing specific 
barriers may be better, but the benefit to health or process outcomes is often modest at best and 
difficult to extrapolate to different contexts (25, 29, 30). Increasingly, theory-informed approaches are 
used to design the complex interventions required to change behavior, yet the cost of doing this relative 
to the benefit remains unclear (31-34). In South Africa, several trials evaluating evidence-informed 
approaches for CPG implementation find a small, but consistent benefit from targeted strategies, yet, 
roll-out of these context-specific strategies remains a gap (35).
Given the limited resources allocated to health, particularly in low- and middle-income settings, knowing 
how best to intervene in efficient and effective ways is paramount. (36, 37).  In this context, exploring 
the views of those involved with CPGs is a reasonable way to learn about local needs. The South African 
Guidelines Excellence (SAGE) project aimed to understand primary care CPG development, 
implementation and capacity needs (38).  For the qualitative component of SAGE we interviewed 
diverse role players involved in primary care CPG development, implementation and/or use. Elsewhere 
we report the findings fromt national CPG developers (39, 40) and frontline healthcare workers who use 
CPGs (33). Related SAGE studies have engaged allied healthcare providers (41-44). In this paper, we 
explore findings that emerged amongst health managers occupying senior management roles in the 
provincial or district government offices. The district managers include those with strictly management 
roles and those with clinical governance and support roles (e.g. members of the District Specialist 
Clinical Teams) or those responsible for training. All participants we spoke to have roles in primary care 
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CPG implementation. We aimed to explore their perspectives regarding barriers to and enablers for 
primary care CPG implementation in four provinces in South Africa 
Methods
Design
We used qualitative methods to understand the phenomena under investigation as experienced by 
those involved. The methods and study context have been described in detail elsewhere (33), and thus 
only a brief summary is provided here, together with more detailed description of participants and 
analysis methods used in this paper.  
Study settings 
Over several decades, the South African national government has increased emphasis on PHC services 
managed through district offices (6, 45-48). Districts are administrative sub-sections of the province, 
usually run as part of the local government. More recently, legislation has been introduced which 
supports the implementation of UHC, through a National Health Insurance system (11). However, its 
implementation is planned for the decade ahead. In general, national government develops strategies 
and CPGs; and provincial governments implement them through regional, district, or community 
healthcare facilities (7). Several programmes to strengthen district clinical governance have been 
introduced and are linked to CPG implementation: 1) The Ideal Clinic is defined as a ‘clinic with good 
infrastructure, adequate staff, adequate medicine and supplies, good administrative processes, and 
sufficient adequate bulk supplies’ includes ensuring access to and use of CPGs (49); and 2) ‘primary 
health care re-engineering’ aims to strengthen district healthcare through ward-based outreach teams; 
school health programmes; and District Clinical Specialist Teams (DCSTs)(10).  DCSTs include clinical 
specialists: family physician, primary health care nurse, obstetrician, advanced midwife, paediatrician, 
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paediatric nurse and anaesthetist. The family physician and primary health care nurse are central to 
primary care CPG implementation through their clinical governance role, including provision of training 
and mentorship with nationally endorsed CPGs. 
Sampling and recruitment
Sampling, both purposive and convenience, took place in four of nine provinces in South Africa chosen 
for their diversity in socioeconomic  status, geography and cultures: Western Cape, Kwazulu-Natal, 
Eastern Cape and Limpopo provinces (33, 46). Within each province, we aimed to interview provincial 
and district managers, or district clinical specialists face-to-face at their place of work or preferred 
venue, lasting between 30 to 60 minutes.  Prior to conducting interviews, we obtained approval from 
Provincial Research Units. In the Eastern Cape we were invited to present at a provincial research day, 
receiving buy-in for our planned research (33).  In the Western Cape we contacted known provincial 
policymakers involved with PHC CPGs. In other provinces, we invited individuals recommended by the 
Provincial Research units.  Once access was negotiated, all those invited agreed to participate. 
Patient and Public Involvement
CPGs are tools that aim to directly impact patient care and guide clinician-patient engagement. In South 
Africa, there is little known from research evidence regarding patients views about CPGs. The research 
question was developed with patients in mind, but did not engage patients views in the design, conduct 
or analysis.  In this SAGE sub-study we were seeking perspectives of health managers in primary care, 
and neither patients or the public were included in the sample. The results of the research will be shared 
with the participants.
Data collection and management 
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We explored experiences of CPG implementation and use for health service delivery. We used a semi-
structured interview guide, asking about experiences of CPG adaptation and implementation processes 
and about potential barriers to and enablers of successful implementation. The guide was adapted 
iteratively drawing on insights from previous interviews and included open-ended questions to allow 
participants to direct the emphasis of the interview (50). Interviewers received training in interviewing 
and two interviewers were present at all interviews.  Interviews were conducted in English. There were 
no requests for translation despite the various first languages spoken in the provinces. All interviews were 
individual, with two exceptions 1) a provincial manager interview in Eastern Cape, where our invited 
participant invited two additional colleagues to participate; 2) the district manager interview in Kwazulu-
Natal, where both the district PHC manager and training coordinator were present. One interview, with a 
Kwazulu-Natal manager, took place telephonically at their request due to challenges with scheduling.
All interviews were recorded. After each interview, reflections and summaries were written to capture 
initial insights and to identify points for further exploration in subsequent interviews. Interviews were 
transcribed verbatim, and reviewed for accuracy (TK, TM). Data were stored electronically on password-
protected computers; and consent forms stored in a locked cabinet.
Analysis
We used an iterative, thematic content analysis approach (50, 51). Two researchers read initial 
transcripts (TK, SA) and agreed on the general meaning and main issues presented. One researcher (TK) 
then re-read transcripts, performing open coding to explore barriers to and enablers of CPG 
implementation, extracting the relevant quotes/coding units. TK then used the quotes to develop the 
condensed manifest descriptions, and from these data were placed in categories (52). Categories and 
their related quotes were further examined (TK, SC, BS, SA) for manifest and latent meanings and to 
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identify meaningful themes (53). Following this, results were discussed with SA to develop the analysis 
further and then presented to all authors for input and verification prior to finalization.
Rigour
Credibility was ensured through detailed capturing and description of our approach to sampling, data 
collection, data management, and analysis. Quotations were included to provide readers the 
opportunity to interpret data, establish confirmability and to show data richness. Complementary 
research competencies and experience of the multidisciplinary team of researchers (social science, 
medical practice, CPG development and implementation) influenced data interpretation and 
strengthened study rigour. 
Results
Twenty-two interviews were held from September 2015 to August 2016. Participants had previously 
worked in clinical positions as nurses (n = 15), or doctors (n = 7), but were currently occupying 
management posts. Provincial and district managers were responsible for health service delivery and 
worked in PHC generally or specific clinical programmes (e.g. HIV, non-communicable diseases), or in 
operational roles. District Clinical Specialists worked at primary and district healthcare facilities 
providing clinical governance support. Our final sample included provincial managers representing four 
provinces; district managers from two districts in each of the four provinces; and district family 
physicians in Limpopo, KZN and Eastern Cape. The Western Cape has not implemented the DCST 
programme. 
Most participants considered CPGs credible sources guiding clinical practice and importantly, believed 
that CPGs impact positively on patients’ health. Some participants described that CPGs can ‘save a life’. 
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District medical doctors particularly shared views regarding the value of CPGs, stating that they are 
‘evidence-based and it works… mortality goes down when we do things properly’.  Further arguments 
supporting CPGs included ‘harmonisation of practice’, ‘quality improvement’, and ‘rational’ medicine 
use. 
We present the findings within two emergent themes, namely: health system factors and socio-cultural 
contextual issues. 
Health system factors 
Senior provincial managers experienced CPG implementation as challenging, under-resourced, and 
sometimes insufficiently planned. They suggested that CPGs were not the issue, but rather the health 
systems capacity to support implementation. An experienced senior manager who had worked in 
several provinces explained:
training and the guidelines are fine, but the bed rock on which we are building is – we are building on 
shaky ground (Provincial manager, doctor, WC)
Financial constraints 
Financial constraints were recurring issues across provinces. One aspect was reflected in the frustration 
expressed by some that funding across different conditions was inequitable, with more funding for HIV 
and tuberculosis, ‘but the other big killers’ such as non-communicable diseases received little or ‘no 
support’. This situation was driven by international donor funding, which influenced which CPGs were 
prioritized for implementation. 
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Access to the right tools and equipment was perceived as a pre-requisite for successful CPG 
implementation. However, all participants spoke about budgetary constraints, and resulting lack of, or 
poorly serviced, clinic equipment and stocks and the associated impact on implementation. A PHC 
district manager expressed concerns, stating:
Budgetary constraints are still a challenge, the systems are still a challenge they are hindering the 
implementation of these guidelines.  For you to get a blood pressure machine, you have to wait for more 
than 2 months.  If this scale is broken, you should follow a tender process for that scale to be repaired, so 
the systems are killing the implementation of guidelines also, the procurement and supply chain systems.  
(District manager, nurse, EC)
Furthermore, the simple issue of limited access to CPG copies on site, due to budgetary constraints, was 
highlighted as an additional barrier for using CPGs. As captured in this quote from a district doctor in 
rural Eastern Cape ‘I mean you just lucky if you get them’. 
Several district managers also mentioned that ‘the challenge is about printing the guidelines’ due to 
budget allocations from national government. Solutions were offered to overcome both the poor quality 
of, and poor access to, CPG copies. A dominant view was that digital access would mitigate these issues 
and increase ‘click and check’ CPG access. Several managers suggested, however, that both the book 
and digital versions are needed, as a rural district doctor said:
‘They [older healthcare providers] like the booklet, but the young ones like the app’ (Provincial manager, 
nurse, LPP)
Despite many participants highlighting the potential value of increasing digital CPG access, financial 
barriers were expressed in all provinces, as some managers suggested: 
‘no computers, no internet, there’s no connection’ (District manager, nurse, KZN)  
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‘I don’t think you will find a single computer that’s got any connection to anything’ (District manager, 
doctor, KZN)
In addition, a district manager in an urban context explained the dilemma of investing in digital solutions 
in the face of limited funding. She asked: ‘do you want to buy more computers, or do you want more 
medication’ (District manager, nurse, WC)
Governance and leadership 
Senior managers explained that effective CPG implementation required strong governance including 
clarity regarding responsibility, and how implementation should be delivered and monitored.  
…it’s an issue of governance, how is implementation of guidelines governed and whose responsibility is it 
and do we have enough capacity to manage governance (Provincial manager2, doctor, WC)
District management were perceived as demotivated because of the volume of policies requiring 
implementing, leaving them feeling ‘completely bombarded and confused’. In addition, lack of support 
for implementation, or in some circumstances the punitive approach taken towards managers struggling 
with implementation within very challenging health systems, was demoralizing. A senior manager, 
having worked in several provinces with differing infrastructure, described his experience: 
There are good people at ground level, but without a level of protection and support they kind of just get 
nailed. So every new policy is looked upon with dread because you are worried that at some point 
somebody is going to come and say you are not implementing it  (Provincial manager, doctor, WC)
Managers offered solutions explaining that it was not only the remit of public servants to lead CPG 
implementation. Community champions and leaders were suggested as additional enablers of CPG 
implementation.  Within the health workforce, this included senior academics who inspired junior staff; 
Page 13 of 33
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Stellenbosch University https://scholar.sun.ac.za
For peer review only
14
in the community it was community leaders including traditional chiefs or religious leaders who 
endorsed local facilities and encouraged patients to follow guidance.
Further recommendations to support governance included developing relationships with non-
governmental organizations (NGO), known as ‘partners’. Given the limited provincial budgets, partners 
were often perceived as the only means for providing training or developing materials for CPG 
dissemination. Partners were mentioned, particularly in the Eastern Cape, both at the provincial and 
district level, as one district manager explained ‘when the guideline is out, we need to call them [NGO 
partners] to be part of us’. The issue of sustainability arose as there was a risk that when NGO funding 
ended, services were withdrawn, and local government lacked capacity to maintain the activities, 
potentially undermining care. 
Accountability approaches 
Several managers suggested accountability mechanisms to enhance implementation. For example, use 
of audit and feedback to measure CPG use was an accountability and quality improvement approach 
cited by various participants. This approach was reportedly better functioning in certain provinces.  A 
provincial programme manager in the Western Cape described a constructive experience: 
(Based on the) situational analysis and audits ……. we pick up the gaps in quality and we start looking at 
what is our opportunity to, either tweak a guideline, develop a guideline or a tool or piece of stationary 
or an algorithm or flow chart that will close that gap (Provincial manager, nurse, WC)
While accountability mechanisms were perceived by some as essential, most managers, on the contrary, 
described audits as punitive and obstructive with potential negative consequences. As stated by a 
provincial manager: 
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then comes the monitoring and evaluation people to monitor that thing, not in a nurturing way, but in a 
‘why didn’t you hit your targets kind of way’ (Provincial manager, doctor, WC)
This concept of punitive audits emerged from several provinces. One senior manager spoke about a 
‘compliance culture’ in which focus was directed primarily to what is measurable, such as structural 
inputs like infrastructure, and the blame that ensues if these targets are unmet. As described:
… when it comes to focusing on clinical guidelines if no one is auditing that in the same way. So, the 
Auditor General is this big bogey man out there. If anything goes wrong, then of course the province gets 
into big trouble. So, there is a lot more gravitas or seriousness attached when the Auditor General says 
something…  (Provincial manager2, doctor, WC).
Another participant from the Eastern Cape provided an analogous account:
We will comply and complain later, if there is a time to complain.  But what is emphasized, is compliance.  
There is that strict compliance.  Compliance. If you don’t comply, it means you are failing your district, or 
your sub-district, or your clinic or your people.  There is no time for complaining or reflecting, it is 
compliance. (District manager, nurse, EC)
The compliance culture and aversion to punitive action was thought to have negative effects on CPG 
implementation and patient care. Participants indicated how the compliance and audit systems ‘just 
adds to the frustration’, ‘distracts’ from the focus on clinical care and ultimately results in rushing ahead 
to meet targets, or as one manager put it: ‘running around like a headless chicken’ (District manager, 
nurse, EC).
Human resource constraints 
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Health workforce constraints were emphasised as pertinent to CPG implementation. Managers 
described the mismatch between the growing workload and unchanging staff numbers:
we have this burden of disease that is growing.  We have resources that are shrinking.  So more of our 
health workers are being asked to do more with less resources (Provincial manager, nurse, WC) 
Health workforce barriers to CPG use were described to be three-fold: staff shortages, insufficient time, 
and inappropriately qualified staff unable to fulfill required tasks. These issues resulted in staff being 
‘overstretched’ and ‘not coping’. It was suggested that staff experience considerable time pressures due 
to their heavy workloads, ‘continuously dealing with patients’ as well as pressure from patients wanting 
them to work ‘fast, fast, fast’. As one provincial manager lamented:
…they [nurses] have no time to look at guidelines, they have no time to do quality work to check the 
quality issues because they are continuously dealing with patients (Provincial manager, nurse, LPP).
Capacity gaps and opportunities 
Linked with human resources is capacity building. Training was emphasised as the primary means by 
which CPGs are implemented. Participants generally agreed that to support implementation ‘you can’t 
just automatically know how to do things, you need to be trained’.  Therefore, building skills and 
knowledge was understood as a pre-requisite to changing practice. 
Primary care nurse training gaps
An issue raised mostly by nurse managers was the poor state of professional training of PHC nurses. 
Nurses were described as ‘not skilled’ and the nurse training syllabuses ‘outdated’, raising concerns that 
nurses entering practice were inadequately prepared. In the most extreme example, a provincial 
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manager suggested that ‘student nurses come out blank….they are the ones that are causing all these 
deaths.’
Several suggestions were made for optimizing training and support through 1) training delivery 
approaches  and 2) post-training clinical support.
Considerations during training 
Regarding training itself, access to workshops and ensuring adequate coverage of staff was identified as 
a significant challenge. Various participants indicated that ‘onsite training is the best one’, as when 
training was delivered off-site, fewer staff could attend, and disseminating learning when back at 
facilities was ineffective: ‘they [the nurses] don’t cascade the information’.  However, ‘lack of time’ and 
‘budgetary constraints’ to provide training in every facility was their reality. Therefore, finding 
contextually appropriate training approaches were suggested, such as ‘training local people to be 
trainers’ and working with NGO’s who have more training resources. Furthermore, ensuring DCSTs are 
maximally used to provide training were considered key. As a district manager in Limpopo suggested:
DCST staff are now doing the training per facility, no more calling people to a centralized place….and 
also [doing] the support visit in the facility (District manager, nurse, LPP)
Several participants recommended that training should be interactive, not didactic. Many commended 
the practical skills training, so-called ‘fire drills’, used for maternal health training. This training require 
staff to demonstrate a response to an emergency during the training, but also subsequently on-site at 
unexpected intervals. 
It was reported that doctors are excluded from training. Ideally, training should be interdisciplinary, 
bringing all clinical disciplines onto the same level. As a senior doctor suggested, ‘the nurse now knows 
more than the doctor. So you have to train everybody at the same time.’  (District clinician, doctor, KZN)
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Post-training recommendations 
Following training, a critical gap raised repeatedly was the absence of ‘clinical support’ and ‘mentoring’. 
As a district clinician suggested, ‘we desperately, desperately need mentors’. It was emphasized that 
regardless of access to up-to-date, high quality CPGs, when post-training support is poor, 
implementation gaps were likely, as captured by the following quote:
on-site facility mentoring, it’s a problem….without that, we can have much, much guidelines, good 
guidelines, but if there’s no on-site mentoring, we are just wasting the government’s money      (District 
clinician, nurse, KZN)
Socio-cultural and geographic challenges to CPG implementation
In addition to health system factors, socio-cultural and geographic factors were raised by most 
participants, particularly those in district settings presumably closer to the day-to-day requirements of 
health service delivery. The explanation given was that there is a mismatch between what is 
recommended in CPGs and what was acceptable due to culture or feasible due to challenges of living in 
rural settings. 
Acceptability and cultural considerations
Several specific CPGs that posed challenges to implementation were mentioned. The CPG 
recommending voluntary male medical circumcision was emphasized as being at odds with cultural 
beliefs and norms in settings where traditional circumcision required specific rituals. As one female 
nurse manager described:
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…. male circumcision, it is a taboo for me to talk about circumcision.  Now you tell people go and do the 
medical male circumcision.  It is as now you are insulting their culture. (District manager, nurse, EC)
 Another example related to when mothers with newborns require follow-up clinic visits after delivery, 
whereas, in some traditional cultures, leaving home for a specified period post-delivery is frowned upon:
after birth, she must stay at home until 10 days (District manager, nurse, EC)
Geographic barriers
Geography posed barriers to CPG implementation. The distance and difficult environmental 
circumstances under which many patients must travel to attend clinic appointments make the 
implementation of certain CPG recommendations unfeasible:
A woman in the Eastern Cape will have to travel 5 kilometers or even more to reach the clinic, so how 
would you ensure that you reach the clinic 6 days after birth?  Those are things that, at times, are 
impossible when you look at the guidelines. (District manager, nurse, EC)
in rural areas, people are scattered, and there are rivers when it is raining, they can’t go to that facility, 
…….there was rain for the whole month and then there were floods, and maybe the bridges are then just 
swept away with the floods.  And then people who can’t go to that clinic to go and fetch their treatment 
for diabetes and hypertension. (Provincial managers, nurses, EC)
One size fits all approach to CPG development 
Critically, the disparity between CPG recommendations and their feasibility were perceived to result in 
unsuccessful CPG implementation and subsequent failure on standardized national indicator ‘report 
cards’:
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Most of the time we will be Number 0 [on audit reports] …., because it [the guideline] is not implemented 
in the Eastern Cape.  It’s not working.  But they [national government] will always say Eastern Cape is 
Number 0.  It’s Number 0 because the tool does not fit here, it’s [the guideline] is just not right, they are 
using something which is round in a square hole… (Provincial managers, nurses, EC)
Many provincial managers reported that consultation between national and provincial government was 
happening, even prior to finalization of a CPG, to address contextual barriers:
So I think in terms of implementation what I’ve seen works really well is when people have been part of 
the process from the policy development side from the word go (Provincial manager, nurse, WC)
However, many participants, particularly district managers did not feel consultations were done 
consistently and in meaningful ways to ensure that the final CPGs and linked indicators were aligned 
with geographical and cultural contexts. Many f lt that CPG content was ‘one size fits all’ and that 
examples of contextually-appropriate implementation were limited.
Despite participants emphasizing the importance of context, processes for the contextual adaption of 
CPGs was not routinely described. One exception was an example provided about the structured 
approach to adopt, adapt, or develop new CPGs in the Western Cape. A provincial manager noted: 
either use the policy from national as is or we either translate it for the local context or we develop 
policy, because national just hasn’t done it (Provincial manager, nurse, WC)
Discussion 
This study explored perspectives of South African provincial and district health managers on potential 
barriers to and enablers of primary care CPG implementation. Two major themes emerged, the first 
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related to broader health system factors such as financial constraints, governance and health workforce 
capacity gaps. The second emphasized the importance of socio-cultural and geographic factors, and the 
need for CPGs to be adapted to fit local contexts. 
Regarding health system issues, we found that despite managers’ willingness to support PHC CPGs use, 
the relative dysfunction of the health system posed barriers to doing so. Aspects of this theme mirrored 
several of the often cited WHO health system building blocks, including leadership and governance; 
financial arrangements; health service arrangements and implementation strategies, such as training 
(54, 55).  
Strong leadership is required to drive CPG implementation (55, 56). Participants, all of whom occupy 
responsible management positions, described governance gaps affecting CPG implementation, a factor 
also identified in other studies of countries in sub-Saharan Africa (57).  Participants described volumes of 
incoming policies without time for consultation, adaptation or planning; and rushed implementation 
responding to political drivers rather than healthcare quality considerations. To address this challenge, 
managers often partnered with community leaders and NGOs.  This was deemed necessary, particularly 
in the Eastern Cape, a province where many health system and financial issues were emphasised by our 
participants and highlighted in national reports (4, 6).  CPG implementation strategies take many forms, 
including professional development, dissemination of summary products to patients and healthcare 
providers, use of key opinion leaders, to name a few (29). In the South African setting, delegating 
responsibility to partners with relevant skills and resources is necessary, however, participants were 
concerned about sustainability of donor funded activities. 
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Relatedly, accountability was a reported gap, specifically clarity regarding who is responsible for CPG 
implementation and how best to monitor success.  For monitoring, audit and feedback was proposed, a 
quality improvement strategy premised on the notion that clinicians may change their performance 
when they receive feedback regarding sub-standard practice (58). Those we spoke to provided examples 
of constructive audit and feedback allowing managers to adapt implementation to address gaps. 
However, mostly, audits were experienced as punitive, driving managers to ‘comply’ rather than 
innovate. A systematic review of 49 trials of audit and feedback found this approach should offer benefit 
in CPG implementation (58).  Importantly, this review identified success factors that need be considered 
including whether the baseline erformance of health professionals is low to start with; feedback is 
recurrent and given both verbally and in writing; and the process includes clear targets and action plans 
(58). Findings from our study suggest that further factors may need to be considered, such as feasibility 
and context, to ensure that implementers feel empowered, rather than discouraged or demotivated, by 
audit and feedback systems.
Most participants described CPG implementation as reactive, rather than proactive, driven by demands 
to implement without adequate time or funds to do so effectively.  Participants spoke of a ‘compliance 
culture’ and explained that requirements were heavily weighted towards administrative reporting rather 
than consideration of clinical quality improvement.  Within the field of ‘quality of care’ measurement, a 
long-standing model posited by Donabedian proposed three measurable facets of quality of care, 1) 
structure (e.g. inputs to care such as facilities, staffing); 2) process (e.g. clinical care) and 3) outcomes 
(e.g. health outcomes, patient satisfaction) (59, 60). In South Africa, the apparent emphasis on structural 
measurement, is unlikely sufficient, as shown by a multi-country cross-sectional study in similarly poor 
settings which reported that infrastructure reports  correlated poorly with clinical care or CPG 
adherence (61). Drawbacks of this narrower structural and process focus have also been described in 
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the UK’s National Health Service, where attempts to create efficiency, resulted in ‘compliance-oriented 
bureaucratised management’ and was felt to hinder quality service delivery rather than enable it (62). 
Financial constraints were identified as critical factors limiting effective CPG implementation. Lack of 
basic equipment, and CPG books was described as the norm. Additionally, lack of infrastructure, 
including internet or devices, was a perceived barrier to using CPGs. These views mirrored those of PHC 
providers in the same districts that we spoke to who described that they would be more likely to use 
CPGs if digital access was possible (33). However, like the managers, lack of internet in facilities, and 
exorbitant costs of data required for downloading CPGs was a barrier (33).
Human resource constraints such as clinical workload and understaffing were another health system 
issue hindering CPG implementation, a finding that echoes a sub-study of PHC clinical staff in these 
districts (33).  
Training is the mainstay of capacity building for human resources for health. Training is vital for building 
skills and knowledge to implement CPGs, but also as a form of enablement for teams more generally.  In 
South Africa, like many low- or middle-income settings, nurses are the backbone of PHC services. Yet, 
poor quality nurse training, found in our study and others, was a concerning issue associated with 
outdated curricula and inaccessible training sites (63). 
To overcome these challenges, many participants pointed to the importance of post-training clinical 
mentorship.  When in place, this clinical mentorship was perceived to provide the necessary, case-
based, in-facility support for CPG implementation and role-modelling CPG use. This view has been 
reported by other South African studies, in particular a study exploring the Ideal Clinic programme 
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implementation suggested that family doctors in the DCSTs have similar perspectives regarding the 
importance of mentorship (64, 65). 
In addition to health systems issues, the importance of context emerged as a significant theme. Within 
the public sector, CPG production in South Africa is generally the responsibility of the National 
Department of Health and implementation a provincial mandate, with further devolvement of decision-
making to districts (6). This decentralised approach is advocated globally, particularly for health systems 
progressing to UHC to enable more responsive ground-up health services (66). However, from our 
participants we learned that the problem with this is two-fold. Firstly, health indicators are aligned with 
national strategies, which do not consider differences between provinces. Secondly, local teams lack 
time and specific training in the adaptation of the CPGs for their setting. These concerns were also 
expressed by national primary care CPG developers, who described that fragmentation between and 
within provinces likely hampers implementation (39). According to our participants, implementation of a 
‘one size fits all’ national CPG may result in several negative consequences including poor scores on 
national indicators due to unfeasible recommendations that are not adequately implemented (‘round 
peg in a square hole’ analogy); and rushed implementation to align with a national programme or 
political drive. 
Despite, and perhaps because of, the contextual challenges these managers encountered, many of them 
described innovative approaches to overcome geographic barriers or cultural issues. For example, a 
female nurse manager in the Eastern Cape led the development of a male nurse-led programme for 
medical male circumcision because in her setting for women to discuss circumcision is a cultural taboo. 
In addition, where geographical barriers arose, such as flooding rivers, district managers tried to provide 
vehicles and airtime to community healthcare workers to reach patients. This was not always successful, 
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due to financial barriers and inadequate procurement processes. A number of managers described plans 
that required impressive ingenuity and commitment to overcome health system and contextual barriers, 
despite all odds, and seemingly with little recognition. Additionally, despite the managers’ evident 
wealth of knowledge, experience and creative solutions, when pressed, there was a notable absence of 
examples provided by participants of opportunities to share lessons learned, innovative approaches, and 
successes or challenges between and within districts or provinces. 
Taken together these health system and contextual barriers to CPG implementation are recognized in 
various CPG frameworks as potential challenges to implementation (27, 67) . However, arguably, those 
frameworks, largely developed in higher-income settings, contain more detail regarding the CPG and 
healthcare provider characteristics and less regarding the social, political and contextual factors. In 
South Africa, availability of CPGs and motivation of healthcare providers and managers to support CPG 
use are less of an issue than those of context and health systems (33). 
Implications for policy and practice
Although substantial research about district health services and systems exists in South Africa and 
elsewhere, there is a paucity of evidence published through the lens of CPG implementation. CPGs are 
amongst the tools used for policy implementation. In this study, participants made recommendations 
regarding structural barriers that hinder CPG implementation and ultimately impact patient care. 
Participants emphasised the importance of strengthening leadership, clarifying roles and putting in place 
constructive accountability measures. Skilled nursing and other clinical services are required to address 
the health burden, along with the equipment and supplies to deliver their services as recommended by 
evidence-informed CPGs. Quality assurance of PHC training programmes, particularly nurses, and 
facilitating interdisciplinary training to ensure all staff are adhering to CPGs was suggested. Innovations, 
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such as the DCSTs, are filling a reported gap in providing clinical mentorship, but needs further 
strengthening. Finally, effective CPG implementation in health services need to consider the unique 
settings in each province, including culture, geography and social needs. Systematic use of available CPG 
implementation checklists to explore, understand and plan for implementation will assist to tailor 
strategies to address local needs, making best use of limited resources (27, 30, 67). 
Limitations 
Elsewhere we have discussed limitations within the broader SAGE qualitative study (33, 40). In brief, 
exploring CPG implementation for all PHC CPGs encompasses a very broad research area. Many PHC 
CPGs are available, each likely has different barriers. However, in our exploratory research, we found 
many cross-cutting issues likely to affect most of PHC CPGs, such as access, training and supply chain 
factors. Future research can build on our findings and identify CPG-specific barriers and enablers.
Regarding this sub-study, a potential limitation is the sample, including provincial and district managers 
in four provinces, which may not sufficiently capture all views for this sub-group of the health services. 
Additionally, we used a mix of purposive and convenience sampling, resulting in inclusion of participants 
who were more likely to be available or responsive. Despite this, common themes emerged and 
triangulated between provinces and with previous research. As this is not a static situation, research in 
the evolving process to UHC is likely necessary. Finally, we cannot rule out the possibility of response 
bias, in which participants respond according to what they believe we want to hear (50). However, from 
most participants, many rich issues arose. Using the individual interview approach may have provided a 
safe space and achieved the depth that we have been able to capture and share in this paper. 
Conclusion 
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UHC is planned for the coming decade with CPGs one of the named tools to achieve evidence-informed, 
effective and cost-effective healthcare (11). We found that health system challenges; and socio-cultural 
and geographic context are central issues requiring attention for successful CPG implementation. Our 
study adds to a body of CPG implementation knowledge providing practical and local insights, from the 
perspective of provincial and district health managers, regarding what needs attention to effectively 
implement primary care CPGs in lower-resourced settings. 
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Chapter 5: Primary care guideline use: barriers and enablers 
 
Summary: This qualitative study describes the views of primary care healthcare providers and end-users 
of guidelines. Healthcare providers, generally nurses and allied health workers, are knowledgeable about 
guidelines, generally trust their credibility and are receptive and motivated to use them. Guidelines are 
seen by nurses to provide confidence and reassurance, as well as professional authority and independence 
where doctors are scarce. Barriers to guideline use include: 1) inadequate systems for printed book 
distribution; 2) insufficient and substandard photocopies; 3) linguistic inappropriateness (e.g. 
complicated language, lack of summaries, unavailable in local languages); 4) unsupportive auditing 
procedures; 5) limited involvement of end-users in guideline development; and, 6) patchy training that 
may not filter back to all providers. Recommendations from participants include: 1) improving the design 
features of guidelines; 2) accessible places to find guidelines; 3) making digitally-formatted versions 
available; 4) more supplementary materials (e.g. posters) to support patient engagement; 5) accessible 
clinical support following training; and, 6) in-facility training for all professional cadres to ensure fair 
access, similar levels of capability and interdisciplinary consistency. 
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Abstract
Background: Clinical practice guidelines risk having little impact on healthcare if not effectively implemented.
Theory informed, targeted implementation may maximise their impact. Our study explored barriers to and
facilitators of guideline implementation and use by South African primary care nurses and allied healthcare workers
in four provinces in South Africa. We also proposed interventions to address the issues identified.
Methods: We used qualitative research methods, comprising focus group discussions using semi-structured topic
guides. Seven focus group discussions were conducted (48 providers) in four South African provinces (Eastern Cape,
Western Cape, Kwazulu-Natal, Limpopo). Participants included mostly nurses, dieticians, dentists, and allied health
practitioners, from primary care facilities in rural and peri-urban settings. The analysis proceeded in three phases.
Firstly, two analysts conducted inductive thematic content analysis to develop themes of data. This was followed by
fitting emergent themes to the Theoretical Domains Framework and finally to the associated Behaviour Change
Wheel to identify relevant interventions.
Results: Participants are knowledgeable about guidelines, generally trust their credibility and are receptive and
motivated to use them. Guidelines are seen by nurses to provide confidence and reassurance, as well as
professional authority and independence where doctors are scarce. Barriers to guideline use include: inadequate
systems for printed book distribution, insufficient and substandard photocopies, linguistic inappropriateness (e.g.
complicated language, lack of summaries, unavailable in local languages), unsupportive auditing procedures, limited
involvement of end-users in guideline development, and patchy training that may not filter back to all providers.
Future aspirations identified include: improving the design features of guidelines, accessible places to find
guidelines, making digitally-formatted versions available, more supplementary materials (e.g. posters) to support
patient engagement, accessible clinical support following training, and in-facility training for all professional cadres
to ensure fair access, similar levels of capability and interdisciplinary consistency.
Conclusions: South African primary care nurses and allied health practitioners have high levels of motivation to use
guidelines, but face many systemic barriers. We used the Behaviour Change Wheel to suggest relevant,
implementable interventions addressing identified barriers. This theory-informed approach may improve clinical
guideline implementation and impact healthcare for South Africa.
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Background
Internationally, high-quality, evidence-informed clinical
practice guidelines (CPGs) are recognised as essential
quality improvement tools [1–3]. CPGs have a range of
purposes, intended to standardise care, improve its qual-
ity and safety, decrease costs, and improve patient out-
comes [3, 4]. They offer a ‘one-stop shop’ for end-users,
by providing synthesised information from systematic
reviews regarding best practices [5]. However, despite
growing availability of CPGs, if not used, they cannot
impact on the quality of the care that is delivered.
South Africa has long been developing CPGs, most
pronounced during the post-apartheid period when
CPGs were considered important tools to redress in-
equity, standardise care and promote cost-effective care
for all. Many CPG development players have been iden-
tified: national government, professional societies, hospi-
tals and clinics all contribute according to their needs
and agendas [6, 7]. However, despite development and
distribution of CPGs, health outcomes remain poor, and
generally worse than expected given the per capita
health spend relative to other similar middle-income
countries [8, 9]. As CPGs aim to optimise care, and yet
care appears not to be optimally delivered, it may be
helpful to understand the barriers to CPG implementa-
tion and use [10, 11].
We know there are no ‘magic bullets’ for improving
CPG implementation [12, 13]. Systematic reviews sug-
gest many potential implementation strategies, such as
audit and feedback, outreach education and key opinion
leaders [14]. Available evidence suggests that tailored,
multi-faceted approaches may do better than generic
and single-focused interventions [13, 14].
Several pragmatic trials of CPG implementation for
lung health, Human Immunodeficiency Virus (HIV)
and broader primary care have been conducted in
South Africa, finding some improvements when educa-
tional outreach is used [15–17]. It is therefore possible
that, when used, CPGs may improve health outcomes. If
we better understood when and how CPGs are used by
South African primary care providers, then CPG devel-
opers may design evidence-informed strategies to enhance
enablers and overcome barriers.
The Theoretical Domains Framework (TDF) is a useful
approach for identifying facilitators of and barriers to be-
haviour change, and for developing tailored interventions
when implementing CPGs [18]. Understanding how best
to enhance healthcare providers’ use of CPGs requires
consideration of the complex interplay of clinician and pa-
tient behaviours, environmental context and social influ-
ences. The TDF intends to integrate theories of behaviour
change, and bridge health psychology, organisational the-
ory and health services, providing a theoretical basis for
implementation research [19]. Several studies have used
the TDF to evaluate healthcare implementation challenges
or to design theory-informed implementation strategies.
Examples include hand hygiene, children’s health checks,
human papilloma virus vaccination, dental infections, and
lower back pain [10, 11, 20–22]. Some of these explora-
tions further informed the design of complex interven-
tions for research or public health programmes [20].
Utilising the TDF, this study aimed to explore primary
care healthcare providers’ perspectives regarding the
context, potential barriers to and enablers of CPG use in
four provinces in South Africa. Based on the findings,
and drawing on concepts from the Behaviour Change
Wheel (BCW), this study also sought to provide recom-
mendations for potential interventions to improve CPG
usage and implementation.
Methods
Theoretical framework
We used a qualitative study design, including semi-struc-
tured focus group discussions (FGDs). The overarching con-
ceptual framework used for this article was the Theoretical
Domains Framework (TDF) that also formed part of our
analysis process described below. The TDF provides a basis
to understand behaviours theoretically and therefore target
processes most likely to implement desired change [19, 23].
The 14 domains of TDF have been further mapped onto the
Capability, Opportunity, Motivation – Behavioural model
(COM-B model), a ‘behaviour system’ model which seeks to
encapsulate the conditions internal to individuals and those
within their social and physical environment necessary for
achieving specified behavioural targets [18]. Three essential
conditions: Capability, Opportunity, and Motivation
(COM-B) are at the core of this system, which posits that
these components interact to generate behaviour, which in
turn influences them in a back-and-forth cycle. These com-
ponents form the hub of what is termed a ‘Behaviour Change
Wheel’ (BCW), around which are a number of interventions
which may be implemented at the individual (e.g. education
and training), or policy level (e.g. legislation or fiscal mea-
sures) to enable the COM-B elements [18]. The BCW is a
practical tool that can be applied in implementation research
to move from identifying barriers and enablers to aligning
these with tailored interventions [24]. Definitions for the
COM-B domains, how they map to the TDF and to the
BCW intervention functions are shown (Table 1).
Study settings
South Africa has a population approaching 57 million and
a health system invested in primary healthcare [25–29].
The country is currently striving for universal health
coverage, publishing a White paper (2015) describing as-
pects of the National Health Insurance system [30]. Finan-
cial federalism is in place in which national government
develops strategies, policies and clinical CPGs; and
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provincial governments implement CPGs, sometimes after
adaptation, to healthcare facilities (from regional, to dis-
trict, to community healthcare facilities) [8].
Sampling and recruitment
South Africa is a large and diverse country. We therefore
selected four of the nine provinces to represent a
spectrum of primary healthcare settings: Western Cape,
Kwazulu-Natal, Eastern Cape and Limpopo provinces.
Each province is different in terms of population size
and density, economic development, healthcare spending
and resources, and health outcomes (Table 2). While the
Western Cape, Eastern Cape and Limpopo have similar
population sizes, the Western Cape is better funded, and
Table 1 Links between COM-B, Theoretical Domains Framework and Behaviour Change Wheel intervention functions
COM-B model Theoretical Domains
Framework
Behaviour Change Wheel Intervention
functions
Motivation
Definition: all those cognitive processes that
direct behaviour, including habitual processes,
emotional responding, as well
as analytical decision-making.
Reflective motivation Professional/ social role and
identify
Education, persuasion, modelling
Beliefs about capabilities Education, persuasion, enablement
Optimism Education, persuasion, modelling,
enablement
Beliefs about consequences Education, persuasion, modelling
Intentions Education, persuasion, incentivisation,
coercion, modelling, enablement
Automatic motivation Reinforcement Training, Incentivisation, coercion,
Environmental restructuring
Emotion Persuasion, incentivisation, coercion,
modelling, enablement
Capability
Definition: the individual’s psychological and
physical capacity to engage in the activity
concerned, and includes having the
necessary knowledge and skills.
Physical capability Physical skills Training
Psychological capability Knowledge Education
Cognitive and interpersonal
skills
Training
Memory, attention and decision
processes
Training, environmental restructuring,
Enablement
Behavioral regulation Education, training, modelling,
enablement
Opportunity
Definition: all the factors that lie outside the
individual that make the behaviour possible
or prompt it.
Physical opportunity Environmental context and
resources
Training, restriction, environmental,
restructuring, enablement
Social opportunity Social influences Restriction, environmental, restructuring,
modelling, enablement
Table 2 Key health and demographic indicators by South African provincea
Indicator Year Province
WC KZN EC LPP
Area as a % of total area of South Africa 2011 10.6 7.7 13.8 10.3
Population 2016 6,279,730 11,065,240 6,996,976 5,799,090
Population % by province 2016 11.3 19.8 12.6 10.4
GDP per capita (USA) 2010 8.69 4.77 3.65 4259
Education level (% population with no schooling) 2015 1.5 6.7 6.1 9.8
Poverty prevalence (food poverty line) 2011 23.2 37.4 40.5 41.5
Population % dependent on public sector 2016 75.96 88.22 90.13 91.58
Health as % of total expenditure 2000 30.0 26.7 20.9 17.8
Per capita public sector health expenditure 2015 4242.5 3623.1 3304.4 2957.7
Life expectancy at birth 2010 68.0 52.9 53.8 63.6
Adult mortality rate (probability of dying between 15 and 60 years) 2010 26.6 52.8 52.2 37.7
Under 5 mortality rate 2015 23.1 57.8 59.6 36.6
aAdapted from South African Health Review 2017 [27]
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has higher educational levels, lower levels of poverty and
a higher life expectancy than the others. Kwazulu-Natal
has the largest population size, a high poverty prevalence
and poor life expectancy, despite health expenditure ap-
proaching that of the Western Cape. Other factors be-
sides available funds, are likely to play a role in this
regard, including high prevalence of infectious diseases,
such as HIV [25]. Within each province, we targeted two
public sector primary care clinics, one rural and one
urban or peri-urban. While we intended to conduct
eight FGDs, we completed seven due to delayed access
in the Western Cape. To identify clinics, we contacted
the provincial research directorates and colleagues work-
ing in the provinces for guidance. All healthcare pro-
viders working at clinics, regardless of cadre, were
invited to participate (Table 3).
Data collection and management
The FGDs enabled us to explore collective experiences
of CPG use at the frontline of healthcare delivery. This
method is suited for exploring complexity surrounding
CPG use within the context of lived experiences, in ways
that encourage participants to engage actively with the
research topic [31, 32].
Seven FGDs were held from November 2015 to August
2016. Group sizes ranged from three to eleven participants
and lasted from 60 to 90min. A total of forty-eight pro-
viders participated. Primary care providers who took part
included nurses, occupational therapists, physiotherapists,
dieticians, dentists, oral hygienists and medical doctors.
The FGDs were guided by a semi-structured topic
guide which explored the following topics: the context
of CPG awareness and use; specific CPGs used (and fre-
quency of usage); access to CPGs; general views and ex-
periences of using specific CPGs; perceptions of barriers
to and enablers of CPG use; and recommendations of
strategies that might address current barriers to use. The
guide was flexible to ensure that participants could ex-
press what was important to them, and so learnings
from previous FGDs could be clarified and probed
further in subsequent FGDs. The FGD guide was not
based on the TDF, but rather sought to understand
nurses’ perceptions about and experiences with using
CPGs on their own terms and their own meaning
frames. The TDF was used during the analysis stage
to help analyse and organise the data as described
below. FGD facilitators received training in facilitation
techniques. All FGDs were conducted in pairs; mem-
bers of the research team (all females) took turns to
facilitate.
FGDs were recorded digitally. Reflections and sum-
maries were written after FGDs to capture insights. Ini-
tial coding and thematic analysis were conducted after
each FGD to guide the sampling process and to ensure
data saturation.
FGDs were transcribed verbatim, and transcriptions
were reviewed for accuracy by the research team (TK,
TM). A few participants including a lay counsellor and
entry level nurse chose to share their views using their
mother tongue which was not English. A research team
member assisted to translate these short sections for us
to include in the analysis. Data were stored electronically
on password-protected computers; a master list and
consent forms were stored in a locked cabinet for which
only the project lead had access.
Analysis
We used an iterative, thematic content analysis ap-
proach [31, 33]. Specifically, two researchers read the
transcripts (TK, SA) and agreed on the general mean-
ing and central issues presented. One researcher (TK)
then re-read transcripts, performing open coding re-
lated to general questions posed, including context,
use, barriers to and enablers of CPG use, extracting
the related quotes [34]. Quotes were then further ex-
amined (TK, SA) for manifest and latent meanings
[35]. At this point, we searched for conceptual frame-
works that might help us better understand and
organize the data. The TDF was considered to pro-
vide a useful model in this regard, enabling us to en-
capsulate the individual and context factors that
facilitate and /or hinder CPG use that we saw emer-
ging from the data. The model was also deemed valu-
able to facilitate the subsequent translation of our
findings into actionable recommendations for inter-
ventions which target specific barriers. This model
has been used successfully by others to evaluate
healthcare implementation challenges and to design
theory-informed implementation strategies [20, 21].
Having examined individual quotes for manifest and
latent meanings, two researchers (TK, SC) then used
the TDF to further categorise the data. In particular,
specific quotations and their meanings were matched
to the 14 domains within the TDF. The two re-
searchers performed the matching independently, and
Table 3 Schedule of Focus Groups
Location Discipline Number of
focus groups
(participants)
Western Cape Nurses, dentists, health promotions
officer
1 (n = 6)
Eastern Cape Nurses 2 (n = 12)
Limpopo Dentists, oral hygienist, occupational
therapy, physiotherapy, dietician,
counsellors, database administrator
2 (n = 17)
Kwa-Zulu Natal Doctors, nurses, quality assurance
officer, dentist, physiotherapist,
counsellors
2 (n = 12)
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subsequently discussed these with each other and the
third researcher (SA) to reach agreement and resolve
uncertainties. Each quotation was coded to at least
one TDF domain, but some we felt could be coded
into two or three domains. In the case of the latter,
judgments were made about which specific domain
the quotes should be categorized, in a manner that
captured the meaning of individual quotes and fitted
with the broader themes that were emerging. Once
our findings were aligned with the TDF domains and
associated COM-B system, then proceeded to map
the findings onto the respective intervention functions
to generate recommendations based on the BCW
[24]. The process of developing recommendations was
informed by the methods used by Michie and col-
leagues to link their analysis of the targeted behav-
iours to appropriate interventions for controlling
tobacco and reducing obesity [18].
Rigour
Credibility was ensured through detailed capturing and
description of our approach to sampling, data collection,
data management, analysis and interpretation [35]. Con-
sideration of issues regarding reflexivity and transferabil-
ity were considered throughout the process. Quotations
were chosen to provide readers the opportunity to inter-
pret data, establish confirmability and to show the rich-
ness of the data. Complementary research competencies
and experiences among all researchers influenced data
interpretation and strengthened study rigour.
Results
Most participants were nurses; two were doctors at one
FGD in Kwa-Zulu Natal (Table 3). Although we col-
lected limited demographic data, we observed that those
in rural facilities had worked for a longer time and lived
in the area, whereas at the more urban facilities, partici-
pants were generally younger, more recently appointed
and potentially more mobile.
In this section we report the potential enablers of and
barriers to CPG use in terms of the COM-B domains of
‘Motivation’ (reflective, automatic), ‘Capability’ (psycho-
logical, social) and ‘Opportunity’ (social, physical)
(Table 1) [23], and reflect on and unpack the TDF cat-
egories within them.
Motivation – Reflective and automatic
Motivation includes behaviors corresponding to reflective
motivation and those that are more automatic or habitual.
We report on both reflective and automatic motivation as
they include issues of emotion, professional identify, be-
liefs about capability and consequences. Strikingly, across
all FGDs, the overwhelming majority of participants
expressed motivation to use CPGs. CPG use appeared to
evoke a range of positive emotional responses, particularly
amongst nurses. Sentiments included ‘reassuring’, inspiring
‘confidence’ and providing a sense of autonomy or ‘inde-
pendence’. The latter was particularly pronounced in more
rural settings, with few doctors:
It makes [allows] us to be in line with the doctors, it
makes us doctors ourself [sic], so it means you will be in-
dependent (Nurse_LPP_rural).
Additionally, CPGs were perceived as useful tools to
engage the community, share information and protect
healthcare providers’ professional integrity, which fur-
ther motivated use:
Even if there is a complaint among the community
members that we have mismanaged this client, so we say,
I have managed this client … through the guidelines and
we show him the guidelines (Nurse_EC_rural).
Overall, CPGs were perceived as credible sources. Nurses
and allied healthcare providers in several clinics described
having first-hand experience of CPGs improving patient care.
One particularly significant example cited was that of HIV,
where CPGs had changed rapidly as the field of HIV care
changed in South Africa. Providers described having seen pa-
tients transition from dying prior to the availability of HIV
CPGs, to patients living with HIV after CPGs were imple-
mented. This underscored for them the perceived value that
using CPGs bring:
It’s working, because when we want to find out our
statistics, people they are now…[HIV] negative…they
have got ARV’s [antiretrovirals] and they are fine…
(Nurse_KZN_rural).
Compared to nursing staff, the link between CPGs,
professional identity and enablement seemed lesser for
doctors, as one doctor suggested:
I must confess, we doctors are not very good at seeing
this is what the guidelines says. This is the way I do
things and then you go on. It’s not just here but if you
go to another place you’ll find the same thing.
(Doctor_KZN_peri-urban).
Capability – Knowledge and skills
Capability includes knowledge, understanding, decision-making
and skills as fundamental drivers of behaviour. A con-
sistent narrative amongst participants was that know-
ledge of CPGs was not a barrier to usage. Participants
conveyed considerable awareness of CPGs, with many
naming several that were in regular, perhaps even
daily use. In addition to knowledge, remembering and
deciding to use CPGs was not perceived as a barrier.
Some participants even voiced curiosity about why we
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would conduct research on something that was so ob-
viously part of routine clinical care.
While some participants described using CPGs for
‘each and every patient’, others suggested that they were
most likely to use CPGs in particular instances. That is,
they tended to use CPGs when faced with an unfamiliar
clinical case or a change in the recommendations that
sparked curiosity, and required learning:
…what makes me want to read some of them is
because I came across such a patient, and I didn’t
know what to do then I go back to read. That is what
makes me wanna read, otherwise I don’t think I’ll just
sit down and read the guideline
(Oralhealth_LPP_peri-urban).
Despite their own knowledge, participants expressed an
important gap in CPG awareness amongst patients and
the public. Many felt that increasing public awareness of
CPGs was important for successful CPG implementation.
That is, a more health-literate and empowered public was
perceived to encourage accountability of healthcare pro-
viders. Several approaches for raising public awareness
were proposed, including engaging journalists, use of
radio, television and social media:
Maybe when you’re listening to [the] radio and reading
news, they should introduce this change everywhere, be-
cause even [the] patients should know (Oralhealth_LPP_
peri-urban).
Another significant gap identified by participants
was training in CPG usage. Training was perceived as
an essential tool to ‘keep abreast’ or ‘get up to speed’
with CPG content. It was also considered important
for enhancing clinical practice and ensuring that all
disciplines ‘will be on the same level’ and thus prevent-
ing a ‘clash of information’. While training was unani-
mously perceived as necessary for proficient CPG
usage, participants were undecided about the setting
in which training should take place. Specific feedback
about the pros and cons of on-site training and
off-site workshops were provided, which are detailed
in Additional file 1. Though training was considered
key to CPG use, many participants felt that skills
building through training was inadequate. Training,
regardless of whether providers were from urban or
rural settings, was considered insufficient or patchy,
not covering all topics and not inclusive of all clinical
disciplines. This inadequacy was perceived to result in
CPGs which are ‘hard to interpret’ and thus staff hav-
ing to ‘struggle’ on their own to use CPGs properly.
The management process for deciding who would at-
tend workshops was also described as non-transparent
and unfair, with ‘no consistency’ surrounding attend-
ance. Thus, while participants were categorical about
the need for more training, the issue of how best to do
this remains complex.
Opportunity – Social and physical
Opportunity includes both physical opportunity and social
opportunity. Social opportunity considers the social influ-
ences that may impact CPG use. While this domain did not
generate substantial discussion amongst participants, what
emerged consistently, particularly in rural facilities, was the
value of supportive social and professional systems as enab-
ling quality clinical care and CPG use. These systems, in-
cluding involvement of non-governmental organisations,
and associated cohesive teams and strong leadership, were
perceived to enable the culture of CPG use.
So it’s team work that matters, if you are working as a
team you do (Nurse_EC_peri-urban).
Whereas we found generally supportive social and
professional environments, the physical environment
emerged as a considerable obstacle to CPG use. This do-
main generated extensive discussion, with several
sub-themes emerging, namely: the need to adapt to local
context; health system challenges; access to CPGs; CPG
design needs; and digital CPGs. In addition to describing
these barriers in great depth, participants from all disci-
plines also provided practical recommendations for how
these contextual barriers might be addressed.
CPGs being insufficiently adapted to local contexts
emerged as a key issue. Given the diversity in a large
country like South Africa, the context in which CPGs
are used may differ by province. Some CPG recommen-
dations were experienced as ‘not practical’ and not ap-
propriate to local healthcare contexts. Many agreed that
for CPGs to become ‘something that can really apply to
us’ and that ‘actually works to suit the PHC [primary
health care]’, healthcare providers should be part of CPG
development processes.
Health system challenges emerged as another major
barrier to CPG implementation. The ability to operation-
alise CPG recommendations was described as signifi-
cantly hindered by ‘no budget’, ‘slow procurement’, or the
lack of equipment where staff simply ‘don’t have the ma-
chine’. Stock outs of medicines was highlighted as an
issue:
when there is a recommendation and the medication
is not there… we are stuck (Nurse_LPP_rural).
Relatedly, primary care clinic pressures were perceived
to limit providers’ ability to properly read CPGs. All
cadres described that the ‘long queues outside’ and the
time needed to ‘page and page’ through a CPG was not
feasible during a consultation.
Participants also identified barriers related to the
design, layout and language of CPGs, and made
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suggestions for how these might be improved to en-
hance CPG use (Additional file 2). Many spoke about
the lengthy nature of CPGs and the ‘big jargon Eng-
lish’, which limited understanding and use. They
expressed a wish for ‘much more user friendly’ CPGs,
including using ‘short directive’ and more simple lan-
guage, and incorporating ‘summarised’ versions, more
definitions, local vernacular and supplementary tools
(e.g. posters) to aid understanding and support pa-
tient engagement. A doctor suggested that, as people
maybe ‘visual learners’, use of more attractive and ap-
pealing formats, such as graphics, charts, and colour,
would enhance CPG use. Colour-coding in one of the
primary care CPGs (PC101) was described as effect-
ive, as one nurse said, it ‘keeps you on the toes’
(EC_peri-urban).
Poor access to good quality and up-to-date CPGs
materialised as an especially pertinent physical barrier
to CPG usage. Many participants, particularly those in
rural settings, provided detailed narratives about how
‘hard to reach’ CPGs were. Many described how they
frequently ‘get them late’ or have access to ‘only one
copy’ in their clinics. Others spoke about the way in
which CPGs are often stored inaccessibly outside of
consulting rooms, while others highlighted the poor
systems that exist for CPG version control, ultimately
resulting in ‘confusion’ and outdated information. Fur-
thermore, it emerged that even when CPGs are avail-
able, they are frequently of sub-standard quality:
They make copies and pages are missing, the
arrangement of the pages, [it] becomes bulkier
and all these things. So that’s a problem, I mean
people don’t really get the real thing, a reprint or
make a copy and make your own.
(Doctor_KZN_peri-urban).
Numerous participants, both rural and urban,
highlighted that many of these barriers around access
would be addressed if CPGs were available digitally.
They explained that access to digital CPGs would en-
able them to read them in their own time, not only
during consultations, which would in turn make keep-
ing up-to-date easier. They also suggested that it
would improve knowledge transfer after workshops,
reducing issues related to information sharing.
Additionally, many believed that digital CPGs would
result in all healthcare providers receiving CPGs in a
timely manner and further support in-facility capacity
building when new CPGs were disseminated.
Despite general agreement that digital CPGs may fa-
cilitate usage, a number of complexities associated with
this medium emerged. Some participant wondered
whether use of digital CPGs in front of patients would
generate negative patient perceptions, who might believe
that healthcare providers are ‘busy on Whatsapp’, acces-
sing other nonwork-related content, or that they lack
knowledge. At the same time, while some participants
had CPGs on their phones, including the CPG app or
electronic books, this was a minority, and mostly seen in
peri-urban facilities. Most clinics did not have internet
access either via computer stations or wireless internet,
and healthcare providers did not consistently have smart
phones, data and internet access through other means.
This was particularly evident in the more rural clinics
where in a FGD of 11 staff, one nurse reported having
opened a personal email account, and even that was a
recent development. Although participants in the West-
ern Cape FGD described having personal internet access,
they suggested that limited phone memory, high data
costs and the need to download CPGs at their own ex-
pense was a barrier. Thus, use of digital CPGs was de-
scribed to come with its own set of access issues, and
while evidently desirable, remains aspirational from pro-
viders perspectives.
Implications for policy and practice: Theory informed
interventions
The barriers most often expressed by participants
were related to the environmental context, resources
and training needs. We thus used the BCW approach
to map the most relevant intervention functions to
address these specific barriers, as shown in Fig. 1
[18]. In this matrix we provide specific suggestions
for possible interventions to increase use of South Af-
rican primary care CPGs.
Therefore, from our findings, ‘physical and psycho-
logical capacity’, in particular poorly supported training
was a barrier to CPG use; and most strikingly, the ‘phys-
ical opportunity’, in that the environmental context and
available resources were substantial challenges to CPG
use. Based on our results, the following intervention
functions are suggested that align the COM-B domain,
behavioural barriers and possible interventions:
– Training - imparting skills (for example workshops,
on site mentoring and supervision, post-training
support)
– Education – increasing knowledge or understanding
about specific CPG recommendations (e.g.
workshops, post workshop support and clinical
support)
– Environmental restructuring – changing the physical
environment (e.g. making the CPGs more accessible
through different formats, greater design
consideration, summarized simple language, more
appealing tools that support implementation that
help engage patients such as posters and algorithms;
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ensuring supply chain functioning and access to
medicines and equipment; building ICT
infrastructure and creating digital access)
– Enablement – increasing means and reducing
barriers to increase capability or opportunity (for
example, this may include audit and feedback,
clinical support and team building).
Discussion
This study explored the perspectives of primary care
healthcare providers, working in public sector clinics, re-
garding the context, potential barriers to and enablers of
CPG use in four diverse provinces in South Africa. We
investigated these issues through the lens of the TDF, in
order to categorise the barriers and enablers in terms of
COM-B: Capability, Opportunity, and Motivation.
Enablers –motivation, knowledge and social opportunity.
Our findings revealed that primary healthcare nurses
and allied health practitioners generally trust the cred-
ibility of CPGs and are highly motivated to use them.
CPG usage was perceived to be associated with a range
of positive emotional and professional consequences, ex-
periences that have been described elsewhere as poten-
tial benefits of CPGs [3]. In addition, knowledge of
CPGs, along with regular use, were reported by most
healthcare providers, a finding of importance, given that
both knowledge about and positive attitude towards a
CPG are factors that have been identified as potentially
enhancing CPG implementation [36].
Participants in our study, particularly nursing staff,
emphasised the importance of cohesive teams, clinical
supervision and strong leadership to enable CPG use.
This corroborates reports from higher income settings,
which describe the importance of socio-behavioural fac-
tors, such as peer support, to enhance CPG use [36–38].
Studies in South Africa have revealed that support and
supervision for healthcare providers are currently inad-
equate. For example, a qualitative study in which allied
health practitioners and health managers were inter-
viewed, found a lack of support for allied health practi-
tioners in their practice [39, 40]. Similarly, a recent
survey among primary healthcare nurses suggests that
many felt unsupported by supervisors to provide best
quality clinical care [37, 41]. Against this backdrop, and
in light of the findings from our study, enhancing CPG
use in South Africa necessitates developing cohesive
professional teams and building clinical support for
practitioners.
Barriers – Physical capability (skills and training)
Despite apparent knowledge of CPGs and motivation to
use them, patchy and non-inclusive training in CPGs
emerged as an important barrier to their usage. Lack of
requisite skills and self-efficacy are reported barriers to
CPG implementation [36]. The participants in our study
considered skills building in CPGs essential for enhan-
cing proficiency to use CPGs properly, ensuring similar
levels of capability and knowledge amongst healthcare
providers, and for facilitating standardised use across
disciplines.
However, exactly how this training should be delivered
emerged as a complex issue, with participants suggesting
advantages and disadvantages of both on- or off-site train-
ing. Our participants talked about off-site educational
meetings, on-site educational outreach and supportive
Fig. 1 Matrix of COM-B Model barriers and suggested intervention functions. This figure represents a Matrix of barriers that were identified from
participants and the potential interventions to overcome them, as guided by the BCW. The matrix is colour coded and all blue coloured areas
represent where the COM-B domain aligns with the intervention functions. The darker the shade of blue, the more pertinent the need for an
intervention, in light of our findings
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clinical audits as desirable. In an overview of systematic
reviews, several skills building strategies for implementing
health systems in low- and middle-income settings were
reported with varying levels of effectiveness, including
practice facilitation, educational outreach, audit and feed-
back, educational meetings, and local opinion leaders [14].
In South Africa, there have been several trials of educa-
tional outreach for nurse-driven primary care evaluating
CPG implementation [15, 17]. As such, we have support-
ing evidence regarding feasibility of this approach for
managing co-morbidity, and in some studies, evidence of
effectiveness for tuberculosis and HIV CPG implementa-
tion [15, 17, 42, 43]. Thus, while this study revealed a clear
stated need for increased skills building, the best means of
providing this in South African primary care might con-
sider using a combination of methods to enable CPG up-
take and use.
Barriers - physical opportunity (environmental context
and resources)
While other COM-B constructs emerged as enablers of
CPG usage, ‘physical opportunity’ materialised as the
most substantial barrier, with participants highlighting
numerous contextual issues that hinder effective CPG
use. These may be further understood as pertaining to
two aspects, the CPG itself or the environmental context
in which CPGs are implemented.
Regarding the CPG itself, participants perceived that
usage of CPGs is hindered significantly when their content
is impractical to implement and linguistically inappropri-
ate; when CPG design features are not user-friendly; and if
there are inadequate CPG supplementary tools (e.g. pic-
tures) or no summarised versions. This resonates with a
review of different features for ensuring CPG ‘implement-
ability’, together with a supporting checklist for CPG de-
velopers to consider [44]. These resources suggest that
specific features of CPGs are likely to enhance their usage,
including structured recommendations; providing con-
textual information regarding clinical cases; explicit re-
source implications; and supporting algorithms and
clinical tools [44, 45].
In terms of the physical environment, several factors
were identified as critical obstacles to CPG implementa-
tion. In particular, a lack of necessary equipment and re-
ported budgetary and supply constraints, including stock
outs of medicines, were a concern and perceived to be
related to poor district or provincial management sys-
tems. These health system challenges are well described
in the country, including a recent qualitative study in
which access to equipment or medicines posed serious
challenges to delivery of health services for both users
and providers of care [6, 9, 26, 46, 47]. In our study, in-
adequate systems for distribution of printed CPGs and
CPG-related circulars, as well as poor CPG version and
quality control, appeared to impact upon CPG use.
Taken together, this collection of environmental issues
was seen by participants to result in CPGs that are fre-
quently unavailable, inaccessible, of a suboptimal quality
and/or difficult to implement. While these barriers
emerged across the different study settings, they ap-
peared to be particularly pertinent and heightened in
rural areas.
Aspirational enabler - digital access to CPGs
Participants consistently suggested that making digitally-
formatted CPGs and associated technologies (e.g. inter-
net, computers, laptops) available was a key strategy to
increase CPG access and use. Digital CPGs were sug-
gested to redress many of the contextual challenges they
currently face, such as lack of sufficient CPG hard copies
or poor version control. There is growing evidence
regarding the role of handheld devices to support CPG
use. A systematic review reported that doctors and
nurses using a CPG on a handheld device may increase
access to information, adherence to a CPG and support
for diagnosing conditions, in comparison to peers using
paper-based resources [48]. However, despite this
promising evidence, results emanate predominantly from
high-income settings where access and availability of
technologies are different to those in low- and
middle-income settings. Therefore, despite interest in
this area and fast-growing opportunities in technology,
current data costs, lack of infrastructure, internet or
devices, particularly in rural settings, present major
challenges to this becoming a reality, as revealed in our
study.
Implications for policy and practice: Strategic theory
informed interventions to overcome barriers
Given the limited resources to invest in CPG implemen-
tation in many settings, ensuring that the interventions
best match the issues and barriers that emerge is a ra-
tional approach. We identified that investment for
implementing primary care CPGs should consider envir-
onmental restructuring, enablement, and training and
education (Fig. 1).
Training and education is already a major means for
delivering information to primary care via regional train-
ing centres and responsible district training personnel.
However, the results of this and other studies, suggest
specific adaptations and enhancements need to be con-
sidered and implemented [39, 40] such as enhanced
in-facility training and post-training clinical support. An-
other intervention function is enablement. Given the
motivation of healthcare providers to use CPG, further
enablement using evidence-based strategies, such as
constructive clinical audit and feedback, clinical support
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and mentoring or team building, may be effective
methods to build on the current foundation [17]. Finally,
the most substantial barrier, environmental resources,
requires considerable resources and planning regarding
how best and most cost effectively to restructure the en-
vironment to enhance CPG use. Some approaches, such
as making more CPG books available or changing the
physical appearance of the paper resources enhanced
with design features, may be more feasible to achieve
short to medium term; however addressing health sys-
tem reforms including equipment supplies and infra-
structure upgrades are important to have on a
government agenda for urgent consideration.
Choosing and implementing these interventions will
require government buy-in, priority setting and feasibil-
ity assessment. Where possible, interventions already in
place could be enhanced while others may need to be
initiated. The COM-B model is further complemented
by a set of specific criteria that can aid decisions when
considering interventions. These criteria include: afford-
ability, practicality, effectiveness and cost effectiveness,
acceptability, side effects, safety and equity [24]. The
relative effectiveness of the priority options should be in-
formed by available systematic reviews [14].
Limitations
Our study has several limitations. Given the volume of
CPGs and CPG users at play in South Africa, we set out
with a very broad topic - exploring perceptions of all pri-
mary care CPG users for all available primary care CPGs. It
is likely we would have identified more specific responses
had we evaluated a specific CPG and a specific CPG user.
However, given the paucity of published work in our set-
ting, we considered this research exploratory, and the best
approach to understanding the state of CPG use in primary
care, guiding us to further define the research and policy
needs for CPG implementation. A SAGE linked sub-study
explored perspectives of allied health workers, adding to
our more specific knowledge [39, 40].
Our sample is a fair reflection of the South African
public sector primary care, which is predominantly man-
aged by nurses [37]. We have sufficient data on nurse
and allied health providers perspectives, however, further
work with other cadres is required [40]. The two doctors
we spoke to stated that doctors generally do not use
CPGs, suggesting that this cadre of professionals may
hold differing views to nurses and allied health pro-
viders. However, given the small number of doctors par-
ticipating in our study, it is unclear whether this
perspective is widely held by primary care doctors and
further exploration is therefore required.
A possible limitation may be the positionality of the
researchers in eliciting certain responses [31]. It may be
that the presence of researchers asking about CPGs
resulted in more positive responses about CPG use, and
thus positive reporting bias. However, to pre-empt this
possibility, each interview was facilitated by a social sci-
entist, along with a healthcare provider (who understood
the clinic context), which we hope brought balance to
our interviewing, rather than prompting for specific re-
sponses. Given the consistent narratives, regardless of
setting, we hope that most participants felt free to pro-
vide their true experience and perspective.
We reflected on our choice to use the COM-B and
TDF approach, where, following inductive coding, we
mapped the codes and themes to the domains of the
TDF [18, 23]. We found it assisted us to make sense of
the data that emerged, a manner relevant for under-
standing this aspect of health services research. How-
ever, following open coding, the deductive mapping
process was challenging. Several of the constructs were
related to each other, and could be categorised under
more than one domain, for example, professional iden-
tity forms a part of social opportunity, and therefore af-
fects motivation. In addition, judgments were required
regarding how and where to categorise our findings to
best report our understanding of the views of partici-
pants. During the process, where items were unclear, we
discussed this to resolve discrepancies. In this way, we
were able to ensure consistent application of the TDF to
our data.
Conclusions
We found that South African primary care nurses and al-
lied health practitioners are aware of CPGs and have high
levels of motivation to use them, however, they face many
systemic barriers to doing so. Strategies addressing the
most pertinent identified barriers, including physical access
to CPGs, training to use them and the equipment and re-
sources to implement CPGs, should build on and enhance
processes already in place in South Africa. Prioritising po-
tential interventions, including effective training, clinical
audit and feedback, and equipment supply, may strengthen
primary care and improve CPG implementation ultimately
impacting on the health of South Africans.
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Chapter 6: Policy briefs - summarising the research findings for policy and 
practice 
 
Summary: Taken together, the research findings from national, provincial role-players and primary care 
healthcare providers has provided an overview of processes and context of primary care CPG 
development, implementation and use. Participants shared views regarding what they perceived to be 
working, what could be improved and suggested ways to enhance or address primary care CPG challenges. 
The results are summarised in two policy briefs, one which shares the views from national primary care 
CPG development perspective, and the second to inform CPG implementation and use from the 
perspective of implementers and users.  
 
A policy brief is defined in a multitude of ways. I have opted to follow a definition and recommendations 
from the International Development Research Centre (IDRC). They state that a policy brief is ‘a concise 
summary of a particular issue, the policy options to deal with it, and some recommendations on the best 
option. It is aimed at government policymakers and others who are interested in formulating or influencing 
policy’. (IDRC https://www.idrc.ca/en/resources/research-tools). 
 
Dissemination plan: SAGE has a dissemination strategy for all products. The policy briefs will be shared 
with the network of national and provincial policy-makers and implementers involved with primary care 
CPG involvement, who may share it more widely amongst their networks. 
 
Available online at:  
•  South African Primary Care Clinical Practice Guideline Implementation and Use: Gaps & Opportunities 
(Policy Brief)  
•  South African Primary Care Clinical Practice Guideline Development: Gaps & Opportunities (Policy Brief) 
 
Related report: 
The SAGE project ended in March 2019. It included many components, including those outlined in this 
thesis. For an overall report of SAGE, see final report. 
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SOUTH AFRICAN PRIMARY CARE CLINICAL PRACTICE 
GUIDELINE DEVELOPMENT: 
GAPS & OPPORTUNITIES
This policy brief addresses the following questions from the perspectives of national primary care 
guideline developers:
• What are the processes for national primary care guideline development?
• What are strengths and gaps in guideline-development processes and how can we enhance 
transparency and public trust in guideline development? 
WHY ARE PRIMARY CARE GUIDELINES IMPORTANT IN THE 
SOUTH AFRICAN CONTEXT?
Clinical practice guidelines (CPGs) are common tools used for policy and clinical practice. Guidelines 
inform clinical decisions at the bedside, governance of health facilities, health insurer and government 
spending, and patient choices. 
South Africa’s health sector is transitioning to Universal Health Coverage (UHC) funded through a 
National Health Insurance (NHI) system. The planned NHI aims to build on available primary healthcare 
initiatives to transform the previously segregated, inequitable services. Within these plans, guidelines 
are a named tool for supporting the delivery of equitable, standardised, evidence-informed, cost-
effective care. 
Our study undertook research on the current context and processes for South African primary care 
guideline development. We hope that what we have learned may inform improvements in guideline 
activities nationally. 
KEY ACTIONS FOR PRIMARY CARE GUIDELINE DEVELOPMENT
The key actions identified from the studies are listed below, with further details about the study methods 
and findings provided at the end of the brief. 
National guideline developers had the following recommendations:
1. Strengthen coordination of guideline activities nationally.
2. Set minimum standards for all national guideline development and adaptation activities.
3. Allocate funds and resources for technical and administrative tasks required to develop high–quality, 
credible guidelines.
4. Build capacity for guideline development group members, technical support teams and 
methodologists, to keep up to date with global standards for development. 
5. Put in place processes to manage actual and potential conflicts of interests.
6. Establish consultation processes that bridge: national guideline groups; national, provincial and 
district groups and implementers; private and public-sector role players including professional 
societies; developers, end-users and patients.
South Africa
This policy brief targets 
national and provincial 
policy makers, health 
managers, and healthcare 
providers with an interest 
in primary care clinical 
practice guideline 
development processes. 
The brief summarises 
qualitative research 
findings from interviews 
with national guideline 
development role players 
throughout South Africa.
These research findings 
are part of the South 
African Guidelines 
Excellence Project (SAGE). 
SAGE was a multi-partner 
collaborative project that 
aimed to explore South 
African primary care 
guideline development, 
implementation and 
capacity needs. Further 
information on SAGE can 
be found at http://www.
mrc.ac.za/intramural-
research-units/
Cochrane-SAGE
The SAGE Guideline 
Toolkit is a repository 
of global guideline 
resources. This may be 
useful for those who want 
to find, appraise, develop, 
adapt, implement or 
evaluate guidelines. 
To access this free 
resource, go to: https://
guidelinetoolkit.org.za/
The World Health Organization (WHO) definition of a guideline suggests that it offers 
”recommendations for clinical practice or public health policy” with the aim of telling guideline end-
users ”what he or she can or should do in specific situations to achieve the best health outcomes 
possible”. In this way a guideline can offer choices ’among different interventions or measures’ that 
are known to positively impact health or the use of resources.
WHO Guideline for Guidelines Manual, 2nd edition, 2014
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METHODS
Qualitative research methods were used. Interviews 
were conducted with 37 role players involved in primary 
care CPG development and implementation and/or use 
in four provinces in South Africa (Eastern Cape, Gauteng, 
Western Cape, KwaZulu-Natal). The in-depth interviews 
were analysed using thematic content analysis. 
FINDINGS
CHALLENGES IDENTIFIED BY ROLE PLAYERS
Despite a committed guideline community wishing 
to address inequities, guideline development and 
implementation are affected by:
1. insufficient funding for technical and methodological 
work; 
2. fragmentation between groups, and between 
national and provincial health sectors;
3. lack of standardised systems for CPG development 
and implementation;
4. resource gaps create an enabling environment for 
commercial interests or personal agendas; and,
5. no centrally coordinated CPG unit to address these 
needs. 
Recommendations from participants suggested six 
processes should be strengthened to more effectively 
inform national primary care guideline development:
1. Systematic use of evidence following agreed 
standards to ensure trustworthy guidelines.
2. Enhanced stakeholder consultation, to create a better 
understanding of end-users and patients’ needs 
in development processes, ultimately to enhance 
guideline uptake.
3. Ensure transparency in processes and communication 
to avoid the view of guideline development as a ‘big 
black box’ and create credible guidance.
4. Build systems for better management of interests for 
conflict free, trustworthy guidelines; 
5. Create systems for national co-ordination between 
guideline development groups to avoid duplication 
and support or endorse various national guideline 
players.
6. Consider the need for ‘fit-for-context’ guidelines 
that consider unique health system, geographic and 
cultural factors in the different provinces. 
Citations: 
1.  Kredo T, Abrams A, Young T, Louw Q, Volmink J, 
Daniels K. Primary care clinical practice guidelines 
in South Africa: qualitative study exploring 
perspectives of national stakeholders. BMC Health 
Serv Res 2017;17(1):608.  www.ncbi.nlm.nih.gov/
pmc/articles/PMC5575947/pdf/12913_2017_
Article_2546.pdf
2.  Kredo T, Cooper S, Abrams A, Daniels K, Volmink J, 
Atkins S. National stakeholders’ perceptions of the 
processes that inform the development of national 
clinical practice guidelines for primary healthcare 
in South Africa. Health Res Policy Syst 2018;(1):68. 
www.ncbi.nlm.nih.gov/pmc/articles/PMC6069850/
pdf/12961_2018_Article_348.pdf
GUIDELINE DEVELOPMENT: 
PERSPECTIVES OF NATIONAL PRIMARY CARE 
GUIDELINE DEVELOPERS
CONTACT DETAILS:  
Tamara Kredo 
tamara.kredo@mrc.ac.za 
Cochrane South Africa, South African Medical Research Council
June 2019
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SOUTH AFRICAN PRIMARY CARE CLINICAL PRACTICE GUIDELINE 
IMPLEMENTATION AND USE: 
GAPS & OPPORTUNITIES
This policy brief aims to answer the following questions from the perspectives of provincial and 
district guideline implementers, healthcare providers and end users:
• What are the experiences of provincial and district health managers of primary care guideline 
implementation? What is working and what can be improved?
• What do healthcare providers recommend for better primary care guideline implementation 
and use? 
WHAT DO WE KNOW ABOUT THE CURRENT STATE OF PRIMARY 
CARE GUIDELINE IMPLEMENTATION AND USE IN SOUTH AFRICA?
National Health Insurance (NHI) is planned for the coming decade with guidelines being one of the 
named tools to achieve evidence-informed, cost-effective healthcare that spans the sectors, supports 
equitable access and ensures better patient outcomes. Globally, one of the greatest challenges with 
healthcare is the ‘evidence-practice gap’ between what is recommended based on best-available 
evidence and what is done in clinical practice. 
Evidence-informed guidelines have little impact if they are not implemented. In South Africa, 
guidelines are usually developed at a national level while the responsibility for implementation 
lies with provincial and district managers. Understanding the barriers to and enablers of effective 
guideline implementation from the perspective of those provincial and district managers, and 
healthcare providers may provide insights for prioritising resource allocation in primary care guideline 
implementation.  
KEY ACTIONS FOR PRIMARY CARE GUIDELINE 
IMPLEMENTATION 
We conducted two studies to identify the gaps and opportunities in guideline implementation. The 
overall key actions identified from both studies are listed below, with further detail about each study 
at the end of the brief.
HEALTH SYSTEM LEVEL ACTIONS:
• Financial investment in guideline implementation activities including printing and distribution of 
sufficient numbers of guideline books; responsive procurement able to provide necessary basic 
equipment, medicines and supplies to adhere to guideline recommendations; and, development 
of infrastructure to enable digital access to guidelines in all parts of South Africa.
• Strengthening and supporting governance by setting clear roles and responsibilities for guideline 
implementation in provinces.
HEALTH WORKFORCE LEVEL:
• Health managers request support and training to be able to adapt national guidelines for 
provincial contexts.
• Quality-improvement initiatives should include constructive, rather than punitive, audit and 
feedback processes.
South Africa
This policy brief is 
targeted at national and 
provincial policy makers, 
health managers and 
healthcare providers with 
an interest in primary 
care clinical practice 
guideline development, 
implementation and use. 
The brief summarises 
qualitative research findings 
from interviews and/or 
focus group discussions 
with two groups of role 
players – provincial and 
district health managers, 
district clinical specialists 
and primary care trainers; 
and, primary care 
healthcare providers. 
These research findings are 
part of the South African 
Guidelines Excellence 
Project (SAGE). SAGE 
was a multi-partner 
collaborative project that 
aimed to explore South 
African primary care 
guideline development, 
implementation and 
capacity needs. Further 
information on SAGE can be 
found at http://www.mrc.
ac.za/intramural-research-
units/Cochrane-SAGE
The SAGE Guideline Toolkit 
is a repository of global 
guideline resources. This 
may be useful for those 
who want to find, appraise, 
develop, adapt, implement 
or evaluate guidelines. 
To access this free 
resource, go to: https://
guidelinetoolkit.org.za/
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• Healthcare provider training should be part of the 
requirements of clinical service, with time and support 
allocated to attend training events. 
• Training should be accessible and interactive, including both 
off-site training and on-site case-based clinical mentorship. 
• Training should be interdisciplinary, including nurses, allied 
health practitioners, pharmacists and doctors to ensure 
cooperation and standardisation of patient care.
GUIDELINE LEVEL:
• Guidelines need improved design features to attract attention 
and interest through better use of formatting, colours, 
simplified language and use of local languages.
• Digitally-formatted versions will increase ease of access and 
potentially use; this can also ensure access to the most up-to-
date guidelines, avoiding confusion with changing versions.
• Supplementary materials (e.g. posters) can support patient 
engagement. 
• Clinical support should be available for questions that arise 
following training.
RESEARCH METHODS
Qualitative research methods were used in the two studies 
including interviews and focus groups with 70 role players 
involved in primary care guideline implementation and/or use 
in four provinces in South Africa (Eastern Cape, Western Cape, 
Kwazulu-Natal, Limpopo). The data were analysed using thematic 
content analysis. Some data were considered through the lens of 
behaviour-change theory (Theoretical Domains Framework and 
Behaviour Change Wheel). The findings of the two studies are 
described below.
STUDY 1: GUIDELINE IMPLEMENTATION 
FROM THE PERSPECTIVE OF PROVINCIAL 
AND DISTRICT GUIDELINE IMPLEMENTERS
We interviewed 22 role players in four provinces who are 
involved with primary care guideline implementation. These 
included provincial and district health managers, members of 
the District Clinical Specialist teams and district primary care 
trainers. Two main factors impact implementation: health-
system barriers and socio-cultural and geographic context.
HEALTH-SYSTEMS FACTORS:
• Financial constraints impact access to guidelines as well as 
access to the necessary equipment and medicines to adhere 
to guideline recommendations.
• Governance needs to be strengthened including clarifying 
roles and accountability for guideline implementation. Audit 
and feedback should be constructive rather than punitive.
• A ‘compliance culture’ results in a focus on reporting on 
administrative issues for the Auditor General, rather than on 
a clinical audit of health outcomes. 
• Health workforce challenges result in insufficient numbers, 
and inadequately trained primary care providers with limited 
clinical support and mentorship post training.
• There is inadequate interdisciplinary training to ensure all 
clinical disciplines are up-to-date.
• Managers working with non-governmental organisations 
‘partner’, to deliver training and disseminate guidelines, but 
this may not be sustainable and is funding dependant. This 
also drives the kinds of guidelines that are distributed (e.g. 
HIV has greater investment than diabetes).
GEOGRAPHIC AND CULTURAL CONTEXTUAL FACTORS:
• National guidelines are not sufficiently considerate of 
provincial differences including geographic and cultural 
factors, and this results in national indicators that may not be 
applicable or feasible in all provinces.
• Insufficient consultation with end-users and patients limits 
the usability of guidelines which may be result in guidance 
that is not fit for the cultural or geographic context.
• Provinces may need to adapt the guidelines to better fit their 
context, however, there is limited technical knowledge on 
how to go about this and limited support in how to adapt 
guidelines.
Citation: Kredo T, Cooper S, Abrams A, Muller J, Schmidt B, 
Volmink J, Atkins S. Building on shaky ground – challenges to 
and solutions for primary care guideline implementation in 
four provinces in South Africa: a qualitative study. BMJ Open 
(submitted May 2019).
STUDY 2: GUIDELINE USE FROM THE 
PERSPECTIVE OF PRIMARY CARE 
HEALTHCARE PROVIDERS AND END-USERS 
We interviewed 48 primary care healthcare providers, 
generally nurses and allied health workers, in four provinces 
in South Africa. We found that they are knowledgeable about 
guidelines, generally trust their credibility and are receptive 
and motivated to use them. Guidelines are seen by nurses as 
providing confidence and reassurance, professional authority 
and independence where doctors are scarce.  Despite this, 
many barriers to guideline use were reported:
BARRIERS TO GUIDELINE USE INCLUDE: 
• inadequate systems for hardcopy distribution; 
• insufficient and substandard photocopies; 
• linguistic inappropriateness (e.g. complicated language, 
lack of summaries, no availability in local languages);
• unsupportive audit and feedback procedures; 
• limited involvement of end-users in guideline development; 
and,
• patchy training that does not filter back to providers. 
SUGGESTIONS FROM PARTICIPANTS
• improving the design features; 
• increasing accessibility including making digitally-
formatted versions available; 
• more supplementary materials (e.g. posters) to support 
patient engagement; 
• accessible clinical support following training; and, 
• in-facility training for all professional cadres to ensure fair 
access, similar levels of capability and interdisciplinary 
consistency. 
Citation: Kredo T, Cooper S, Abrams A, Muller J, Volmink J, 
Atkins S. Using the Behavior Change Wheel to identify barriers 
to and potential solutions for primary care clinical guideline 
use in four provinces in South Africa. BMC Health Services 
Research 2018;18(1):965.
www.ncbi.nlm.nih.gov/pmc/articles/PMC6295099/
pdf/12913_2018_Article_3778.pdf 
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June 2019
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Chapter 7: Discussion and conclusions  
 
Countries worldwide are striving to achieve strong primary health care systems and UHC that ensure 
access to quality health services without negative financial repercussions for patients or health systems 
(6).  However, the best approach to strengthen primary health care and progress to UHC remains a 
prominent debate (53).  
 
Taking steps towards strong primary health care, the South African national government has introduced 
programmes to improve district-driven health-service delivery (e.g. primary health care re-engineering 
and the Ideal Clinic) and is outlining policies for UHC funded through a NHI mechanism (3, 18-20). Within 
these policies, CPGs are named as potential tools to support evidence-informed, cost-effective and 
standardised decision making.   
 
CPGs are evidence-based guiding statements developed by policy-makers; and implemented and used by 
health managers, healthcare providers and patients to inform their decisions about options for care (54). 
By their design, CPGs include consideration of evidence of effectiveness alongside aspects of  ‘quality care’ 
outlined by the WHO, including cost effectiveness, feasibility and acceptability (4, 55). Therefore, CPGs 
have the potential to bridge not only evidence and patient care but may also to be tools to guide funding 
decisions and health-system structuring required to ensure access to the recommended care.  
  
Overall, in South Africa, the planned NHI system will require agreement and integration across sectors and 
jurisdictions. National CPGs will need to speak to the healthcare needs of all to ensure equal service 
delivery and redress of persistent ‘fault lines’ in the current health system (21). This transition from the 
current health system to NHI-funded UHC provides a window of opportunity to explore the ‘state of play’ 
of CPG development and implementation to help inform NHI goals and processes. Thus, in this global and 
national health policy context, the research conducted as part of this dissertation explored the role-
players, context, processes, barriers to and enablers of South African primary care CPG along the 
continuum of guideline activities from development, to implementation and use. 
 
Primary care guideline developers 
Overall, from the many role-players involved with CPG development, we found that there is a committed 
CPG community aiming to address inequities through CPG development and implementation. As our 
participants stated their views about the current context of private and public health sectors and its 
impact on access to healthcare as ‘hopelessly inequitable’   suggesting that CPGs are a means to ‘level the 
playing fields’. Corresponding with other studies, we also found that the NDoH leads several CPG 
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programmes (35). For primary care these include condition-specific guidelines (e.g. malaria, HIV, 
tuberculosis) and the Essential Drugs Programme (EDP) which develops comprehensive Standard 
Treatment Guidelines for rational prescription at all levels of care (primary, secondary and tertiary). 
Additionally, academic departments and professional societies develop CPGs, addressing gaps in what is 
available from the NDoH. However, CPG work is affected by inadequate funding for the increasingly 
demanding technical and methodological work required to underpin trustworthy CPG development. CPG 
processes were described as ‘chaotic’, ‘uncoordinated’ and ‘opaque’, which may be indicative of the lack 
of national standards to underpin CPG development and implementation, without which, regardless of 
commitment and best intentions, CPGs continue to be developed that do not meet global quality 
standards.  
 
Guidance and standards for CPG development are available from the Institute of Medicine and Guidelines 
International Network including checklists for assessment, conduct and implementation of trustworthy 
guidelines (56-59). However, despite the evolution of methods for CPG development, the capacity to do 
what is required has lagged (60, 61). For example, more recent AGREE II quality assessments of CPGs, 
including in the United States of America, continue to report that editorial independence and 
methodological rigour are poor, reflecting our findings from South Africa (34, 60, 62). Improvements to the 
WHO CPG programme since implementing their Guideline Review process highlights the importance of 
setting standards and effective oversight of CPGs and the potentially positive impact on CPG credibility 
(32, 33).  
 
Findings suggest that the gap in agreed standards and insufficient resourcing of CPG development 
processes in South Africa creates an enabling environment for commercial interests or personal agendas 
to influence recommendations. The main intention of CPG development - wellbeing of patients and 
efficient use of limited resources - should be the primary interest of developers. However, poorly managed 
secondary interests, either of a personal or financial nature, may dominate decision making. As stated by 
one of our participants ‘we have been very conscious of the role and the influence of industry in shaping 
decision-making, even within the various well-respected national societies…’.   The potential influence of 
secondary interests has been documented, one example is the case study of two iterations of the American 
College of Chest Physicians Antithrombotic Guidelines where the most-recent version ensured that 
guideline panel conflicts were more actively managed, and that there was more methodological support 
and rigour in the process. This impacted on not only what was recommended, but also on the strength of 
the recommendations (conditional and strong) with fewer strong recommendations made when the 
evidence base was less robust (63). Two systematic reviews evaluating conflicts of interest reported a 
paucity of studies and evidence about this topic (64, 65). The more recent 2011 review found that the effect 
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of interests on CPG recommendations was limited to case studies, usually about financial conflicts, where 
the secondary interests are likely to impact decisions. However, there was very little about non-financial 
interests (64). The Guidelines International Network have published guidance on managing interests for 
CPGs that several organisations have adopted (66, 67). Additionally, prominent CPG groups, such as the 
US Preventive Services Task Force, have ongoing research and ‘continuous improvement processes’ to 
manage potential conflicts and enhance public trust in CPG panels (68). From our participants, it was 
evident that conflicts of interest were not well understood or consistently managed, suggesting that 
further research would assist to understand this issue further and recommend changes. 
 
Additional concerns raised by participants were inadequate investment in coordinated communication 
and linkages within and between CPG groups and other role-players, including national government 
programmes (e.g. maternal and child health, HIV, etc.) and the EDP CPGs; and between national, provincial 
and district managers; healthcare providers and patients; and between the private health insurance and 
public-sector systems. The resulting silos increase the potential for duplication, competition for technical 
skills and resources and, at times, recommendations that are not feasible to implement – as one of the 
national developers described it ‘I do not think we have really found a mechanism of really engaging the 
people who are at the frontline of implementation on how do you really want us to package some of this 
document’.   
 
National CPG developers suggested that to improve CPG development there needs to be better 
coordination of CPG activities. To explore the role of CPG coordination, the SAGE Project team undertook 
a cross-sectional analysis of national CPG units to find out about their structure and function (69) [report 
available here: Scoping project: Evaluating clinical guideline coordination units globally]. We identified 21 
units, including nine in a more detailed evaluation (Table 1). We found that units had vastly differing tasks 
ranging from CPG development (7 units); providing a clearinghouse for accessing CPGs (4 units); 
approval/endorsement of CPGs or implementation (3 units); methodological support (2 units); conduct of 
HTA (2 units). Other tasks mentioned included multi-stakeholder engagement; commission CPGs; critical 
appraisal; develop standards for guideline development; capacity building; implementation; and, 
monitoring and evaluation. Only the National Institute for Health and Care Excellence (NICE) in the United 
Kingdom and the Guideline Review Committee and Secretariat (WHO) had coordination or governance 
functions.  This scoping review provides some guidance on the kinds of tasks that could be considered for 
South Africa. 
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Table 3. Guideline Units included in SAGE cross-sectional analysis, 2017 
1. Agency for Healthcare Research and Quality (AHRQ) / National Guideline Clearinghouse  
2. (United States) 
3. CONITEC – National Committee for Health Technology Incorporation (Brazil) 
4. Guideline Review Committee and GRC Secretariat (WHO)  
5. Haute Autorité de Santé (HAS) (France) 
6. National Clinical Effectiveness Committee (Ireland) 
7. National Guideline and Pathway Committee (Qatar) 
8. National Institute for Health and Care Excellence (NICE) (UK) 
9. Saudi Center for Evidence Based Healthcare (EBHC) (Kingdom of Saudi Arabia) 
10. Scottish Intercollegiate Guidelines Network (SIGN) (Scotland) 
 
Overall, the dissertation research found that primary care developers are invested in CPGs and want 
support to improve their credibility. Suggestions comprise development and endorsement of agreed 
standards that increase systematic evidence use and transparent processes; enhanced stakeholder 
consultation, including end-users and patients; better management of interests; enhanced 
communication and coordination between and within CPG development groups and end-users; and, 
systematic consideration of ‘fit-for-context’ CPGs that consider local context, feasibility, culture and 
preferences in the recommendations.  
 
Provincial and district managers and guideline implementers 
We visited four provinces and spoke to health managers, trainers, district clinical specialists and 
healthcare providers, mostly nurses and allied health practitioners, about their experiences with primary 
care CPGs. This provided further insights into CPG uptake and expanded on the findings from the national 
role-players.  Like CPG developers, those we spoke to were inherently driven to improve patient care and 
support uptake and use of CPGs. Yet, they reported several challenges to doing this. These included 
perceived structural barriers to CPG use, such as access to CPGs, or supply chain issues blocking adequate 
equipment supply, along with inadequate clinical training and supervision.  
 
From the literature, individual motivation to use a CPG may be more difficult to shift than the structural or 
physical/environmental issues  (e.g. providing more guideline copies, conducting training or ensuring 
essential equipment) (70). Stated differently, the baseline motivation of participants to implement or use 
CPGs is an encouraging springboard for enhancing CPG use. Activities that make CPGs more 
‘implementable’ may further motivate and support their uptake and use. 
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CPG implementation falls within the ambit of implementation research in which exploring and 
understanding context and behavioural theories about capacity, opportunity and motivation to use a CPG 
provides insight into how to effectively enhance CPG use or change practice (71-74). Effective 
implementation strategies to change practice have been researched and recommended for decades, yet 
how best to do this and the relative cost-effectiveness in different settings remains areas for further 
research (75-77). Outreach education is a known strategy that has been evaluated in systematic reviews 
and reported to offer benefits (78). Importantly, this strategy has been tested in pragmatic trials in primary 
care in South Africa also finding modest but consistent benefits (79-82). Considering both local and global 
implementation evidence, strategies such as this can and should be considered for scale up. 
 
During interviews, a few managers were wary of our questions, seemingly fearful of punitive action from 
senior management related to implementation. Further interviews revealed that this was a common 
challenge experienced by provincial and district managers where the emphasis on ‘compliance culture’ 
and punitive audits were perceived to have negative professional consequences when CPG 
implementation was delayed, inefficient or unsuccessful. Audit and feedback are amongst the most well-
researched implementation strategies, generally showing modest but consistent benefits (78, 83, 84). 
However, there were stories of mixed success from our participants, some using the process to identify 
gaps and amend practice, while others felt audits were regimentally applied and not constructive. Further 
research on how this can be enhanced, learning from the extensive literature, is warranted.  
 
Despite reported negative experiences, managers continued to strive to address the everyday challenges 
they faced with commitment and innovation, including linking with better-funded non-governmental 
partners to overcome barriers to CPG implementation. Managers expressed that poor funding of CPG 
activities such as training, printing of CPG books and development of additional supportive 
implementation resources (e.g. posters) impacted on CPG distribution and access and were perceived to 
impact use. Primary care healthcare providers corroborated this, explaining that poor CPG distribution 
and version control, as well as lack of supporting materials in accessible local languages, limited their use. 
It stands to reason that insufficient investment in CPG implementation may result in poor CPG uptake. 
Identifying the most cost-effective strategies for CPG activities and how to sustain these remains 
uncertain. Funding could be considered the role of government, however, in the absence of a budget for 
CPG activities, other funders may step in, with their own agendas and priorities. Our participants described 
the role of ‘partner’ non-governmental organisations (NGOs) as important and helpful, however, NGO 
interests drove the support that was offered, resulting in greater investment in HIV and tuberculosis 
relative to non-communicable diseases.   
 
Stellenbosch University https://scholar.sun.ac.za
103 
Contextual factors were consistently described as a hindrance to CPG adherence. In rural districts, culture, 
social norms (e.g. traditional practices) and geography (access to facilities) hindered the uptake of CPGs. 
Implementers indicated that what was recommended was at odds with what was either acceptable or 
feasible within their setting. As with our research, the role of context emerged as a dominant theme from 
an overview of systematic reviews exploring causes of the evidence to practice gaps for complex 
interventions in primary care (85). The themes identified in the review included: external context; 
organisation; professionals and intervention. One of the main findings was the importance of the ‘fit’ 
between the context and the intervention and its critical role in determining successful implementation 
(85). Although the review included only studies from high-income primary care settings, the results reflect 
ours, and particularly the critical importance of considering the context in which the service is delivered. 
Considering the range of cultural and geographic barriers raised by our participants, how best to 
contextualise South African primary care CPGs will likely be a challenging but necessary area for further 
investigation. However, it is evident that, if not addressed, implementation remains strained and 
potentially ineffective. 
 
Guideline implementation guidance consistently puts forward the importance of considering context and 
views of end-users including healthcare providers and patients when developing recommendations and 
implementation strategies (59, 73, 86). Our participants also suggested consultation and involvement of 
provincial role-players in national CPG development to ensure feasible CPGs. One approach that could 
help is the inclusion of ‘evidence-to-decision’ frameworks that guide CPG panels to systematically 
consider evidence of effectiveness and safety, alongside evidence about feasibility, acceptability, costs 
and equity, such as the approach used by the GRADE Working Group (87). Although, this does not remove 
the need for expert judgment, it does capture different views more transparently, and ensures that issues 
of cost, cultural and social norms, equity and acceptability, amongst others, are all considered as part of 
final recommendations. The evidence-to-decision frameworks can also be used for CPG adaptation at the 
provincial or district levels. That is, evidence of efficacy and safety may remain unchanged, but provincial 
health managers can consider contextual issues of culture and preferences which can play a prominent 
role in guiding recommendations and implementation planning (88). 
 
It was striking that although there were many examples of innovations and successes from healthcare 
managers in provinces and districts, they described few occasions to share these between managers and 
within and between districts and provinces. These success stories offer a potential opportunity for mutual 
learning and scale up of projects in other districts. Further research exploring case studies of ‘champions’ 
of primary care may offer examples of approaches for enhancing primary care service delivery.  
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Building skills and knowledge for CPG activities was a cross-cutting need for health managers and 
healthcare providers. Capacity building requirements for healthcare managers and those involved with 
implementation including learning about CPG contextualisation or adaptation, constructive audit, quality 
improvement approaches and implementation planning and evaluation. Training for healthcare providers 
in the content of the CPG is central to successful CPG adherence and use (78, 80, 82). In South Africa, 
regional training centres, which have a coordination function, are already in place in most provinces. 
However, those we interviewed consistently reported that training is patchy and there is a need for inter-
disciplinary training bringing all practitioners in a facility onto the same level. We found that healthcare 
providers valued both in-facility, case-based training and opportunities for training off-site. However, they 
strongly expressed the wish for post-training clinical mentorship and supervision.  
Implications for policy and practice 
CPGs are intended to provide evidence-informed statements to improve patient care but can only do so if 
effectively developed and implemented. The research conducted for this dissertation has explored views 
of those directly involved with CPGs and identified gaps and opportunities for enhanced CPG development 
and implementation for South African primary care. For example, CPG development is already 
institutionalised in national government, with academics, clinicians and health managers committed to 
the process of evidence-informed CPG development. If nationally accepted standards can be adopted to 
support the process, along with capacity building for CPG technical and methodological work, the rigour 
of development and likelihood of credible, trustworthy CPGs may improve. Additionally, if development is 
more consistent with consultation of end-users, and considerate of the health service and system issues 
that limit CPG implementation, it is possible that more contextually relevant, acceptable CPG 
implementation may occur, resulting in enhanced CPG use and, importantly, better patient care.  
 
Decisions about how best to allocate resources to address the CPG implementation and development gaps 
should be led by healthcare managers and policy-makers. One suggested approach for prioritising the  
necessary activities includes the use of the APEASE criteria which include: affordability, practicability, 
effectiveness/cost-effectiveness, acceptability (to public, professional groups and the political role-
players), safety/harms, equality (89).  
 
Strengths and limitations of the research 
The planned NHI fund heralds a major shift in health system arrangements for South African primary 
health care. Health-technology assessment (HTA) and CPG development are both named in the national 
NHI strategy (3). Yet, to date, our understanding of the players and processes for HTA and CPGs has been 
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limited and anecdotal. Therefore, the strength of the research is that it addresses a gap in knowledge at a 
time when changes in CPG governance are taking place. Additionally, the findings suggested specific 
actions that could be considered by national and provincial decision-makers to improve processes for CPG 
development and implementation as outlined in the policy briefs. A further possible strength is that this 
formative research has thrown light on many research gaps to further enhance our understanding of CPG 
activities but, more importantly, to improve how CPGs are developed and implemented. 
 
The involvement of a multi-disciplinary team along with external support and guidance from the project’s 
inception can be considered a strength of the research. The team has changed over the years, but has 
included clinical epidemiologists, social scientists, doctors, allied health practitioners and public health 
specialists, all with research training and experience. The ability of the team to share their views and 
differing perspectives regarding the data has enriched and deepened the analysis and interpretation of 
the participants’ views.  
 
A limitation of the research is the breadth of the topic we have chosen to investigate. Primary health care 
is a wide-ranging field of study and, as mentioned throughout the papers, by having this broad focus, we 
may have missed CPG- or condition-specific contextual issues for development or specific barriers to and 
enablers of implementation. However, given the paucity of published literature on CPG development and 
implementation, this may be a reasonable approach for formative research to inform a future research 
agenda.  
 
An additional consideration of the broad topic of primary care CPGs was that, unlike most countries 
globally, South Africa has consolidated/amalgamated CPGs that address all conditions for a level of care, 
rather than many condition-specific CPGs. For example, there are two CPGs for public sector healthcare 
providers that address all primary care conditions. One is the national Essential Medicines List Standard 
Treatment Guideline which is a medicine-driven CPG developed by the EDP at the NDoH. The related CPG, 
Primary Care 101, is a symptom-based CPG which covers all conditions and is tailored for nurse 
practitioners. These two CPGs form the basis of CPGs used for South African public-sector primary care, 
complemented by a core set of infectious diseases guidelines (HIV, tuberculosis and malaria), Basic 
Antenatal Care guidelines for maternal and childcare and a health promotion CPG.  
 
Furthermore, despite the broad research question, identifying gaps in capacity and health system 
arrangements mirror other health services and systems research from South Africa and is likely 
generalisable regardless of the CPG (14, 21). However, accepting that important specific contextual issues 
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have likely been missed and that healthcare service delivery evolves, these findings provide the 
groundwork for further research. 
 
A further limitation may be that we used only qualitative research methods to explore perspectives of 
developers, implementers and users. Further mixed-method or quantitative studies would be 
complementary. For example, a review evaluating implementation strategies for LMICs is important to 
take stock of what has been tested in similar settings to South Africa. Such a review has recently been 
published by Cochrane’s Effective Practice and Organisation of Care Review Group (78). Further, surveys 
or delphi studies may be helpful to prioritise barriers and enablers for implementation, however, this 
approach may be most appropriate when a specific CPG is being explored in depth. Overall, use of a 
qualitative method was appropriate for the research question and enabled the gathering of rich data 
about the experiences of those involved with CPG development and/or implementation, which would not 
have been possible with other study designs (50).  
 
Finally, a limitation may be that the important voices of patients have not yet been captured along the 
continuum from CPG development to use. Unquestionably, exploring patients’ views of CPGs is a critical 
gap in understanding what will work for CPG uptake. However, this research may be appropriate to hinge 
on a specific condition and its linked CPG recommendations. This is therefore another prospect for future 
research. 
Research gaps 
Several knowledge gaps have emerged during the conduct of the studies within this thesis and suggest 
some future research aspects outlined below.   
 
Clinical audit and understanding baseline standards for key conditions and treatments: One of the 
greatest challenges for those developing policy is there is not a good source of data regarding the indicator 
clinical outcomes that are linked with the CPGs produced and disseminated. This is particularly so in the 
public sector, where there are very few electronic medical records in place outside of HIV care; 
performance measures and indicators are not set; and, clinical audits are not always in the public domain. 
One way to explore the gaps between what is recommended and what is happening in practice may be to 
systematically evaluate available audit reports and baseline data of primary studies. We have drafted a 
protocol to take this forward [Appendix 6]. 
 
Managing conflicts of interest for guideline groups: management of interests is poorly understood and 
probably equally poorly implemented across CPG development groups in South Africa, and likely in other 
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countries in the region. Further exploration of current practice, decisions and potential impacts of 
financial and personal interests is indicated. Additionally, interventions to increase transparency in 
funding of CPGs can be tested. This research could be explored for different sub-populations, including 
private health insurance, patient representative and consumer groups, and professional associations. 
Guidance could be developed to inform interest management.  
 
Development and implementation barriers for specific guidelines: Exploration of specific CPGs and their 
development and use can inform needs and opportunities for tailored implementation and enhanced use. 
There are some important examples of this research in South Africa, particularly from the University of 
Cape Town’s Knowledge Translation Unit which has led pragmatic cluster trials and informed our 
understanding of some of the local successes and challenges with specific CPGs for tuberculosis and 
primary care (40). Additionally, a thesis by Pather has provided in-depth understanding of the asthma 
guidelines in South Africa and suggested a framework for implementation that may be applied and should 
be further tested (37).  Views of different role-players from those we spoke to are required, particularly, 
views of medical doctors who may have different perspectives from the nurses and allied health 
practitioners we interviewed. Research exploring innovations and lessons from district health managers 
regarding how they have overcome implementation gaps, would be helpful to explore further. 
 
Community and patient’s involvement in development and implementation: Substantial research and 
experience exists elsewhere for patient involvement in CPGs – such as the Guidelines International 
Network Public Toolkit, the NICE patient involvement guidance and the James Lind Alliance priority 
setting to name a few examples.  However, patients and the public’s views on CPGs remain a knowledge 
gap in South Africa and regionally. Patient’s representatives have little or no formal involvement in CPG 
development and their views about the CPGs in use in the health services is limited. Clinic committees 
(linked with specific primary health care facilities) may play an important role in the delivery of health 
services and CPG advocacy and uptake – it would be valuable to explore how their role could be maximised 
to support CPG implementation for South Africa. 
 
UHC and guidelines: The planned NHI provides an important research opportunity. Understanding how 
the health system can and should transition in constructive, progressive ways requires substantial health 
systems and services research. Examples include understanding how training of health staff around CPGs 
should be done optimally; how the private and public sector will intersect to make decisions about service 
packages; healthcare access and provision for all and how this would be reflected in CPGs; and, 
importantly, how the public and the community can participate in the process of UHC decision-making 
that reduces inequity and increases health for all. 
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Conclusion 
Overall, the dissertation findings consider South African health services and systems through the lens of 
CPGs. As the South African government aligns with the global community to strive to attain strengthened 
primary health care systems and UHC, there needs to be investment in development and implementation 
of high-quality CPGs informed by evidence and implemented according to global experience and local 
context. Overall, this work requires the political commitment of national and provincial governments to 
provide the leadership and funding for training, technical work and revitalisation of the, at times, defunct 
systems that hamper development, implementation and adherence to national primary care CPGs. If 
addressed, this has the possibility to enhance the provision of trustworthy and effective care for all in 
South Africa.  
Stellenbosch University https://scholar.sun.ac.za
109 
Appendices  
 
  
Stellenbosch University https://scholar.sun.ac.za
110 
Appendix 1: Literature review: clinical practice guidelines 
Citation: Kredo T, Bernhardsson S, Machingaidze S, Young T, Louw Q, Ochodo E, et al. Guide to clinical 
practice guidelines: the current state of play. Int J Qual Health Care. 2016;28(1):122-8. 
 
  
Stellenbosch University https://scholar.sun.ac.za
Perspectives on Quality
Guide to Clinical Practice Guidelines:
The Current State of Play
TAMARA KREDO1, SUSANNE BERNHARDSSON2,3,
SHINGAI MACHINGAIDZE1, TARYN YOUNG1,4, QUINETTE LOUW5,
ELEANOR OCHODO4, and KAREN GRIMMER5,6
1South African Cochrane Centre (SACC), South African Medical Research Council, Francie van Zijl Drive, Parow
Valley, Cape Town 7505, South Africa, 2Närhälsan Rehabilitation, Region VästraGötaland, Hönö, Sweden, 3Depart-
ment of Medical and Health Sciences, Division of Physiotherapy, Linköping University, Linköping, Sweden, 4Centre
for Evidence-Based Health Care (CEBHC), Faculty of Medicine and Health Sciences, Stellenbosch University, Francie
van Zijl Drive, Tygerberg, Cape Town 7505, South Africa, 5Department of Physiotherapy, Faculty of Medicine and
Health Sciences, Stellenbosch University, Francie van Zijl Drive, Tygerberg, Cape Town 7505, South Africa, and 6Inter-
national Centre for Allied Health Evidence (iCAHE), University of South Australia, City East Campus, P4-18 North Ter-
race, Adelaide 5000, Australia
Address reprint requests to: Tamara Kredo, South African Medical Research Council, South African Cochrane Centre,
Cape Town, South Africa. Fax: +27-21-938-0836; E-mail: tamara.kredo@mrc.ac.za
Accepted 21 October 2015
Abstract
Introduction: Extensive research has been undertaken over the last 30 years on the methods under-
pinning clinical practice guidelines (CPGs), including their development, updating, reporting, tailoring
for speciﬁc purposes, implementation and evaluation. This has resulted in an increasing number of
terms, tools and acronyms. Over time, CPGs have shifted from opinion-based to evidence-informed,
including increasingly sophisticated methodologies and implementation strategies, and thus keeping
abreast of evolution in this ﬁeld of research can be challenging.
Methods: This article collates ﬁndings from an extensive document search, to provide a guide de-
scribing standards, methods and systems reported in the current CPG methodology and implemen-
tation literature. This guide is targeted at those working in health care quality and safety and
responsible for either commissioning, researching or delivering health care. It is presented in a
way that can be updated as the ﬁeld expands.
Conclusion: CPG development and implementation have attracted the most international interest
and activity, whilst CPG updating, adopting (with or without contextualization), adapting and impact
evaluation are less well addressed.
Key words: clinical practice guidelines, guideline development, implementation, adaptation
Introduction
High-quality, evidence-informed clinical practice guidelines (CPGs)
offer away of bridging the gap between policy, best practice, local con-
texts and patient choice. Clinical guidelines have been upheld as an es-
sential part of quality medical practice for several decades. An early
deﬁnition of CPGs by the Institute of Medicine (IOM) [1] described
it as ‘systematically developed statements to assist practitioner and
patient decisions about appropriate health care for speciﬁc clinical
circumstances.’ This deﬁnition was updated in 2011 to more strongly
emphasize rigorous methodology in the guideline development pro-
cesses: ‘Clinical guidelines are statements that include recommenda-
tions intended to optimize patient care that are informed by a
systematic review of evidence and an assessment of the beneﬁts and
harms of alternative care options’ [2]. In this rapidly evolving ﬁeld
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of research, a more recent deﬁnition suggested a modern twist to the
guideline description: ‘Guidelines are a convenient way of packaging
evidence and presenting recommendations to healthcare decision
makers’ [3].
Guidelines have a range of purposes, intended to improve effective-
ness and quality of care, to decrease variations in clinical practice and
to decrease costly and preventable mistakes and adverse events. They
generally include statements of expected practice; provide benchmarks
or standards against which individuals can audit; compare and poten-
tially improve their practices; or guidance regarding undertaking par-
ticular tasks [4, 5]. Quality improvement initiatives are linked with
CPGs, as evidence-informed recommendations form the basis for
identifying core outcomes and measurable standards of care [6]. Inter-
nationally, over the past decade in particular, an industry seems to
have developed around CPG development, reporting, adoption, con-
textualization or adaptation, evaluation and implementation. The
growing volume of evidence and the acronyms used in this ﬁeld can
be overwhelming, even for those involved. This article is targeted at
individuals and organizations working in health care quality and
safety; and responsible for either commissioning, researching or deli-
vering health care. We aim to provide a guide describing common
standards, methods and systems used in current international CPG
activities and the various activities to produce and communicate them.
Terminology
Guidelines, CPGs, protocols and care pathways are commonly used
terms, but without common agreement about their deﬁnitions [7]. De-
ﬁnitions that we have found useful are that guidelines relate to broader
systems, such as those found in primary care (e.g. water or air quality,
food security, incident reporting and investigation, etc.) and are gen-
erally developed and used by policy-makers, service organizations,
funders or regulatory authorities. CPGs relate to clinical matters,
generally dealing with clinical conditions or symptoms, and are typic-
ally intended for use by health care providers and clinic managers [4].
They can include best-practice statements for any one or combination
of concerns regarding screening, diagnosis, management or monitor-
ing. The term ‘protocol’ is commonly used to prescribe behaviours at
diplomatic and societal events. In health, it has the meaning of rules or
instructions about how to do a particular process explicitly, and with-
out error. Care pathways generally relate to a series of evidence-
informed steps, which can involve a multidisciplinary team at various
care levels (i.e. primary, secondary), which should underpin the
journey of care of patients with a particular diagnosis [8, 9]. Whilst
broadly similar to CPGs, clinical pathways differ by being more
explicit about the sequence, timing and provision of interventions.
They are usually based onCPGs and contextualized for usewithin spe-
ciﬁc environments or circumstances [9].
Development
There are detailed processes available for developing a CPG. Notably,
there are well-credentialed international and national guideline devel-
opment groups, including the World Health Organization (WHO)
[10], the Scottish Intercollegiate Guidelines Network (SIGN) [11],
the National Institute for Health and Care Excellence (NICE)
[12] and the Australian National Health and Medical Research
Council (NHMRC) [13], each with their own approach to guideline
construction and writing, usually described in a guideline develop-
ment manual.
Globally, potentially many hundreds more health departments, in-
surers and other health care organizations, professional associations,
hospitals, specialty colleges and individuals have attempted to pro-
duce recommendations to improve and/or standardize local clinical
practices, all using their own interpretations of the best way to con-
struct and write CPGs. The most common approach to CPG develop-
ment seems to come from the efforts of small teams of dedicated
volunteers, often working with minimal funding and variable under-
standing of CPG development methods, to produce recommendations
for practice in local settings, based on a range of evidence sources.
These include peer-reviewed literature, grey literature, other CPGs
and expert opinion. Historically, CPGs were built mostly on expert
opinion, which included variable (and often selective) reference to re-
search evidence [14, 15]. Such CPGs are still found today, albeit in de-
creasing numbers, as transparently constructed evidence-informed
approaches integrated with expert opinion and patient values have
rapidly gained acceptance over the past two decades as the best ap-
proach to CPG development [14, 15]. To add to the complexity of
the evolution of CPG development, developers around the world
have used a range of different and purpose-built approaches to iden-
tify, appraise, synthesize and describe the evidence base underpinning
best-practice statements. Thus, there is no standard approach to any
aspect of CPG activity.
However, evidence of a maturing CPG development culture inter-
nationally is seen in recent attempts to standardize practices. In 2011,
the Institute of Medicine (IOM) introduced eight standards for CPG
development [16], which are similar to those promoted by the Guide-
lines International Network (G-I-N) [17] (Table 1).
In addition, a recent enterprise, conducted by McMaster Univer-
sity, systematically and comprehensively reviewed the methodological
Table 1 Comparing the elements of clinical practice guideline development between the Institute of Medicine (IOM) and the Guidelines
International Network (G-I-N)
IOM [2] Guidelines International Network (G-I-N) [17]
Standard 1: Establishing transparency 1: Composition of Guideline Development Group
Standard 2: Management of conﬂict of interest 2: Decision-making Process
Standard 3: Guideline development group composition 3: Conﬂicts of Interest
Standard 4: Clinical practice guideline – systematic review intersection 4: Scope of a Guideline
Standard 5: Establishing evidence foundations for and rating strength of recommendations 5: Methods
Standard 6: Articulation of recommendations 6: Evidence Reviews
Standard 7: External review 7: Guideline Recommendations
Standard 8: Updating 8: Rating of Evidence and Recommendations
9: Peer Review and Stakeholder Consultations
10: Guideline Expiration and Updating
11: Financial Support and Sponsoring Organisation
2 Kredo et al.
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content of 35 international CPG development manuals, to identify key
CPG development components. This work included the G-I-N and
IOM criteria. TheMcMaster Group developed a checklist of 18 topics
and 146 items [18]. This project, Guidelines 2.0, itemized all poten-
tially relevant CPG steps, linked to primary resources and is able
to be contextualized or adapted to local contexts. This provides a com-
prehensive resource; however, given the extensive list of items
included, it may not be user-friendly. In another example of efforts
to standardize methods, a step-by-step manual was developed to assist
CPG developers in the area of head and neck cancer surgery [19].
Given thesewidely available best-practice approaches to CPG devel-
opment that are now available to all, it seems sensible to reconsider the
need for future ad hoc CPG development that does not comply with re-
commendations from at least one of these approaches [16]. Moreover,
there is a wealth of freely accessible, good-quality CPGs from inter-
nationally respected development agencies [9–12] that can be adopted
and then conﬁgured to meet local needs, using emerging CPG context-
ualization or adaptation methods (refer to ‘adopting, contextualising,
adapting’ section) [10–13]. Thus there seems little merit in producing
new CPGs, unless a true gap exists in available guidance. This gap
should be veriﬁed by a comprehensive search of CPG repositories before
any de novo activities take place. Where de novo CPGs are required,
there are many comprehensive evidence-synthesis resources available
(such as the Cochrane database of systematic reviews), which should
make the CPG development processes less demanding. Given these ef-
ﬁciencies in sourcing the research evidence, the key issues for discussion
by the development teams could then be oriented to the use and inclu-
sion of local contextualized evidence regarding resource requirements,
feasibility, cultural issues, patient preferences, values and approaches
for shared decision-making.
Determining the strength of the body of evidence
A critical methodological quality issue in CPG development is how best
to describe the strength of the evidence underpinning recommendations.
Numerous approaches to grading evidence have been developed. How-
ever, in the last few years, twomain approaches have emerged to support
systematic and comprehensive evidence synthesis: Grading of Recom-
mendations Assessment, Development and Evaluation (GRADE)
[20–23] and the Australian NHMRC approach, Formulating Recom-
mendations Matrix (FORM) [24]. The GRADE approach has gained
momentum internationally, with acceptance by, among other organiza-
tions, the WHO’s Guideline Review Committee [10]. The GRADE and
FORMapproaches not only assist CPGdevelopers to summarize the evi-
dence body for a recommendation and consider its local relevance but
also provide advice on how to proceed from evidence to recommenda-
tions in a standardized and transparent manner.
Quality appraisal
Similar to evidence grading, a number of tools have been developed
to support critical appraisal of CPG quality. Many of them have fo-
cused on structural issues such as the composition of the CPG team,
the review dates, the layout and the CPG purpose and end use, whilst
others focus on rigour of methodological development and applic-
ability [25–27]. The AGREE II instrument (Appraisal of Guideline
ResEarch and Evaluation) [28, 29] emerged internationally ﬁve
years ago. It comprises six domains with a total of 23 items, each
scored 1–7 (Strongly Disagree through to Strongly Agree). More
than one scorer is required to determine a valid score, and a scoring
rubric is required to combine scores into one composite score for
each domain. A new, simpliﬁed tool, the iCAHE CPG quality check-
list, was recently developed as an alternative to the AGREE approach
[30]. The iCAHE instrument items were based on perspectives of
CPG quality of busy clinicians, educators and policy-makers. It has
similar domains to AGREE II, but only 14 questions, each with a
binary response (Yes/No), requiring one scorer, and the overall
score is the sum of the ‘Yes’ responses. Both instruments include
questions regarding the CPG process, that is, the identiﬁcation and
reporting of the body of evidence underpinning the CPG. The two
instruments show moderate to strong correlation in pilot testing
(r = 0.89) with the iCAHE tool requiring signiﬁcantly less time to
administer.
Updating
Considering the substantial international effort invested in CPG devel-
opment, there has been much less research into the process of CPG
updating. Whilst the importance of updating is noted in most CPG
development manuals, speciﬁc processes for doing so are poorly
described [31]. Examples of guidance on updating from the G-I-N
and IOM development standards are provided in Table 2.
A recently published systematic review aimed to identify best prac-
tices for updating CPGs [31]. The review authors systematically iden-
tiﬁed and appraised 35 CPG development handbooks which included
information on CPG updating. They concluded that the available
guidance on updating processes was lacking in detail, used variable
terminology, and that more rigorous and explicit guidance would
increase the trustworthiness of updated CPGs. This review did not in-
clude the systematic approach published in 2003 by Johnston et al.
Table 2 Examples of guidance for updating from the Institute of Medicine (IOM) and the Guidelines International Network (G-I-N)
IOM STANDARD 8: Updating [2] Guidelines International Network (G-I-N) [17]
The CPG publication date, date of pertinent systematic evidence review, and
proposed date for future CPG review should be documented in the CPG.
Literature should be monitored regularly following CPG publication to
identify the emergence of new, potentially relevant evidence and to
evaluate the continued validity of the CPG.
CPGs should be updated when new evidence suggests the need for
modiﬁcation of clinically important recommendations. For example, a
CPG should be updated if new evidence shows that a recommended
intervention causes previously unknown substantial harm, that a new
intervention is signiﬁcantly superior to a previously recommended
intervention from an efﬁcacy or harms perspective, or that a
recommendation can be applied to new populations.
A guideline should include an expiration date and/or describe the process
that the guideline groups will use to update recommendations.
Guidelines become outdated at different rates depending on the availability
of new evidence. Therefore, it is important to identify the expiration date
of a guideline, as well as an update process, if planned. Developers
should prospectively determine whether and when they will update a
guideline or when it should be considered inactive if an update is not
performed.
CPGs: current state of play • Quality Management 3
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from the Cancer Care Ontario Practice Guidelines Initiative, which
reports four criteria for use after an updated literature review has
been performed. These criteria provide clear guidance regarding
how recent literature might alter the earlier strength of the body
of evidence (p. 648) (Table 3) [32]. These criteria have been used
for the last three updates of the Acute pain management CPG by the
Australian and New Zealand College of Anaesthetists and Faculty of
Pain Medicine [33].
Technologies for ‘dynamic updating’ of CPGs are also emerging
[34]. The GRADE group is currently piloting an international collab-
orative initiative in CPG writing with corresponding implementation
plans, aimed at ready implementation of recommendations – DE-
CIDE: Developing and Evaluating Communication strategies to
support Informed Decisions and practice based on Evidence [3].
This Consortium has supported the development of two interactive
CPG development tools, the GDT (http://gdt.guidelinedevelopment.
org/) [35] and ‘Making GRADE the Irresistible Choice’ MAGICapp
(http://www.magicapp.org/) [36]. These multi-layer development and
dissemination software tools could put up-to-date CPGs literally ‘in
the pockets’ of clinicians via smartphones and tablets. These tools
also allow for dynamic updating of evidence sources, and integration
of evidence with electronic medical record tools [34].
Presentation and communication
Concurrent with the evolution of standardized CPG development
principles, there has been increasing interest in the manner in which
recommendations are written and presented to best support uptake.
This interest has stemmed from concerns with the need to address
structural barriers to CPG uptake, in the way recommendations are
worded and presented, as well as external barriers to implementation
such as access and relevance [37]. To address this, a speciﬁc tool was
developed for CPG developers and implementers (GuideLine Imple-
mentability Appraisal (GLIA)) that provided 10 dimensions of 31
items, including decidability and executability, global, presentation
and formatting, measurable outcomes, apparent validity, ﬂexibility
and effect on process of care [38]. The DECIDE consortium is
exploring methods to ensure effective communication of evidence-
based recommendations targeted at key stakeholders: health care
professionals, policy-makers and managers, as well as patients and
the general public. Their multi-layer development and dissemination
software tools allow one-click adaptation of display of content
depending on the audience [3].
Implementation
Another recently launched tool, GUIDE-M, is intended to enhance
quality, implementability and acceptability of CPGs, the ‘Guideline Im-
plementability for Decision Excellence Model’ (www.guide-m.ca) [39].
This tool was developed to reﬂect an evidence-informed, international
and multidisciplinary perspective to putting CPGs into practice.
There is surprisingly little decisive guidance on how CPGs can be
successfully implemented, and the knowledge gap regarding the effect-
iveness of CPGs on patient health outcomes is substantial. More is
known about the effectiveness of various implementation strategies
on process outcomes (how the system works) rather than clinical out-
comes, although this impact is often modest [37, 40]. An overview by
Grimshaw (2012) showed effects of evidence implementation strat-
egies (not speciﬁc to CPGs) such as educational measures, audit and
feedback, opinion leaders and tailored interventions, which resulted
in 4.3–12% in median absolute improvements in care [41]. CPG im-
plementation often requires behaviour change by health care profes-
sionals, patients and other stakeholders within the health care
system, because they may need to change or discard ‘usual’ practices
in light of current best-evidence recommendations.
CPG recommendations often include the introduction of new tech-
nologies or interventions or discontinuation of ineffective, costly or
harmful interventions. To do this requires signiﬁcant and often swift
changes in clinician behaviour. For behaviour change to be successful,
consideration of the context in which the CPG is to be used is para-
mount [42–44]. Several implementation theories account for context
explicitly, e.g. the Promoting Action on Research Implementation in
Health Services framework [45], the Consolidated Framework for Im-
plementation Research [46] and the Theoretical Domains Framework
(TDF) [47, 48]. The TDF is a validated framework that includes 14 do-
mains of theoretical constructs and has been tested for developing com-
plex interventions to implement changes in health care settings [49].
Theoretical frameworks of implementation can facilitate planning
and executing implementation of CPG recommendations, as well as
support evaluation of CPG impact [50–53]. However, few published
CPG implementation interventions use speciﬁc theories. A recent sys-
tematic review reported that only one-ﬁfth of the 235 CPG implemen-
tation studies reviewed used a speciﬁc theory [54]. Moreover, critics of
implementation theories have highlighted the poor evidence supporting
them and suggested that a common-sense approach may do just as
well [55, 56]. However, there seems to be emerging evidence that
behaviour-change processes applied in CPG implementation, that are
informed by theory are more effective than those that are not and that
theory should be used to establish causal relationships between theoret-
ical constructs and effects of aspects of implementation [56, 57]. Further
research is required to understand the practical aspects of how CPG re-
commendations can be effectively and efﬁciently implemented in ways
that produce improvements in processes and clinical outcomes.
Conﬁguring CPGS to different settings: adopting,
contextualizing or adapting
Since the early 2000s, there has been increasing international recogni-
tion of the potential for efﬁciency and value of taking CPGs developed
in one country and applying them to other countries. This is intended
to avoid duplication of effort in de novo guideline development, when
Table 3 Clinical Practice Guideline Update elements [32]
1 The new evidence is consistent with the data used to inform the
original practice guideline report. The recommendations in the
original report remain unchanged.
2 The new evidence is consistent with the data used to inform the
original practice guideline report. The strength of the
recommendations in the original report has been modiﬁed to reﬂect
this additional evidence.
3 The new evidence is inconsistent with the data used to inform the
original practice guideline report. However, the strength of the new
evidence does not alter the conclusions of the original document.
Recommendations in the original report remain unchanged.
4 The new evidence is inconsistent with the data used to inform the
original practice guideline report. The strength of the new evidence
will alter the conclusions of the original document.
Recommendations in the original report will change. This change is
a priority for the working party members. Modiﬁcations to the
guideline are in progress.
4 Kredo et al.
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useful CPGsmay exist elsewhere [26, 58]. There is no consensus on the
appropriate terminology to use for transferring CPGs from one health
system or health setting to another, or for subsequent conﬁguration
of CPGs for local contexts and needs. The ADAPTE Collaboration,
a strategic collaboration between two international CPG research
groups (ADAPTE and Practice Guideline Evaluation and Adaptation
Cycle) proposes an ‘adaptation’ approach in their resource manual
(distributed via G-I-N (ADAPTE Collaboration 2009)) [59]. Their
work describes the direct transfer of CPGs across similar income
and health systems settings.
Another approach, that of adopting and then contextualizing,
underpinned an innovative Filipino CPG implementation project
[60]. The ADAPTE process lacked detail on the speciﬁcs of ‘how to’
transfer recommendations from CPGs developed in high-income to
low-income country settings, where health care policy and contexts,
funding, workforce, resources and training are signiﬁcantly different.
The CPG working group from the Philippines Academy of Rehabilita-
tion Medicine differentiated between the notions of ‘adaptation’ and
‘contextualization’ and proposed an innovative adoption and context-
ualization approach, by mapping recommendations from multiple
CPGs into a typical Filipino patient pathway, and then developing
local ‘context points’ to support local uptake [61]. This work has
since been recognized as best practice for lower- and middle-income
countries by the International Society of Physical and Rehabilitation
Medicine (ISPRM) and provides a practical, cost-effective and efﬁcient
alternative approach to developing local context de novo CPGs.
Shared decision-making
Shared decision-making occurs when patients and their health care
providers make joint decisions about health care interventions based
on best research evidence, and layered by patient preferences, values,
clinical judgement and local contexts [62, 63]. When done well,
shared decision-making and mutual agreement on the way forward
for the management of a patient’s condition could be considered the
desired end-point of CPG implementation [62, 64]. Where high-
quality evidence is lacking, shared decisions will rely more heavily
on clinician perspectives and patient preferences [65]. Barriers to ef-
fective shared decision-making include lack of time, skills, knowledge,
mutual respect and effective communication processes [63, 66]. ACo-
chrane review evaluating shared decision-making interventions re-
ported low-quality evidence for the effectiveness of any intervention
targeting health care professionals, patients or both. However, the
authors conclude that despite the low-quality evidence, any interven-
tion targeting both parties is consistently better than targeting either
one or no intervention [63].
Decision aids are tools designed speciﬁcally to help with decision-
making, with particular application in the context of low-quality or
uncertain evidence [66]. These tools have been reported to increase ab-
solute knowledge of patients amongst other beneﬁts; however, effects
on clinical outcomes are to date uncertain [67]. Rapid developments in
evidence mean that decision aids may be out-of-date, and the process
for updating may be onerous and, in many cases, not done [66]. There
is a move to use new technology to support this process. Point-of-care
decision aids include short one-page summaries as in ‘Option Grids’
(www.optiongrid.co.uk) [68]. Technology in development includes
the previously mentioned MAGICapp group, where the layered ap-
proach extends to patient end-user tools for use in consultation, linked
with the SHARE-IT project evaluating the value of the decision aid in
clinical care (http://magicproject.org/share-it/) [69].
Conclusion
This paper explores the standards, methods and systems in use by
those involved with CPGs and provides a synthesis of the current
state of play of international guideline activity. It also highlights the
immense efforts being made by researchers, clinicians and policy-
makers who are committed to optimizing ways in which evidence is
packaged to improve care.
The tools described in this paper are not all uniformly accessible or
user-friendly. They have variable evidence of psychometric properties
and utility, and many require additional research to ensure that they
can be applied appropriately in different CPG contexts.
CPG activities are evolving processes. We anticipate that the next
decade will see signiﬁcant further research into tools to underpin best
practices in CPG activities. Given the increasing number of high-
quality CPGs that are freely available internationally for a range of
health conditions, we propose that the growth areas in CPG methods
in the next decade will be in updating, adopting, contextualizing and/
or adapting, and implementing.Moreover, the next generation of CPG
activities should build on knowledge of current activities in develop-
ment, advance processes of end-user engagement, and evaluate CPG
impact on health outcomes.
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Abstract
Background: Reducing the burden of disease relies on availability of evidence-based clinical practice guidelines
(CPGs). There is limited data on availability, quality and content of guidelines within the Southern African
Development Community (SADC). This evaluation aims to address this gap in knowledge and provide
recommendations for regional guideline development.
Methods: We prioritised five diseases: HIV in adults, malaria in children and adults, pre-eclampsia, diarrhoea in
children and hypertension in primary care. A comprehensive electronic search to locate guidelines was conducted
between June and October 2010 and augmented with email contact with SADC Ministries of Health. Independent
reviewers used the AGREE II tool to score six quality domains reporting the guideline development process.
Alignment of the evidence-base of the guidelines was evaluated by comparing their content with key
recommendations from accepted reference guidelines, identified with a content expert, and percentage scores
were calculated.
Findings: We identified 30 guidelines from 13 countries, publication dates ranging from 2003-2010. Overall the
‘scope and purpose’ and ‘clarity and presentation’ domains of the AGREE II instrument scored highest, median 58%
(range 19-92) and 83%(range 17-100) respectively. ‘Stakeholder involvement’ followed with median 39%(range 6-75).
‘Applicability’, ‘rigour of development’ and ‘editorial independence’ scored poorly, all below 25%. Alignment with
evidence was variable across member states, the lowest scores occurring in older guidelines or where the
guideline being evaluated was part of broader primary healthcare CPG rather than a disease-specific guideline.
Conclusion: This review identified quality gaps and variable alignment with best evidence in available guidelines
within SADC for five priority diseases. Future guideline development processes within SADC should better adhere
to global reporting norms requiring broader consultation of stakeholders and transparency of process. A regional
guideline support committee could harness local capacity to support context appropriate guideline development.
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Introduction
Clinical practice guidelines bridge the gap between pol-
icy and practice and should be based on up-to-date,
high quality research findings [1,2]. Reducing the burden
of disease in resource-poor settings relies on the avail-
ability of such evidence-based clinical practice guidelines
[3]. Gaps in these guidelines may impact on the health
of the public they are meant to serve. These omissions
may be a result of opinion-based rather than evidence-
based guidance; recommendations from guideline devel-
opment groups with undisclosed conflicts of interest; or
poor planning for implementation of a guideline [4-8].
There is little data regarding the quality and content of
guidelines in Southern Africa, a region facing serious
health issues including poorly contained communicable
diseases, increasing non-communicable diseases and
under-resourced, often poorly managed health systems.
This demands increasing attention from both develop-
ment agencies and researchers to support research
aimed at strengthening guidelines and policy [9].
Several guideline appraisal tools have been developed
to assess the quality of guidelines [10]. Of these, the
Appraisal of Guidelines for Research and Evaluation
(AGREE) tool has been validated and is most widely
accepted [11-13]. None of the available instruments
assesses the clinical content of the guideline or the qual-
ity of the supporting evidence [10]. It is important to
develop methodology for assessing alignment of pub-
lished guidelines with current best evidence.
Our project aimed to evaluate clinical practice guidelines
(CPGs) from the Southern African Development Commu-
nity (SADC) member states, for priority diseases, with
respect to availability, quality and alignment with current
reference guidelines. This study formed part of a larger pro-
gramme, the Southern African Regional Programme on
Access to Medicines (SARPAM) for harmonising CPGs and
essential medicine lists for reforming regional procurement.
Methods
Prioritising guidelines
We considered two issues: firstly, priority diseases should
be representative of the following key components: adult
& paediatric conditions; communicable & non-commu-
nicable diseases; chronic and acute onset diseases; mater-
nal health; hospital-based & primary health care
conditions. Secondly, time and feasibility limited our
selection to five diseases. The following conditions were
prioritised by the SARPAM study team: HIV in adults;
malaria in children and adults; essential hypertension in
primary care; pre-eclampsia; and diarrhoea in children.
Search strategy for guidelines
A public health clinician used an electronic search and
e-mail enquiry strategy to obtain the CPGs for each
SADC country: Angola, Botswana, the Democratic
Republic of Congo (DRC), Lesotho, Malawi, Mauritius,
Mozambique, Namibia, Seychelles, South Africa, Swazi-
land, United Republic of Tanzania, Zambia and
Zimbabwe. The search strategy incorporated possible
document and disease terms which were added to the
country names (Table 1). Medline and Google were
searched using an iterative approach. We contacted
Ministries of Health via the SADC secretariat. Only
English language guidelines were accepted for this
evaluation.
AGREE II instrument
Two reviewers (TK, AG) independently evaluated the
global quality of the five CPGs for each of the SADC
states and the reference guidelines using AGREE II.
This tool is a recently revised and validated version of
the AGREE instrument [14-18]. AGREE II contains 23
key quality items categorised in six domains scored with
a 7-point Likert scale. Standardised guideline domain
scores were calculated by summing scores of individual
items and standardising the total as a percentage of the
maximum possible score for that domain. The six
domain scores are independent and were not aggregated
into a single quality score. Uncertainties in the applica-
tion of AGREE II were resolved in consultation with a
third investigator (NS). We used Microsoft™ Excel to
record the scores. As the data was nonparametric, we
calculated a median (range) for each domain across
countries to provide overall results.
Alignment with reference standard guidelines
and expert opinion
We invited one South Africa-based content expert for
each of the five priority areas to give input on this pro-
ject. The current gold standard reference guideline for
each topic was identified in consultation with the con-
tent expert [19-26]. The key items of evidence that
should appear in a current guideline on that topic were
then extracted (TK) and the list judged and summarised
by the relevant content expert. These lists represent the
recommendations against which alignment with current
best evidence could be checked with the in-country
guideline. The list of recommendations from each of the
reference guidelines was assigned a point score accord-
ing to the number of recommendations that should be
present to indicate alignment with the reference guide-
line. For example, 25 key items were identified for HIV
guidelines from the WHO 2010 guidelines for the man-
agement of HIV/AIDS in adults and adolescents(19); all
current HIV management guidelines should include
these and would score 100% if all 25 points were identi-
fied (Table 2; tables for list of recommendations for all
reference guidelines are available on request). All
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in-country CPGs were assessed for concordance with
the recommendations list. There were no specific
weightings for the individual recommendations, as each
item is considered a key item for inclusion in current
guidelines on those topics. For each of the five diseases,
we summarised the concordance of the CPGs using a
percentage score and noted any differences.
Results
Search results
The search was conducted between June and October
2010, including feedback from a SADC secretariat meet-
ing in September 2010. The MEDLINE search yielded
no results. Using Google™ and personal contacts the
search yielded 30 guidelines from 13 SADC states
(Table 3). The publication dates of the available guide-
lines ranged from 2003 to 2010. HIV guidelines were
available from 13 of the 14 states; three were in lan-
guages other than English. Malaria treatment guidelines
were available from 13 of the states, two were not in
English, leaving 11 evaluable for this review, three of
which were sections within other CPGs. Hypertension
guidelines were available from nine countries, only two
of which were disease-specific guidelines (South Africa
and Mauritius)[27]. We did not locate guidelines dedi-
cated to management of diarrhoea in children or pre-
Table 1 Search terms used for finding clinical practice guidelines within SADC
Search concepts Search terms
Medical terms HIV; AIDS; ART; ARV; HAART; Anti-retroviral treatment/therapy; Communicable disease/s
Malaria
Diarrhoea; acute; paediatric; child/ren
Hypertension: cardiovascular disease; CVD
Pre-eclampsia: hypertension; pregnancy
Countries Angola, Botswana, The Democratic Republic of Congo, Lesotho, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South
Africa, Swaziland, United Republic of Tanzania, Zambia and Zimbabwe
Clinical practice
guidelines
Standard treatment guideline/s; STG/s; Standard Treatment; Treatment; Treatment guideline/s
Essential medicine
lists
Essential medicine list; EML; Essential drug list; EDL; Central medical store; procurement list; CMS; Medicine procurement list
Ministries of health Department of Health; DOH; Ministry of Health; MOH; National Aids Commission; Aids Commission; NAC
Table 2 Key recommendations from the reference guideline for the management of HIV in adults
WHO 2010 Details Points
Recommendation 1 When to start - CD4 count < 350
- WHO Clinical stage 3 and 4 irrespective of CD4 count
2
Recommendation 2 What to start - AZT+3TC +EFV
- AZT+3TC+NVP
- TDF+3TC/FTC+EFV
- TDF+3TC/FTC+NVP
4
Recommendation 3 ART for HIV/TB - Start ART in all patients with TB
- Start TB treatment first
- Prefer EFV
- Start ART within 2-8 weeks of starting TB treatment
- If CD4 count < 200, start ART within 2 weeks
5
Recommendation 4 ART for HIV/Hep B - Start ART in all patients who require treatment for their Hepatitis B
- Start TDF and 3TC/FTC
2
Recommendation 5 ART for pregnancy - Start ART in all pregnant women if CD4 count < 350
- Start ART in all women with clinical stage 3 or 4 disease irrespective of CD4 count
- AZT preferred in pregnancy
- EFV or NVP can be used
- Do not start EFV in first trimester
6
Recommendation 6 When to switch -
(note: if VL 5000 or less,
will be accepted e.g. 1000)
- VL > 5000copies/mL on at least two occasions
- Use CD4 count if VL not available
2
Recommendation 7 Second line ART
(note: if any one of the
protease inhibitors
included, will accept)
- Boosted PI + 2 NRTIs recommended
- Atazanavir/ritonavir or Lopinavir/ritonavir or darunavir/ritonavir recommended
- If TDF used in first line, use AZT/D4T next
- AND if AZT/D4T used in first line, use TDF in second line
4
ART = antiretroviral therapy; TB = tuberculosis; Hep B = hepatitis B; VL = viral load; PI = protease inhibitor; NRTIs = nucleoside reverse transcriptase inhibitors;
TDF = tenofovir; AZT = zidovudine; D4T = stavudine; EFV = efavirenz; NVP = nevirapine
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eclampsia. We did evaluate the broader primary care
CPGs for these diseases in seven member states for the
former condition and eight member states for the latter.
Summary of AGREE II findings
We present the results according to diseases (Table 4).
Matrices are shown which report the intersection of
AGREE II by domain and alignment with best evidence
(Figures 1, 2, 3, 4 and 5). AGREE II evaluation of the
reference guidelines is shown in Figure 6.
HIV/AIDS
Of the available HIV guidelines, most were disease-speci-
fic guidelines, except that from Seychelles, which had an
abbreviated guideline on HIV management, forming part
of the larger primary care CPG. Two of the guidelines
were in the process of being revised after the release of
the recent WHO 2010 guideline (Table 3) [19]. The
‘clarity and presentation’ and ‘scope and purpose’
domains scored highest with median scores of88% (range
33-94) and 57% (range 19-78) respectively across all
countries. ‘Rigour of development’ and ‘editorial indepen-
dence’ were most poorly reported scoring a median score
of 16% (range 6-30) and 4% (range 0-29) respectively.
Malaria
The ‘scope and purpose’ and ‘clarity and presentation’
domains scored highest, median scores of 71% (range
Table 3 SADC member state guidelines and the reference standard guidelines
SADC
countries
HIV therapy in
adults
Malaria therapy in
adults and
children
Diarrhoea
therapy in
children
Hypertension
therapy in primary
care
Pre-eclampsia therapy Primary care
clinical practice
guidelineiv
Angola N/Ai N/A N/A N/A N/A N/A
Botswana 2008ii 2007 N/A N/A N/A N/A
Democratic
Republic of
Congo
2005 (French)iii 2005 (French) N/A N/A N/A N/A
Lesotho 2010 draft N/A N/A N/A N/A 2005
Malawi 2008 N/A N/A N/A N/A 2009
Mauritius 2009 (French) ?date N/A ?date N/A N/A
Mozambique 2009
(Portuguese)
2006 (Portuguese) N/A N/A N/A N/A
Namibia 2009 2005 N/A N/A N/A 2010
Seychelles N/A N/A N/A N/A N/A 2003
South Africa 2010 2009 N/A 2006 N/A 2008
Swaziland 2006 2009 N/A N/A N/A N/A
Tanzania 2005 2006 N/A N/A N/A 2007
Zambia 2007 N/A N/A N/A N/A 2008
Zimbabwe 2010 draft N/A N/A N/A N/A 2006
Standard
reference
guideline
World Health
Organization,
201019
World Health
Organization,
201020
World Health
Organization,
200522,23
National Institute for
Clinical Excellence
200424-26
Royal College of
Obstetricians
Gynaecologists, 200621
i N/A indicates that the guideline was not available during the search period
ii Dates of publication indicated where was available. Where date was not clear we have indicated this with ‘?date’
iii The language of the guideline-if other than English-is indicated in brackets
iv Primary care guidelines were used to assess alignment when no disease-specific guideline existed
Table 4 Aggregated AGREE II Scores across diseases [median(range)]
Priority diseases Domains of AGREE II
Scope and
purpose
Stakeholder
involvement
Rigor of
development
Clarity and
presentation
Applicability Editorial
independence
HIV (n = 10) 57(19-78) 43(22-58) 16(6-30) 88(33-94) 22(0-58) 4(0-29)
Malaria (n = 11) 71(19-89) 38(6-53) 20(6-32) 88(17-97) 15(0-52) 0(0-25)
Pre-eclampsia (n = 8) 58(31-83) 36(22-61) 14(5-20) 75(36-89) 10(0-27) 0(0-25)
Diarrhoea in children (n
= 7)
58(25-83) 36(22-58) 14(6-20) 83(42-100) 10(0-27) 4(0-25)
Hypertension (n = 9) 75(39-92) 42(22-64) 11(6-44) 81(53-97) 10(0-42) 4(0-50)
Overall 58(19-92) 39(6-75) 14(5-44) 83(17-100) 10(0-58) 0(0-50)
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19-89) and 88% (range 17-97), whereas the ‘applicability’
and ‘editorial independence’ scored poorly, median 15%
(range 0-52) and 0% (range 0-25) respectively.
Pre-eclampsia
Eight guidelines were evaluated, including the 2010 draft
version of the Namibian CPG. The lowest score was seen
for the ‘editorial independence’ domain, median 0%
(range 0-25) and the highest score was seen in the ‘clarity
and presentation’ domain median 75% (range 36-89).
Diarrhoea in children
Domains ‘scope and purpose’, ‘stakeholder involvement’
and ‘clarity and presentation’ received highest scores;
the lowest score was seen for editorial independence
median 4% (range 0-25).
Hypertension in adults
The median score for the domain on ‘clarity and presen-
tation’ was 81% (range 53-97), and the ‘scope and pur-
pose’ median score was 75% (range 39-92), however the
Figure 1 Matrix of AGREE II and alignment with evidence-HIV guidelines within SADC.
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other domains scored largely below 50% with ‘editorial
independence’ scoring lowest, median 4% (range 0-50).
Alignment of CPGs with reference standards
Key recommendations from the reference guidelines
were identified with input from experts in the respective
fields.
HIV/AIDS
The Zimbabwe (2010) and Lesotho (2010) guidelines,
both in draft form, were best aligned with current evi-
dence-based guidelines and expert opinion, achieving >
80% alignment (Figure 1). Older guidelines, such as that
from Tanzania (2005), were not well aligned and pre-
sented out-dated recommendations such as the use of
Figure 2 Matrix of AGREE II and alignment with evidence-Malaria guidelines within SADC.
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stavudine as first-line antiretroviral therapy. The guide-
line from Zambia (2007), achieved good alignment
despite having been published prior to the current
WHO recommendations. This guideline made provi-
sions for recommending the antiretroviral Tenofovir
prior to, but in anticipation of, its availability for first-
line therapy in the country.
Malaria
The five malaria guidelines that were part of a larger
primary care CPG were limited in their scope and gen-
erally did not provide comprehensive management
advice (Figure 2). Older primary care CPGs were less
likely to be in-line with current evidence and tending to
score lower in their alignment (Lesotho 2005, Seychelles
Figure 3 Matrix of AGREE II and alignment with evidence-Pre-eclampsia guidelines within SADC.
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2003). Guidelines from South Africa (2009) and Swazi-
land (2009) were best aligned with current evidence-cer-
tain recommendations that differed from reference
standard advice were justified due to local cost or
regulatory constraints, rather than lack of adherence to
best standards (e.g. use of parenteral quinine rather than
artesunate in South Africa where the drug is not yet
registered by the National Regulatory Authority).
Figure 4 Matrix of AGREE II and alignment with evidence-Childhood diarrhoea guidelines within SADC.
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Pre-eclampsia
Most guidance regarding the management of pre-
eclampsia was brief, scoring poorly overall. Malawi
(2009) was most recently published and was current
in its recommendations and scored above 50%
(Figure 3).
Diarrhoea
Diarrhoea management has not changed significantly in
the recent years and as such, most CPGs produced after
the WHO publication in 2005 (22,23) had fair concordance
with recommendations, including the use of zinc in all
guidelines. Zimbabwe (2006), South Africa (2008) and
Malawi (2009) scored 80% alignment (Figure 4).
Hypertension
Two countries with dedicated hypertension guidelines,
South Africa (2006) and Mauritius (unknown date),
scored best in their alignment with current best evi-
dence [27] (Figure 5). The remaining primary care
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Figure 5 Matrix of AGREE II and alignment with evidence-Primary care hypertension guidelines within SADC.
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guidelines did not provide adequate diagnosis and care
recommendations hence scoring poorly.
Discussion
To our knowledge this is the first study to report on the
availability and appraisal of quality and content of clini-
cal guidelines for five priority diseases within the SADC
region. Of the available guidelines overall scores were
poor using the AGREE II assessment-particularly with
respect to rigour of development, applicability and edi-
torial independence. Alignment with best evidence was
highly variable, with better scores for guidelines that
were more recently published and those that were dis-
ease-specific rather than sections within larger primary
health care CPGs.
Summary of main findings
HIV and malaria were most likely to have disease-speci-
fic guidelines which may reflect the global funding
streams and political impetus targeting these conditions.
The other priority diseases occupied sections within lar-
ger primary care CPGs. Our review found that the sec-
tions within other manuals that we evaluated were not
comprehensive and provided incomplete guidance and
were less likely to be up-to-date. Overall, the ‘scope and
purpose’ and ‘clarity and presentation’ domains of the
AGREE II tool were reported most comprehensively.
However, the purpose, health question and target users
were not explicitly described. Rather, the information
was incorporated within the introduction and foreword
sections and required extraction in order to identify the
scope and objectives.
Most documents employed clear and consistent meth-
ods for identifying key recommendations, such as flow
diagrams, tables and highlighted text, making the docu-
ments accessible for end-users and resulting in good
scores in ‘clarity and presentation’. The value of the
clarity and presentation has been questioned as it does
not strictly reflect the internal and external validity of a
guideline document [28]. However, the usability of a
guideline may impact on the applicability of the docu-
ment. Target-users are not necessarily trained to discri-
minate on the quality of the guideline, but may be
encouraged to use it if simple to navigate and apply [29].
The remaining four domains scored poorly across all
diseases. The guidelines described the ‘stakeholder invol-
vement’ of multidisciplinary professional groups; how-
ever, little was reported about the contribution of
primary-care doctors and target patients. This is increas-
ingly recognised as important for assuring that guide-
lines represent the needs of both the target users and
patients. Involving these groups in the guideline devel-
opment process, for example by pre-testing the guide-
line, or evaluating and incorporating preferences and
values, may aid in securing the successful implementa-
tion of the guideline [30,31].
Figure 6 AGREE II scoring for reference guidelines.
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In our study, as in previous studies, ‘rigour of develop-
ment’ scored poorly [12]. A minority of guidelines pro-
vided references to the primary data and despite this
many guidelines were highly aligned with current evi-
dence (Figures 1, 2,3, 4 and 5). A plausible explanation
is that the data required to evaluate this domain may
exist in supporting documentation, such as appendices,
which our search failed to locate. In addition, many of
the SADC guidelines base their recommendations on
other reference guidelines, such as WHO publications.
Within SADC there may be members that have the
capacity to appraise, synthesise and apply current evi-
dence but generally it is accepted that few SADC coun-
tries are currently equipped with the necessary technical
and financial resources. Despite this, had the guidelines
we assessed clearly referenced their source guideline,
they should have scored higher in this domain. In future
similar evaluations, it may be prudent to augment the
‘rigour of development’ domain to clearly interrogate
the source of the guidelines document, including
whether it is based on another reference guideline.
Many of the guideline documents we evaluated indi-
cated that there would be a process for updating but
none were explicit in their methods or the timing of
updates. An important finding from this report is the
lag between revisions of some of the guidelines with the
result that the recommendations are no longer informed
by current evidence potentially posing a risk to public
health.
The methods necessary to successfully implement the
guidelines, were not clearly delineated, hence the low
scoring ‘applicability domain’. Facilitators and barriers to
applying the guidelines should be described to support
implementation. The process of defining facilitators and
barriers to application should be integrated early in the
guideline development process and include professionals
proficient in implementation strategies [29].
The low score in the ‘editorial independence’ domain
reflects the poor reporting of potential conflicts of inter-
est of stakeholders and the potential influence of fun-
ders in the guideline development process. Although the
absence of these declarations does not necessarily imply
that inappropriate influences guided the final recom-
mendations, the presence of such declarations ensures
that a guideline can be considered trustworthy [8,13,32].
Higher alignment scores were attained when guide-
lines were dedicated to a specific illness as seen with the
malaria, HIV and hypertension guidelines. Gaps in the
key recommendations occurred when the guidelines
were out-of-date, occurring more frequently in the pri-
mary care CPGs. Pre-eclampsia scored poorly for align-
ment-indicating that the primary care CPGs we
evaluated did not reflect current evidence. This condi-
tion requires hospital-based care and we did not identify
any secondary or tertiary hospital guidelines during this
review. Good alignment was achieved in guidelines
despite poor scores in the ‘rigour of development’
domain-indicating a possible mismatch of the tool with
the local practice of basing guidelines on WHO or
equivalent high quality guidelines.
Agreement with previous research
A systematic review evaluating 42 guideline appraisal
studies, including 626 guidelines, between 1988 and
2007 using the AGREE tool found similar distributions
of low and high scores, supporting the notion that the
domains within the guidelines that require improvement
are similar despite disease or region [12]. Our scores for
rigour of development, editorial independence and
applicability were substantially lower than those
described-indicating areas that require particular atten-
tion for future guideline development within SADC.
Our study further highlights the need for support to
improve the quality of guidelines by implementation of
current normative standards of reporting within guide-
lines such as those developed by established guideline
developers [33-35].
Strengths and limitations
We were mandated by the SADC Secretariat Pharma-
ceuticals Programme and therefore received cooperation
from the ministries within the member states to assist
with locating the relevant guidelines. We have attempted
to address the research-knowledge gap by communicat-
ing a technical summary of the results to the SADC
secretariat with specific recommendations for improving
the availability, content and quality of CPGs within
SADC. Although the AGREE II tool has been adopted
widely as the reference tool to be used to evaluate
guideline quality, this is the first time, to our knowledge,
that it has been systematically applied across several dis-
eases in a number of resource-constrained countries in
Africa. This study can therefore contribute to a valida-
tion of the AGREE II tool and support uptake in our
setting. The assessment of the alignment of the contents
of the CPGs in this review was conducted with both
published normative standard guidelines, such as WHO
guidelines, and the input from experts in the respective
fields.
We did not locate all relevant documents given the
absence of a central or country-level repository. The
outstanding documents would be required to provide a
representative baseline analysis for SADC. The guide-
lines we evaluated included a combination of disease-
specific guidelines and sections within larger primary
care manuals. These guidelines may not lend themselves
to be pooled in analysis, but do provide a true reflection
of current guidance of the management of the included
Kredo et al. Health Research Policy and Systems 2012, 10:1
http://www.health-policy-systems.com/content/10/1/1
Page 11 of 13
Stellenbosch University https://scholar.sun.ac.za
diseases. AGREE collaborators recommend that increas-
ing the number of reviewers increases validity [11,19].
Cost and time constraints dictated the feasible number
of content experts and reviewers for this evaluation.
There is currently no validated method for assessing
alignment with evidence; therefore we used a method
that will need future review to assess validity. Lack of
timely translation prevented us from reviewing the
guidelines from French- and Portuguese-speaking coun-
tries. This should be addressed in a future evaluation.
The overall appraisal of quality of the guidelines would
be enhanced by supplementary consultation and inter-
view-based data collection with ministries, giving parti-
cular attention to guideline development processes and
strategies and the roles of various members of the min-
istries of health, scientists and technical experts in for-
mulating the guidelines [10]. Although the AGREE II
tool may be applied across regions and settings, our
experience suggests that ‘rigour of development’ domain
may have scored more poorly than warranted, as the
majority of SADC guidelines rely on guidance from the
WHO, and therefore do not reference primary research
as the domain requires. For this reason we recom-
mended that this domain be amended for future evalua-
tions for use in our setting.
What have we learned?
It is important that gaps in the availability of CPGs be
identified and addressed. A repository of all guidelines
in an accessible database will facilitate access for all
SADC member states. It will facilitate cataloguing of
guidelines and enable identification of those that may be
relevant but missing or out-of-date. This could be done
in collaboration with organisations such as the Guide-
line International Network [36].
There may be value in creating a SADC guideline sup-
port committee, through the SADC Pharmaceutical Pro-
gramme, to assist all member states to adapt, maintain
and update in-country guidelines of high standard [37].
This will facilitate that expertise in guideline develop-
ment be shared. This committee may enlist expertise in
reviewing current evidence with regards its applicability
and generalisability to local healthcare needs. Such a
committee should include, amongst others, the following
relevant stakeholders-content experts; funders; policy
makers; public health professionals; physicians, nurses
and pharmacy staff; patient representative groups and
an external review committee. Collaboration with
experts in the field of guideline development could sup-
port capacity development and aid the process of brid-
ging research and practice.
The value of this review has been to identify specific
gaps in the quality and content of the guidelines within
SADC. There is increasing awareness that the transfer
of research evidence into policy and practice is a com-
plex issue, sensitive to the context of each country. In
order to inspire confidence in the quality and evidence-
base of guideline recommendations and in the transpar-
ency of the development process, each newly developed
or updated guideline should adhere to the recom-
mended reporting norms currently in use globally.
Non-standard abbreviations
CPG: clinical practice guideline; AGREE: Appraisal of
Guidelines for Research and Evaluation.
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Decisions made by healthcare professionals on the prevention and 
management of ill health are at the core of an effective, efficient and 
trusted health system. Clinical practice guidelines (CPGs) can have a 
substantial influence on clinical decision-making, with consequences 
for health outcomes, patients’ access to care, health system costs and 
resource use.
The white paper on National Health Insurance (NHI) policy for 
South Africa (SA)[1] released in June 2017 suggests that detailed 
treatment guidelines, based on the best available clinical and cost-
effectiveness evidence, will be used to guide the delivery of health 
services under NHI. Under NHI, standard treatment guidelines 
(STGs) developed by the National Department of Health (NDoH) 
for primary, secondary, tertiary and quaternary levels of care will 
play an integral role in determining access to and quality of care, 
and additional treatment guidelines will be used or developed where 
gaps in the therapeutic areas covered by the STGs are identified. In 
addition, the NHI Policy states that ‘efforts will be put into place 
to ensure that the general public is provided with the relevant 
information to support access and ensure empowerment regarding 
these guidelines’.[1]
However, no central, accessible database of CPGs developed in SA 
currently exists.[2] The CPG mapping project described in this article 
aimed to address this gap in knowledge of up-to-date guidelines, and 
to assist the NDoH by: (i) improving the current understanding of 
the CPG landscape in SA; and (ii) providing a starting point for a 
co-ordinated CPG review and development programme under NHI. 
The primary objective of this project was to identify and collate all 
publicly available CPGs and, where available, to provide the details of 
the developers/commissioners of such guidance.
For the purpose of this research, and the intended NHI-focused 
requirements of guideline production in SA, we defined CPGs 
in their broadest sense as documentation that advises on the 
clinical management (including screening, prevention, diagnosis, 
treatment, rehabilitation and palliation) of individuals in a particular 
setting for a particular disease area/condition. The use of a more 
restrictive definition of CPGs, for example the Institute of Medicine’s 
2011 definition that includes a requirement that CPG statements/
recommendations ‘are informed by a systematic review of evidence 
and an assessment of the benefits and harms of alternative care 
options’,[3] was not considered practical or appropriate, as the 
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Background. South Africa (SA) is in the process of implementing National Health Insurance (NHI), which will require co-ordination of 
health provision across sectors and levels of care. Clinical practice guidelines (CPGs) are tools for standardising and implementing care, and 
are intended to influence clinical decision-making with consequences for patient outcomes, health system costs and resource use. Under 
NHI, CPGs will be used to guide the provision of healthcare for South Africans. It is therefore important to explore the current landscape 
of CPG developers and development.
Objective. To identify and describe all CPGs available in the public domain produced by SA developers for the SA context.
Methods. We conducted a cross-sectional evaluation using a two-part search process: an iterative, electronic search of grey literature and 
relevant websites (161 websites searched), and a systematic search for peer-reviewed literature (PubMed) after publication year 2000. CPGs 
were identified, and data were extracted and categorised by two independent reviewers. Any discrepancies were referred to a third reviewer. 
Data extracted included a description of the developer, condition, and reporting of items associated with CPG quality.
Results. A search conducted in May 2017 identified 285 CPGs published after January 2000. Of those, 171 had been developed in the 
past 5 years. Developers included the national and provincial departments of health (DoH), professional societies and associations, ad 
hoc collaborations of clinicians, and the Council for Medical Schemes. Topics varied by developer; DoH CPGs focused on high-burden 
conditions (HIV/AIDS, tuberculosis and malaria), and other developers focused on non-communicable diseases. A conflict of interest 
statement was included in 23% of CPGs developed by societies or clinicians, compared with 4% of DoH CPGs.
Conclusion. Accessing CPGs was challenging and required extensive searching. SA has many contributors to CPG development from the 
public and private sectors and across disciplines, but there is no formal co-ordination or prioritisation of topics for CPG development. 
Different versions of the CPGs were identified and key quality items were poorly reported, potentially affecting the usability and credibility 
of those available. There was substantial variation in CPG comprehensiveness and methodological approach. Establishing a national CPG 
co-ordinating unit responsible for developing standards for CPG development along with clinical quality standards, and supporting high-
quality CPG development, is one essential step for moving forward with NHI.
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CPG landscape in SA is fragmented and 
not currently standardised, with limited 
technical skills available.[4] As a result, 
the CPGs included in the database vary 
considerably in terms of their development 
methods, quality and comprehensiveness.
Objective
To identify and describe all CPGs available 
in the public domain, produced by SA 
developers for the SA context.
Methods
We conducted a cross-sectional evaluation 
of publicly available CPGs through an 
iterative, electronic search of grey literature 
and relevant websites, as well as a systematic 
search for peer-reviewed literature.
Documentation relevant to the clinical 
management of individuals in SA (see full 
definition above) produced and published 
after 1 January 2000 in English was included 
in the CPG database. Only one version or 
presentation of any CPG was included, and 
non-clinical guidelines describing ethical, 
legal, organisational or infrastructure factors 
for healthcare were excluded. Continuing 
medical or professional education articles 
and academic textbooks were also excluded.
The electronic search of grey literature and 
relevant websites (national and provincial 
departments of health, professional 
societies, associations, universities) was 
conducted between 1 September 2016 and 
15 November 2016, and repeated between 
22 and 25 May 2017. The list of society and 
association websites searched was informed 
by a separate Society, Association and 
Council Mapping Project,[5] as well as the list 
provided on the Health Professions Council 
of South Africa’s website (http://www.hpcsa.
co.za/Links). In the initial search, terms 
including ‘clinical guideline’, ‘treatment 
protocol’ and ‘recommendations’ were used 
to identify websites and grey-literature 
sources. This was followed by a pragmatic, 
within-site strategy to ensure that the search 
was comprehensive and that sources were 
fully examined.
The systematic search for peer-reviewed 
literature was conducted in PubMed and the 
South African Medical Journal (SAMJ) on 
18 October 2016, and updated by the first 
reviewer and repeated by the second reviewer 
on 12 May 2017. Articles published between 
1 January 2000 and 12 May 2017 were 
identi fied using search terms that included 
‘South Africa’ and variations of the following 
keywords: guideline; clinical management; 
treatment; protocol; recommend; algorithm; 
clinical practice guideline; decision support; 
managed care; diagnoses; preventive; public 
health; and health service. Two reviewers 
independently reviewed the abstracts against 
the prespecified inclusion and exclusion 
criteria, with any disagreement discussed 
and referred to a third reviewer if not 
resolved. The Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses 
(PRISMA) flow chart for the literature 
search is presented in Fig. 1.
Two independent reviewers extracted and 
categorised relevant information from the 
CPGs, with any disagreement discussed and 
referred to a third reviewer if not resolved. 
Information extracted included a description 
of the developer, condition and reporting of 
items associated with quality CPGs (e.g. 
declarations of conflicts of interest, funding 
sources, references or evidence base, and 
stakeholder involvement).
Results
In total, 285 CPGs published online after 
the year 2000 were retrieved. Fig. 2 provides 
an overview of the CPGs developed and 
published between January 2000 and May 
2017 in SA and the broad therapeutic areas 
they relate to. Most CPGs provide guidance 
on non-communicable diseases (NCDs) 
(46%, 130/285), maternal, neonatal and 
child health (MNCH) (21%, 59/285) and 
HIV/AIDS, tuberculosis (TB) or malaria 
(12%, 35/285). We found that 171/285 CPGs 
(60%) were developed after 1 January 2012. 
The apparent increase in CPG development 
since 2000 (Fig. 2) could in part be explained 
by the fact that only the latest version of any 
CPG was included in the database.
CPGs were categorised based on their 
scope as:
• Covering multiple conditions and popu-
lations. Short guidelines/algorithms cov-
ering multiple unrelated conditions or 
interventions.
• Detailed. Guidelines that include the fol-
lowing information regarding the condi-
tion or intervention: general information, 
symptoms and presentation of disease, 
diagnosis, and management/treatment 
recommendations.
• Position statement. Short (usually 1 - 3 
pages) recommendations or statements 
where the content is mainly based on the 
collective views of the organisation and 
not necessarily supported by analysis or 
synthesis of local evidence.
• Poster/algorithm. Algorithm or poster on 
the management of a particular condition 
or use of an intervention.
We identified five groups of CPG developers: 
(i) the NDoH; (ii) provincial departments 
of health; (iii) societies or associations; (iv) 
collaborations of clinicians and academics; 
and (v) the Council for Medical Schemes 
(CMS).
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Fig. 1. PRISMA flow diagram of clinical practice guidelines (May 2017).
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CPG developer types and categorisation 
are shown in Table 1. CPGs in each category 
vary in development methodology, length, 
target audience and scope (guidance on an 
individual intervention v. management of a 
condition).
Department of Health CPGs
Nine NDoH CPGs ‘covering multiple 
conditions and populations’ were identified: 
(i) three STGs for SA (primary care level, 
and hospital level for adults and children); 
(ii) Tertiary and Quaternary Level Essential 
Medicines Recommendations, 2016; (iii) 
Integrated Management of Childhood Illness 
(IMCI), 2014; (iv) Adult Primary Care guide, 
2016/2017; (v) Newborn Care Charts, 2014 
(these were developed by the Limpopo 
Initiative for Newborn Care, a joint initiative 
of the Department of Paediatrics and Child 
Health at the University of Limpopo and the 
Limpopo Department of Health, but have 
been categorised as an NDoH guideline 
owing to their national implementation 
and use); (vi) Guidelines for Neonatal Care, 
2008; and (vii) the STG for common mental 
health conditions. Outdated versions (when 
newer versions of the CPGs are available) of 
the STGs, the IMCI and the Adult Primary 
Care guide (previously named Primary 
Care 101) were found on multiple websites, 
including those of the NDoH, universities, 
provincial DoHs and professional societies 
and associations.
Most of the ‘detailed’ NDoH guidelines 
(n=45) were for HIV/AIDS, TB or mala-
ria (28%, 15/45), followed by CPGs for 
MNCH (20%, 9/45), NCDs (20%, 9/45) 
and communicable diseases and infections 
(19%, 8/45). Some of the NDoH CPGs were 
adaptations of World Health Organi zation 
(WHO) guidelines, and many were developed 
in collaboration with, or with financial 
or technical support from, international 
development aid agencies such as the United 
Nations Children’s Fund (UNICEF), United 
States Agency for International Development 
(USAID), United Nations Population 
Fund (UNFPA) and Joint United Nations 
Programme on HIV/AIDS (UNAIDS).
Only three of the ‘detailed’ CPGs by 
provincial DoHs were produced in the past 
5 years. Two of these were developed by 
the KwaZulu-Natal DoH for preventing 
and managing malnutrition, and one by 
the Western Cape DoH on antimicrobial 
management. The KwaZulu-Natal DoH 
also produced protocols for management of 
mental health conditions, and two paediatric 
CPGs ‘covering multiple conditions and 
populations’ in 2007.
Society or association CPGs
A total of 156 CPGs developed by 63 
societies or associations were identified, with 
the majority of organisations (54%, 34/63) 
producing or contributing to more than one 
CPG. Some of the CPGs were adaptations 
of guidelines developed by professional 
societies outside SA.
The majority of the CPGs were ‘detailed’ 
(67%, 104/156) and were mostly produced 
after 1 January 2012 (62%, 96/156). Sixy 
percent (94/156) of the CPGs advised on the 
management of NCDs, with many referring 
to musculoskeletal (14/94), cardiovascular 
(13/94) and gastrointestinal (12/94) condi-
tions.
None of the position statements identi-
fied (n=41) were published in a peer-
reviewed journal, and they were mainly 
developed by five societies: the South African 
Spine Society (n=12), the South African 
Vitreoretinal Society (n=6), the South 
African Gastroenterology Society (n=4), 
the South African Society of Cardiovascular 
Intervention (n=4) and the South African 
Society of Obstetricians and Gynaecologists 
(n=4).
Ten poster/algorithm guidelines were 
included in the CPG database, of which nine 
were produced by the Resuscitation Council 
of South Africa.
CPGs produced by clinicians and 
academics
Thirty-seven CPGs containing no formal 
statement linking their development to the 
DoH or a specific society or association were 
included as clinician/academic-produced 
CPGs. The majority of the CPGs were for 
MNCH (40%, 15/37), followed by NCDs 
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Fig. 2. CPGs produced in SA between January 2000 and May 2017 by broad therapeutic area (N=285). 
(CPGs = clinical practice guidelines; SA = South Africa; TB = tuberculosis; MNCH = maternal, neonatal, 
and child health; NCD = non-communicable disease (NCD). *One CPG on the use of blood products 
in SA has been included under the ‘Trauma and emergency’ field; however, this document includes 
guidance covering more than one broad therapeutic area for both adults and children. †The ‘Multiple 
(adults)’ field includes four documents that consist of a package of adult-focused CPGs covering more 
than one broad therapeutic area. Paediatric CPGs covering more than one broad therapeutic area are 
included under the MNCH field.)
Table 1. Overview of clinical practice guidelines in South Africa by developer type
National 
Department of 
Health, n
Provincial 
department of 
health, n
Society/
association, n
Clinicians/
academics, n
Council for 
Medical 
Schemes, n Total, N
Multiple conditions and populations 9 3 1 0 1 14
Detailed 45 10 104 37 14 210
Position statement 2 1 41 0 0 44
Poster/algorithm 3 4 10 0 0 17
Total 59 18 156 37 15 285
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(32%, 12/37), other communicable diseases and infections (14%, 
5/37) and HIV/AIDS, TB and malaria (8%, 3/37).
Most (33/37) of the CPGs were published in the SAMJ, with the 
rest available on journal and university websites: African Journals 
Online (AJOL) (n=1), the Journal of Endocrinology, Metabolism and 
Diabetes of South Africa (JEMDSA) (n=1), the University of KwaZulu-
Natal (n=1) and the University of Cape Town (n=1).
Council for Medical Schemes CPGs
Fifteen CPGs developed by the CMS were identified. These consist 
of one CPG ‘covering multiple conditions and populations’, which 
contains the algorithms specifying the minimum standards required 
(under Prescribed Minimum Benefits (PMB)) in the management 
of the 25 chronic conditions on the Chronic Diseases List, and 14 
‘detailed’ Diagnosis Treatment Pair CPGs published on the CMS 
website as a result of the PMB Definition Project.[6] The Diagnosis 
Treatment Pair CPGs all relate to cancer, cardiovascular disease and 
organ transplants.
Key quality criteria of included CPGs
Sixteen percent (47/285) of CPGs contained a statement regarding 
the authors’ conflicts of interest, and 23% (65/285) explicitly declared 
the funding source. The methods for stakeholder consultation as part 
of the CPG development process was described in 26% (75/285) of 
CPGs, and 71% (203/285) included references. A brief summary of 
the findings by developer type is presented in Table 2.
Seventeen of the 59 NDoH CPGs (29%) stated the involvement of 
international development partners (e.g. WHO, UNICEF, USAID) 
in the CPG development process. These CPGs had a strong focus 
on MNCH (n=8) and the management of HIV/AIDS, TB and 
malaria (n=6). Pharmaceutical industry involvement was declared or 
assumed (based on pharmaceutical industry advertisements directly 
within the CPG) in the development of 54 CPGs, of which two-thirds 
(36/54) were focused on NCDs.
Discussion
CPGs developed in SA vary considerably in terms of their topics, 
scope, development methods, funding streams and accessibility. 
This variability is not surprising considering the number and 
diversity of CPG developers, and the lack of formal co-ordination 
or standardisation between them with regard to CPG topic selection 
and prioritisation, development methodology and reporting 
principles.
The individual topic selection/prioritisation process followed 
by the developers was generally not reported, and therapeutic 
topics vary considerably. The majority of DoH CPGs were focused 
on high-burden conditions such as HIV/AIDS, TB and malaria, 
while CPGs from other developers were more likely to provide 
guidance on NCDs. One possible explanation for this variation in 
CPG topics is the difference in the type of conditions treated by 
public and private healthcare providers, and as a result the types of 
CPGs they need or are likely to access. The effect of the aims and 
objectives of funding organisations (e.g. pharmaceutical industry, 
international development partners) on CPG topic selection was 
not considered as part of this mapping project, but may warrant 
future research to ensure that CPG topics are prioritised and 
selected based on the needs of the population and the healthcare 
community.
CPGs identified in the public domain were often out of date (with 
more up-to-date versions available elsewhere) and key quality items 
we extracted were poorly reported, potentially impacting on the 
usability and credibility of those available.
Accessing CPGs was challenging, as no central database of CPGs 
currently exists. CPGs can be submitted to the SAMJ for publication, 
but no formal ‘clinical guidelines’ were published in the period 
between the introduction of the AGREE II assessment to the SAMJ 
critical appraisal process for clinical guidelines in 2014[7] and May 
2017. The systematic search for CPGs in the SAMJ retrieved 87 
Continuing Medical Education (CME) articles published between 
2014 and May 2017 that contained the features of a CPG. However, 
these articles were not subject to a peer review process prior to 
publication[8] and were not included in the CPG database. Some 
societies, associations, departmental organisations and universities 
publish CPGs on their websites, but in many cases the CPGs were 
out of date. The Ideal Clinic programme website consistently 
contained up-to-date versions of most of the core DoH guidelines 
(https://www.idealclinic.org.za). The Ideal Clinic programme is an 
NDoH initiative, initiated in 2013, with a strong focus on the use of 
guidelines to support its aim of ‘systematically improving the quality 
of care provided in Primary Health Care facilities’.[9]
Table 2. Summary of findings: Items associated with good-quality CPGs
National 
Department of 
Health (n=59)
Provincial 
department of 
health (n=18)
Societies / 
associations 
(n=156)
Clinicians and 
academics 
(n=37)
Council 
for Medical 
Schemes (n=15)
Funding statement Funding source not stated* (81%) 
or unclear† (3%)
Funding source 
not stated* 
(73%) or 
unclear† (2%)
22% declared 
pharmaceutical 
industry 
involvement 
Funding not 
stated* (59%) or 
unclear† (5%)
32% declared 
pharmaceutical 
industry 
involvement
Not stated 
(100%)
n=1 stated 
pharmaceutical 
industry 
involvement
None stated 
pharmaceutical 
industry 
involvement
Conflict of interest statements, % 0 17 21 30 0
References available, % 54 28 74 100 93
Description of stakeholder consultation process, % 32 28 26 30 0
CPG = clinical practice guideline.
*A CPG funding source was categorised as ‘not stated’ if there was no explicit statement in that regard. There were cases where the involvement of international partners or the pharmaceutical 
industry in CPG development was stated, but the nature of their involvement (human resources or financial) was not declared.
†A CPG funding source was categorised as ‘unclear’ if the funding source was not stated, but a commercial advertisement or logo of a pharmaceutical company appeared in the CPG.
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Strengths and limitations of the literature search
A systematic approach to identifying CPGs produced in SA and 
extracting the relevant data was followed. Detailed inclusion and 
exclusion criteria were established, based on a clear scope for the 
literature search. Dual review and data extraction of CPGs, as well 
as a search of grey literature, were conducted to minimise potential 
selection bias.
Despite the comprehensive search, given the difficulty with 
identifying CPGs it is probable that CPGs are missing. Non-English-
language CPGs were excluded, so guidance produced in any of the 
other official languages in SA will not have been retrieved, and 
guidelines that were not dated may potentially have been missed.
Key criteria regarding funding and conflicts of interest were 
extracted, but a robust quality assessment of CPGs was not conducted. 
Two prior studies have evaluated the quality of a sample of CPGs 
in SA using the AGREE II checklist, and consistently found the 
reporting on several aspects of the methods for CPG development to 
be of low to moderate quality.[2,10] Further quality appraisal on the full 
set of CPGs may not provide additional insight.
Conclusions
SA has a diverse CPG-developing community, but the challenges 
faced by clinicians in accessing up-to-date CPGs and the lack of 
co-ordination between developers may limit the impact of CPG 
developers’ efforts to guide and improve the delivery of high-quality 
patient care.
Developing and maintaining an accessible, up-to-date CPG 
repository is a practical and useful first step towards improving the 
availability of CPGs in SA. The 285 CPGs identified through this 
mapping project provide a starting point for such a repository. In 
addition to a point of access for clinicians, this CPG database can 
also be used to inform the planning and determination of service 
benefits under NHI, and provide information for a clinical guidance 
gap analysis to identify topic areas where future CPG development 
will be most beneficial. Useful lessons can be learnt from information 
technology organisations such as the Open Medicines Project and 
Essential Medical Guidance (EMGuidance), which are already working 
collaboratively, developing and maintaining smartphone applications 
that provide access to the most up-to-date versions of NDoH 
CPGs (STGs, Tertiary and Quaternary Level Essential Medicines 
Recommendations, TB and HIV)[11] and some CPGs produced by 
other SA developers.[12]
Stakeholder involvement is a crucial component that needs to be 
incorporated in all stages of the CPG development process. The South 
African Medical Association (SAMA) is currently ‘engaging its medical 
practitioner members to contribute substantively to the development 
of guidelines, sharing their experience and expertise in the process’.
[13] This could potentially improve the credibility and acceptability of 
CPGs by healthcare professionals across both the private and public 
sectors, and ultimately result in meaningful changes in clinical practice. 
Clinical quality standards are useful tools that can be used to further 
aid and enhance CPG implementation, and evaluate their clinical 
impact under NHI. Patient involvement in the CPG development 
process should also be considered, to ensure that patients are involved 
and empowered in decisions affecting their health.
In addition, the findings from this CPG mapping project and the 
South African Guidelines Excellence (SAGE) project[4] demonstrate 
the need for a national, co-ordinating CPG unit that will enable a 
standardised, co-ordinated and evidence-based approach to CPG 
development. A national co-ordinating body will be essential if CPGs 
are to inform patient care under NHI, with a likely impact on quality 
of care. Ideally it will be responsible for developing and upholding 
key components of CPG production, which includes robust processes 
for topic selection and prioritisation, development, publication/
implementation and review.
Full lists of CPGs and CPG developers are available on the 
PRICELESS SA website (www.pricelesssa.ac.za).
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South Africa (SA) remains one of the most unequal 
societies in the world.[1] Addressing the various 
challenges we face requires multidisciplinary, 
multipronged approaches, including consideration 
of strategies for improving the delivery of healthcare. 
Quality of healthcare can be understood to encompass a number of 
dimensions, including effectiveness, efficiency, accessibility, patient-
centredness, equity and safety.[2] SA’s call for primary healthcare 
re-engineering suggests an acute awareness of local challenges. The 
planned restructuring, including the National Health Insurance 
initiative, is a means for reducing inequality in the provision 
of healthcare, which will require new approaches to healthcare 
delivery, with greater emphasis on health promotion and preventive 
activities.[3,4] These changes necessitate a collaborative approach for 
achieving improvements in key health processes and outcomes, as 
well as changes in clinician and patient behaviours, all underpinned 
by innovative interventions.[5] In the changing healthcare system, 
healthcare providers need clear, trustworthy guidance on how best 
to care for their patients so that all can reasonably reach the ideals 
of quality in healthcare. High-quality, evidence-informed clinical 
practice guidelines (CPGs) are potentially reassuring tools for 
healthcare providers, as they are a means of bridging the gap between 
policy, best practice, local contexts and patient choice.
CPGs have long been upheld as an essential part of quality 
medical practice. ‘Clinical guidelines are statements that include 
recommendations intended to optimise patient care that are informed 
by a systematic review of evidence and an assessment of the benefits 
and harms of alternative care options.’[6]
CPGs have a range of purposes, intended to improve the efficiency 
and cost-effectiveness of health system utilisation and to decrease 
costly and preventable mistakes. They generally include statements 
of expected practice, and provide benchmarks or standards 
against which individuals may audit and potentially improve 
their practices, or guidance with regard to undertaking particular 
tasks.[7] Internationally, over the past decade there has been a 
growing volume of research evidence around CPGs, including the 
processes of guideline development, adaptation, contextualisation, 
implementation and evaluation. There are detailed processes 
available for the development of CPGs, but there is no standard 
approach. Notably, there are well-credentialled international and 
national guideline development groups, including the World Health 
Organization,[8] the Scottish Intercollegiate Guidelines Network,[9] 
the National Institute for Health and Care Excellence[10] and the 
National Health and Medical Research Council,[11] each with its own 
approach to guideline construction and writing, usually described in 
a guideline development manual.
Globally and locally, potentially many hundreds more groups (such 
as health departments, insurers and other healthcare organisations, 
professional associations, hospitals, specialty colleges and even 
small unaffiliated groups of individuals) have attempted the task of 
producing guidelines with the purpose of improving or standardising 
local clinical practice. They often use their own interpretations of the 
best way to construct and write clinical guidelines. Historically, CPGs 
were built mostly on expert opinion, which included variable (and 
often selective) reference to research evidence.[12,13] Such guidelines 
are still found today, albeit in decreasing numbers. Better and more 
transparently constructed evidence-informed approaches integrated 
with expert opinion and patient values have gained acceptance as 
the best approach to clinical guideline development. To support this 
progress, in 2011 the Institute of Medicine (IOM) introduced eight 
standards for guideline development (IOM 2011), the Guidelines 
International Network produced 11 relatively similar standards,[14] 
and McMaster University compiled a checklist of 18 topics and 146 
items to guide developers.[15]
SA has been a contributor to CPG development and implementation 
for several decades. Guideline development occurs at national, 
provincial and hospital levels. In addition, professional societies 
have played an important role, developing guidance based on their 
areas of expertise. For example, the National Department of Health 
spearheads an Essential Medicines Programme that drives the 
development of standard treatment guidelines to inform rational 
prescription at all levels of care (primary, secondary and tertiary, 
quaternary) in an equitable, cost-effective manner throughout the 
country. Regionally, there is evidence that SA is a node of technical 
expertise in this field, with the quality of our guideline development 
exceeding that of our regional neighbours in the Southern African 
Development Community.[16] However, against a global backdrop 
SA’s guidelines do not yet demonstrate all the aspects of expected 
guideline quality indicators according to recognised global standards. 
To address concerns with the quality of CPGs, the SAMJ has 
introduced a Guideline Review Committee to provide peer review 
before publication in the Journal.[17]
In addition to contributions to guideline development, SA 
researchers are global leaders in research into implementation, 
conducting high-quality cluster trials of complex interventions 
evaluating guideline uptake. For instance, the Knowledge Translation 
Unit at the University of Cape Town has conducted pragmatic 
trials evaluating outreach education and task shifting of care from 
doctors to other health professionals, compared with standard care 
for implementing guidelines for respiratory conditions, including 
tuberculosis and more recently HIV.[18-20] The guidelines, developed 
and implemented by this team for SA, are now being rolled out 
to other settings in Botswana and Malawi, where a similar trial to 
contextualise the effectiveness of the educational intervention has 
been tested.[21] This research team is currently expanding its work 
to include guideline implementation for a package of primary care 
conditions, the results of which are impacting on clinical care at 
primary care level throughout SA,[22] and has recently gone into 
partnership with the British Medical Journal.[23]
Despite these innovative SA research activities into CPG 
development and implementation, there is still limited knowledge of 
the overall context and processes of guideline development, adherence 
by clinicians to clinical guidelines, and factors that could improve 
accessibility and use of guidelines in the local healthcare context. 
Our work is based on the premise that high-quality, evidence-
informed CPGs offer a cogent and persuasive way of bridging the gap 
between evidence and best practice, local contexts and health provider 
behaviour. Understanding the current state of play in SA primary 
care CPG development and implementation can therefore pave the 
way for better-focused and more effective and efficient interventions 
to improve healthcare. Project SAGE (South African Guidelines 
Excellence) is a 3-year research project, funded by the South African 
Medical Research Council through the Flagship Project scheme (http://
www.mrc.ac.za/cochrane/sage.htm).[24] The overarching goal of the 
Flagship Projects is to support large-scale, innovative, interdisciplinary 
research projects to address health problems in SA.
Project SAGE is an innovative research partnership between 
Cochrane South Africa, the Centre for Evidence-based Health Care 
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and the Department of Physiotherapy in the Faculty of Medicine 
and Health Sciences, Stellenbosch University, and the International 
Centre for Allied Health Evidence, University of South Australia. 
Project SAGE has five goals that aim to improve the quality and 
reach of SA primary care CPGs (Fig. 1). Using stakeholder-driven 
processes, SAGE will provide tools to assist effective SA CPG 
activities in developing, adapting, adopting, contextualising and 
implementing primary care CPGs.[24]
In a resource-limited setting such as SA, where access to resources 
for health is limited, ensuring the best use of effective and cost-
effective primary care diagnostics and treatments is key to reducing 
waste, improving access and hence improving quality of care.[25] 
CPGs should be seen to transparently and systematically consider 
best research evidence to produce believable recommendations, 
which can then be credible vehicles for knowledge translation. 
Once there is agreement on what constitutes SA best practices in 
CPG development, implementation and evaluation, primary care 
clinicians can be assured that the CPGs developed and implemented 
in SA will support best practice, are achievable by all end users, and 
will lead to improved patient care.
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PROTOCOL SYNOPSIS 
Title 
Mapping the role players, processes and context for clinical practice guideline (CPG) development 
and use for primary health care (PHC) conditions in South Africa (SA) 
 
Introduction  
Little is known about the quality or amount of clinical practice guideline (CPG) activity in SA. This is 
particularly concerning considering the diverse contexts of care across the country, and limited 
resources available to underwrite quality healthcare for all. There is an urgent need to improve the 
quality of PHC practices across SA, to ensure good use of available resources, equity of access, and 
best value for spend. The proposed research will bring together key individuals and organisations 
to problem solve, establish current practice and activities, and support the development of a 
standardised approach to underpin the production of high quality, evidence-based, timely, 
appropriately-implemented guideline recommendations contextualised to SA PHC need. 
 
Aims 
- To conduct SA guideline stakeholder and agenda mapping to understand ‘players’, drivers and 
context for PHC CPG development and implementation 
- To conduct CPG stakeholder requirement mapping to inform the barriers and facilitators to 
guideline implementation in the SA PHC context. 
 
Objectives 
1. Describe/map the role players, processes and context for CPG development and use for PHC 
conditions in South Africa  
2. Evaluate the needs of CPG users based in South African PHC facilities to understand context-
specific facilitators and barriers to guideline use.  
Methodology 
Study 1:  
Qualitative research methods will be used. Stakeholders involved with PHC guideline development, 
implementation or use will be purposively sampled and data collection will be undertaken using 
interviews. In order to capture the voice of stakeholders such as doctors, nurses, pharmacists and 
community health care workers, focus groups will be conducted. The interviews and focus groups 
will be conducted by trained interviewers, and captured using a digital voice recorder. Additional 
field notes will be taken to ensure full and accurate data capturing. Data will be transcribed for 
analysis purposes. Names of participants will not appear in the transcriptions and data analysis 
and interpretation will be done by the investigators by identifying key themes which emerged.  
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Study 2:  
Qualitative and quantitative research methods will be used. Stakeholders similar to those 
described above will be purposively sampled, using a snowballing approach, starting with well-
networked change champions from Study 1 (clinicians, policy-makers, academics, managers, 
insurers, patients). The sample will then be classified into end-user clusters (e.g. clinical disciplines, 
healthcare sectors etc.). Lists of factors (barriers and facilitators) will be compiled, without order 
or preference, and will be grouped into preliminary factors. Following this, a Delphi study will be 
conducted by email of the sample. Using the priority PHC conditions, participants will rank the 
barriers, match barriers with facilitators and offer their suggestions on useful solutions to barriers. 
Barriers and facilitators not previously identified will also be sought. The findings will go to broad 
public consultation in South Africa (including media releases, academic publications, clinical 
meetings, policy briefings). Feedback will be sought from interested individuals, on barriers, or 
facilitators on effective evidence application, particularly CPG use. Data management and analysis 
will be conducted using de-identified data to ensure confidentiality 
Anticipated risks 
The risks of participating in this form of research are anticipated to be low. We will invite a range 
of stakeholders affected by clinical care guidelines. Most participants will be working in the 
healthcare sector, at various levels including public and private care. We will also engage patient 
advocacy or consumer groups, and they will receive the same support to ensure full informed 
consent procedures are followed before enrolment in the study. All those invited will be free to 
withdraw at any stage without any negative impacts.  
Anticipated benefits 
 
The findings of these two studies will allow us to map the networks of players involved with CPG 
development and use in PHC in SA. This will inform the development of a stakeholder driven 
manual as part of the larger Project on South African Guideline Excellence (SAGE) proposal which 
aims to provide an innovative leadership plan for applying SA relevant CPGs efficiently and 
effectively, to improve practices and outcomes, within the context of PHC. The links and 
relationships built through this process may be harnessed for longer term collaborative work to 
ensure high quality guideline processes are inculcated in the SA CPG development and use 
community. Of importance is the broad buy-in which will be sought by engaging the public in the 
wider consultation. We anticipate this will encourage a broader audience to engage with the value 
of CPGs. 
Ethical considerations 
Ethical approval will be sought from the South African Medical Research Council, Stellenbosch 
University and University of South Australia Ethics Committees. Where indicated, the relevant 
Department of Health will be asked for permission to conduct the research. Participants will be 
asked to sign informed consent for participation in the study, for digital recording of the interviews, 
and for using and disseminating the anonymous information provided by them. Participation in 
these studies will be voluntary and participants will be informed of their right to withdraw at any 
moment. There will be no monetary compensation provided for participation. For face-to-face 
meetings, the researchers will aim to visit interviewees at their places of work. Any travel costs 
that arise for participants (e.g. taxi), will be paid for by the project, with travel arrangements made 
by the MRC operations. Refreshments will be served where appropriate for. The confidentiality of 
the participants will be protected and data will be analysed using participant numbers.  
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BACKGROUND 
Clinical practice guidelines in the South African primary healthcare context 
Little is known about the quality or amount of clinical practice guideline (CPG) activity in South Africa (SA). 
Currently, there is little known about the leadership in SA to support efficient, effective and timely activities 
by groups developing, adapting, contextualising and/ or implementing CPGs for SA health conditions. This is 
particularly concerning considering the diverse contexts of care found across the country, and the limited 
resources available to underwrite quality healthcare for all. 
Internationally, over the past two decades, CPGs have increasingly become a familiar tool in policy and 
clinical practice [Turner 2008]. Clinical decisions at the bedside, governance of health facilities including 
hospitals and clinics, health insurer and government spending, and patient choice are all being influenced 
by CPG recommendations. CPGs were defined by the Institute of Medicine (IOM) in 2011 as: 
‘statements that include recommendations intended to optimize patient care that are informed by a 
systematic review of evidence and an assessment of the benefits and harms of alternative care options’ 
[IOM 2011].High quality, evidence-informed CPGs offer a way of bridging the gap between policy, best-
practice, local contexts and patient choice. Good quality CPGs offer a ‘one stop shop’ for end-users, by 
providing composite information from comprehensive literature reviews regarding best practices in 
assessment, diagnosis, management and/ or monitoring of specific conditions. The development of CPGs 
has traditionally been motivated by the need to improve efficiency and cost-effectiveness of health system 
utilization, and to decrease costly and preventable mistakes and adverse events.  CPGs are intended to 
provide transparent synthesis of the evidence on which sound ‘on balance’ judgments can be made by 
clinicians, administrators, policy-makers and patients.  Evidence-informed decisions should minimise over-, 
under- or mis-use of services.   
There is an urgent need to improve the quality of primary healthcare practices across South Africa, to 
ensure good use of available resources, equity of access, and best value for spend [Kleinert.2009; Mayosi 
2012]. There is international acceptance of the value of CPGs in improving healthcare practices, in all 
countries.  However there is no standard international approach to developing, contextualizing or 
implementing CPGs efficiently or effectively. There is also no current way for SA end-users (stakeholders) to 
access advice on the best way forward to use CPGs in their local context.  The proposed SAGE project, lays 
out a three year plan which will develop the platform and background knowledge to support context driven 
implementation of guidelines for SA.  
SA Healthcare system changes: The current transformation in the healthcare system in SA provides a 
window of opportunity for reviewing the current practices in guideline development, to make 
recommendations for supporting and improving the current guideline groups to ensure high quality 
products with strong, context specific implementation plans. CPGs [DoH 10 Point Plan 2009]. These should 
be relevant to healthcare delivery at all levels and sectors of healthcare, including primary, secondary and 
tertiary care, public and private sectors.  To ensure consistency in the quality of healthcare delivery, 
clinicians and managers need to access and use high quality evidence and context informed CPGs. These 
guidelines should be rigorously and transparently developed, up-to-date and based on the best available 
evidence of what works, what doesn’t work and what may be harmful in the South African context. These 
guidelines should be aligned with the national essential drug list and increasingly to address health inequity 
with the introduction of National Health Insurance (NHI). 
SA’s evidence-implementation needs: There are complex drivers for developing CPGs, fragmented 
guidance as to how to develop good quality and implementable guidelines, and variable knowledge about, 
and experience in the methodology of CPG development, adaptation/ contextualisation and 
implementation. High quality CPGs, produced by several organisations in high income settings exist, but 
cannot readily be contextualised and implemented in developing countries. This is due to differences in 
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clinical care pathways, limited resources, barriers and facilitators and readiness of all stakeholders, 
including patients, to embrace the uptake of evidence.  As outlined previously, the key international 
institutions which develop guidelines use different processes to identify guideline topics and review 
questions, as well as different literature review mechanisms, critical appraisal approaches and ways of 
evidence synthesis and reporting.  Each CPG development group has produced manuals to assist its users to 
understand and replicate its processes.  However, after a decade or more of high quality CPG development 
globally, there are issues which have not been addressed comprehensively, even in the well-resourced 
high-income countries.  
The issues that have not yet been addressed globally include: 
 For countries which do not have the resources to develop de novo guidelines, why do so?  Why not 
use already available guidelines and contextualise to local settings and need?  
 How can evidence for high priority primary care conditions be embedded in current practice, to 
ensure that decisions are evidence-informed, context-appropriate and patient-centred?  
 What implementation plans should support guidelines to ensure that evidence is translated 
sustainably into practice? 
 Could a standard approach be developed for SA that builds on high-income country processes for 
guideline development? 
 What local environmental, philosophical, educational, policy and funding barriers would attenuate 
the success of such an approach?  
 What education is required in methodology to ensure that decisions regarding the best evidence to 
use in guideline recommendations are standardised?  
 
The research proposed in this application will bring together key individuals and organisations to problem 
solve, establish current practice and activities, and support the development of a standardised approach to 
underpin the production of high quality, evidence-based, timely, appropriately-implemented guideline 
recommendations contextualised to SA need. The context for doing this is PHC, although the learning from 
this research would be applicable more broadly. The outcomes of this research will make a direct impact on 
SA PHC health processes, outcomes and costs, as well as key deliverables of the re-engineering of PHC plan.  
This project will support clinicians to practice according to the national essential drug list and locally 
available resources. The process of the research requires an integrated, multi-step, multi-disciplinary 
approach, with each step informing the next. The main product of the overall project will be a stakeholder-
driven guideline development manual specifically for SA guideline activities. Secondary products include a 
better understanding of current guideline users (including their processes, CPG applications, and end-users 
needs), networking and capacity development across stakeholders, including National Department of 
Health, professional societies and private health insurers, and training for stakeholders in CPG activities and 
quality improvement practices. Such a collaborative approach is essential to improve SA PHC practices and 
impact. 
Project SAGE (South African Guideline Excellence) 
Project SAGE is a collaborative project of the South African Cochrane Centre and Health 
Systems Research Unit at the South African Medical Research Council and the Centre for 
Evidence-based Health Care and Physiotherapy Division of the Faculty of Medicine and 
Health Sciences, Stellenbosch University, and the International Centre for Allied Health 
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Evidence (iCAHE), University of South Australia. It aims to provide an innovative leadership 
plan for applying SA relevant CPGs efficiently and effectively, to improve practices and 
outcomes, within the context of PHC. This project includes 5 phases (Table 1, Figure 1). 
Phase 1 and 3 are included in this proposal to ethics, as they form the basis for the 
qualitative methodology needed to underpin the other phases of the project.  
 
Table 1: Overview of full Project SAGE plan 
Goals and methods 
1. SA Guideline stakeholder and agenda mapping: Describe/map the role players, 
processes and context for CPG use for PHC conditions in SA. Qualitative research 
methods and social network analysis will be used.   
2. PHC Guideline identification and appraisal: Evaluate the quality of international 
PHC-related CPGs, and those currently in use in SA 
3. CPG stakeholder requirement mapping: Evaluate the needs of CPG users based in SA 
PHC facilities to understand context-specific facilitators and barriers to guideline use. 
4. CPG Writing and implementation manual for SA: Develop a stakeholder-driven 
guideline manual specific for SA including templates for de novo guideline 
development, and guideline adaptation/ contextualisation, with a focus on 
implementation of context-specific recommendations using comprehensive 
dissemination strategies. 
5. Capacity building, dissemination, training and development: Develop, implement 
and evaluate best-practice training modules regarding CPG use. 
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Figure 1: Project SAGE overview 
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1. STUDY ONE METHODS 
1.1 AIM 
Map the role players and processes of primary healthcare guideline development and 
implementation in South Africa 
1.2 OBJECTIVES 
1.1.1. Establish new knowledge regarding ‘current players and practices’ in PHC CPGs  
1.1.2. Describe what processes of PHC CPG development, contextualisation and 
implementation are in place 
1.1.3. Determine key role players in PHC CPG development, contextualisation and use  
1.1.4. Determine what the needs for implementation of CPGs are by users 
1.1.5. Determine how CPGs are received by end-users 
1.3 STUDY DESIGN 
Qualitative research methods and social network analysis will be used. The qualitative 
methodology is proposed as narrative discourse analysis, using a validated theoretical analysis 
framework designed for behaviour change implementation research [Cane 2012]. This approach 
is proposed because rich data is required to explain South African implications of CPG use, now 
and in the future. This is an appropriate strategy as its aim is to examine the structures within 
which decisions are made by asking the questions ‘what is happening’ and ‘why is it happening’? 
[Liamputtong 2005]. The qualitative findings will be interpreted using social network analysis 
models, to assess important ‘player’ clusters.  
Qualitative research is by tradition emergent in design (Newton Suter, 2012).  This means that 
the process is not predetermined and that researchers anticipate that they may have to adjust 
their data collection techniques once the research starts so as to better answer their central 
research question.  As the initial phase of our data collection has unfolded it has become clear to 
us that we need a stronger focus on understanding the collective experience of guideline 
implementation at the frontline of health care delivery.  While we are developing a very good 
understanding of guideline development from speaking with researchers and policy makers, we 
need to also understand how practitioners, who use the guidelines, receive and interpret these 
documents.  We therefore wish to expand our techniques so as to include focus groups within 
an expanded constituency of doctors, nurses, pharmacists, community health workers in 
addition to the currently listed participants in the protocol.  Since information gathered through 
group discussions (Kitzinger, 1994) can be different from that collected in individual interviews 
(O’Kane 2008) focus groups can provide useful data on the context and the intra-
spacial/political/social dynamics of guideline writing. Focus groups can provide a useful means 
of triangulation.  Such triangulation will make an important contribution to this study because it 
will allow us to compare the guideline and policy intention (as espoused by guideline 
developers) with the actual practice of using them at the frontline (as collectively expressed by 
health workers participating in the focus groups).  This comparison will lead to a deeper and 
richer understanding of the guideline terrain within South Africa. 
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1.4 STUDY POPULATION AND SETTING 
For the purposes on this study we have attempted to engage with as many stakholders as 
possible within South African health sector who are relevant to understanding CPG development 
and use. We will identify the individuals for the first round of interviews in each of these sectors 
through our own networks who will then in turn suggest others to ensure a comprehensive 
sample.  Our sample will therefore include guideline developers, implementers and users for 
example: 
 National Department of Health 
 National Health Insurance field 
 University settings 
 Pharmaceutical Industry 
 Medical Aids 
 Allied Health Associations 
 Professional Societies (e.g. HIV, renal, hypertension) 
 Non-Governmental organisations (e.g. MSF) 
 Doctors   
 Nurses 
 Pharmacists 
 Community health workers 
 Consumer groups 
 Patients  
The data collection will be conducted in conference rooms and offices within the participants’ 
working environment. 
1.5 SAMPLING TECHNIQUE AND ENROLMENT 
In-Depth Interview Sampling and Enrolment: 
A core group of individuals with lead roles in guideline development, implementation and/or 
application will be identified through the investigators’ networks, and invited to join the study. 
These individuals are ‘key players’ in primary care guideline activities in South Africa.  The core 
group of individuals will then be asked to nominate others who meet the eligibility criteria of a 
‘key player’, who may not be known to the investigators.  Thus the participant sample for In- 
Depth Interviews for Study 1 will be recruited purposively initially, then enlarged using a 
snowballing approach until no new names of ‘key players’ are identified (i.e. until participant 
saturation has been reached). This approach is appropriate when a reference population is 
difficult to identify [Noyes 2008, Atkinson & Flint 2001].We will invite between 10-20 stakeholders 
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for the first round of interviews. Through the suggestions, further stakeholders will be invited to 
be interviewed. The list of the names of decision-makers will be captured in a Microsoft Excel 
spread sheet. Each participant will be given a study number for identification purposes. All the 
available participants will be invited to participate and appointments with participants will be 
arranged telephonically or via email.  
Focus Group Sampling and Enrolment: 
Focus group attendees will be recruited through purposeful sampling of the stakeholders listed in 
this protocol, including health carers such as doctors, nurses and pharmacists, by researchers with 
experience in conducting focus groups. We aim to conduct two focus groups in each of the 
following four provinces: Kwazulu-Natal, Western Cape, Limpopo and Eastern Cape, with 
consideration to expand to additional provinces should it be relevant (e.g. Gauteng or 
Mpumalanga etc). We will invite participants from one peri-urban clinic and one rural clinic from 
each province. Focus groups will include anywhere from 6 – 10 participants.  The list of the names 
of focus group participants will be captured in a Microsoft Excel spreadsheet, which will have 
restricted access. Each participant will be given a study number for identification purposes. 
We recognize that hierarchy exists in clinic settings and would constitute the focus groups 
accordingly as follows. We intend to conduct focus groups with all tertiary-trained health 
professionals per clinic in one group in order to understand how guidelines are received, 
implemented and used as a team at the clinic/facility level. We want to understand the 
interactions around guidelines within the clinic between the different professionals. We agree that 
there is a power difference, especially if community health workers were involved. We know that 
there are differences in understanding between levels of training and job descriptions, but we 
believe that tertiary trained people would have some common language to discuss how one 
guideline is used and interpreted. These focus groups are about norms across the group, but we 
will augment our understanding by interviewing individuals involved in the focus groups (as 
already approved) in order to tease out additional information. Community health workers and 
other non-tertiary trained clinic staff would be interviewed separately. 
 
1.6 DATA COLLECTION AND OUTCOMES 
In-Depth Interviews: 
Data will be collected using key informant interviews using the semi-structured questions 
framework that elicit free-flowing information and ideas. The questions are outlined in the guide 
(Appendix B). The interviews will be conducted by trained interviewers, whose role is to facilitate 
the conversation, and ensure that the interviewee is encouraged to provide as many insights into 
clinical practice guideline use for primary health care in South Africa.  The interview data will be 
captured using a digital voice recorder. Additional field notes will be taken by an independent 
observer in each interview.   
One-on-one interviews may be conducted face-to-face, by telephone, Skype or videolink as 
required, by trained interviewers.  
Focus Groups: 
Focus groups will be recorded using a digital voice recorder, with additional field notes taken by 
the group faciliitator and/or independent observer when available and present. Focus group 
recordings will be transcribed by an independent transcriber. The investigators will retain written 
notes and participatory materials created during focus group sessions. Photographs will be taken 
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of any materials made during participatory activities and stored digitally on the investigators’ 
computers under password protection. Additional field notes will be taken to ensure full and 
accurate data capturing. Data will be transcribed for analysis purposes. Names of participants will 
not appear in the transcriptions and data analysis and interpretation will be done by the 
investigators by identifying key themes which emerged. 
 
1.7 DATA MANAGEMENT AND ANALYSIS 
Digitally recorded interviews and focus groups will be transcribed in full using a professional 
service (which ensures independence of transcription). Audiotapes shall be transcribed verbatim, 
including any nonverbal or background sounds. All transcripts shall be audited for accuracy by the 
interviewer who conducted the interview. Where appropriate, member checking will occur to 
ensure accuracy of capture of information.  Names of participants will not appear on the 
transcriptions. Data analysis will be undertaken both by hand coding, and by use of qualitative 
analysis software (ATLAS Ti) to identify key themes, associated sub-themes and exemplar 
quotations relating to these.  Differences between the findings from hand coding and software 
analysis will be discussed within the research team.  Interpretation of the meaning of the themes 
will be undertaken by the entire investigator team by discussing what the themes mean in terms 
of the study objectives. 
Network analysis: The links between ‘players’ and how and why ‘players’ interact will be mapped 
using social network theoretical modelling [Wasserman 1994]. This will illustrate clusters of 
‘players’ and how these can be used to drive best practices in CPG use in the research conducted 
in later components of the overall project. 
1.8 ETHICS AND CONSENT 
Individual consent forms (Appendix A) will be signed and they will fully explain the purpose and 
conduct of the study. Participation in this study will be voluntary and participants will be informed 
of their right to withdraw at any moment. The confidentiality of the participants will be protected 
and data will be analysed using participant numbers. Names of participants will not appear in the 
transcriptions (these will be coded, with the principal investigator holding the only master list of 
codes and names). No monetary compensation will be provided for participants. The researchers 
will travel to the interviewees. However, if travel costs do arise (e.g. taxi) these costs will be 
covered by the project. Refreshments will be served, if appropriate. Ethical approval will be 
sought from the South African Medical Research Council, University of Stellenbosch and the 
University of South Australia Research Ethics Boards.  
Focus groups have limitations that must be acknowledged. Participants will be warned that 
information they share in focus groups has the potential to be more widely shared, while at the 
same time we will remind all participants that information shared in the group setting may be 
private and should be considered confidential. The potential for information shared in focus 
groups to cause conflict, political strife or other forms of discomfort will be avoided as best as 
possible by constantly reminding participants of their right to leave the focus group at any point, 
and their ethical responsibility to one another to respect each other’s opinions and private 
information.  Appropriate permission to conduct the focus groups will be sought from the relevant 
provincial office and the local clinical setting, as required. 
1.9 ANTICIPATED BENEFITS 
The findings of study 1 will provide new knowledge regarding politics, drivers and contexts of CPG 
use in SA, and assist to identify ways in which the quality and impact of SA-relevant CPG activities 
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can be improved. This study will identify ‘Change Champions’ who could assist the overall SAGE 
project and ensure that the research is informed and driven by the stakeholders.  This will be part 
of the sampling approach to identify the participants in the Study 2 described below. 
1.10 DATA DISSEMINATION PLAN 
This study is the first step in understanding the field of CPG development and use in SA in the PHC 
field. Results of this study will inform later steps in the overall project. We would share this report 
with the ‘change champions’ identified through this study, to allow their comment and feedback 
and ensure our ‘map’ is comprehensive and inclusive. We anticipate sharing the results of this 
study in a published report in a relevant peer-reviewed journal. We will also disseminate the 
results at relevant conferences in which methodological issues regarding guidelines and 
knowledge translation are presented. Finally, if requested, we would share results in other public 
forums, particularly with those working in the field of PHC CPGs at national and provincial 
government levels. 
 
1.11 TIMELINES STUDY 1 
Activity  Dates  
Ethics application January 2014 
Recruitment (invitations for 
interviews) 
April 2014  
Recruitment (focus groups) February 2015 (depending on ethics approval) 
Data collection  May 2014 – September 2015 
Data management and analysis  June 2014 - April 2015 (Interviews); February – 
August 2015 (Focus Groups) 
Writing-up and communication December 2015 – January 2016 
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2. STUDY TWO METHODS 
2.1 AIM 
To understand context-specific facilitators and barriers to guideline use we aim to conduct CPG 
stakeholder mapping to evaluate the needs of CPG users based in SA PHC facilities.  
2.2 OBJECTIVES 
2.2.2. A  list of factors of PHC CPG users’ preferences, barriers and facilitators regarding CPG 
use for PHC conditions  
1.1.1. Common and innovative local strategies for addressing barriers  
1.1.2. Broad public engagement in the project, to ensure buy-in across sectors, disciplines and 
agendas  
2.3 STUDY DESIGN 
Mixed methods (descriptive qualitative and quantitative research approaches) will be used. 
This study is conducted in three stages.  
2.3.1 Stage 1: Collating data items   
Preliminary lists of barriers and facilitators to guideline implementation will be 
compiled, without order or preference from the study 1 interviews. This list will be 
based on the priority PHC conditions also identified in study 1 interviews. These will be 
grouped into preliminary factors for the Delphi study.  
2.3.2 Stage 2: Delphi study 
A Delphi study will be conducted by email, using the entire sample from Study 1, 
Participants will be invited to rank the barriers, match barriers with facilitators and offer 
solutions to barriers. Barriers and facilitators not previously identified will also be 
sought. It is proposed that it may take 3-4 iterations of the Delphi approach to obtain 
consensus on priority barriers, and mechanisms to address them [Barras 2009]. 
2.3.3 Stage 3: Obtaining broad buy-in 
The findings of the Delphi study will be sent for broad public consultation in 
South Africa via a range of strategies (media releases, academic publications, 
clinical meetings, policy briefings etc). Feedback will also be sought directly from 
interested individuals, on barriers, or facilitators on effective evidence application, 
particularly CPG use in primary health care.  
2.4  STUDY POPULATION AND SETTING 
The study population will include well-networked stakeholders involved with guideline 
implementation, contextualisation and on the ground use of guidelines for PHC conditions in 
South Africa. Guidelines implementers may include policy makers, guideline developers, 
researchers or other academics, and health facility managers. 
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Guideline users may include multi-disciplinary public and private clinical health care workers 
including doctors, nurses, pharmacists, allied health practitioners. In addition, where possible, 
feedback will be sought from patient’s representative groups, consumer groups and patients. 
All participants should be linked with PHC facilities and be using or expected to be accessing 
and using CPGs.  
The Delphi study will occur via email, with reminders sent at 1 month intervals to those who 
have not completed for the duration of the survey (up to 4 months). 
The broad buy-in phase will use multiple vehicles of communication to engage the public 
(media releases, academic publications, clinical meetings, policy briefings etc). 
2.5 SAMPLING TECHNIQUE AND ENROLMENT 
A snowballing sampling approach will be applied by asking the purposively sampled group of 
individuals for the Delphi approach to identify others who currently play similar roles, or who 
could provide insights into how to change the system from within.  Snowball sampling will 
continue until no new names are identified. No limits will be placed on sample size, as it is 
important that this Study captures as broad a voice for change as possible. The sample will 
then be classified by the investigator team into end-user clusters (e.g. clinical disciplines, 
healthcare sectors, patient groups). 
2.6  DATA COLLECTION AND OUTCOMES  
Delphi component: Data will be collected electronically, via email contact. Using the priority 
PHC conditions identified in Study 1, participants will be invited to rank the barriers, match 
barriers with facilitators and offer solutions to barriers. Barriers and facilitators not previously 
identified will also be sought. It is proposed that it may take 3-4 iterations of the Delphi 
approach to obtain consensus on priority barriers, and mechanisms to address them. 
The framework for identifying potential barriers will follow the suggestions outlined in Table 2, 
however, these may be adapted based on the emerging themes from the data (Michie 2005, 
Michie 2011).  
Table 2: Framework for grouping preliminary factors 
 
Factor Potential barrier(s) 
Patient Expectations and knowledge 
Evidence-based 
process 
Identifying and implementing evidence based healthcare can 
be difficult & time-consuming  
Team Issues Different configurations of multidisciplinary teams, lack of 
uniformity of team approaches 
Care process Lack of uniformity of decision-making, range of service delivery 
models 
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Management 
Support 
Changes in leadership and direction 
Time/facilities/cost Time pressures, cost effectiveness, structural limitations 
Health System Aligning stakeholder expectations 
 
Broad-buy-in component: Feedback will be sought from the wide audience on barriers, or 
facilitators on effective evidence application, particularly CPG use in primary health care. This may 
be sought via a range of strategies (media releases, academic publications, clinical meetings, policy 
briefings etc). Feedback may be written or verbal and will be recorded anonymously.  
2.7  DATA MANAGEMENT AND ANALYSIS 
The list of the names of stakeholders included in the Delphi process and the broader engagement 
will be captured and de-linked in a Microsoft Excel spread sheet. Each enrolled participant will be 
given a study number for identification purposes.  
A dedicated survey feedback mechanism will be developed using available, accessible software 
such as Survey Monkey. All the de-identified responses to the Delphi consultation and the 
broader engagement that follows will be collected in a purpose built MS Excel based framework. 
Round 1 responses to questions will be collected, collated and subsequently reported back to the 
stakeholder clusters. These will then continue to further rounds for agreement, consensus or 
rejection. The iterative process will continue until there is a greater than 70% agreement in the 
factors and therefore stability of data. 
Data analysis will be conducted on the Delphi and public consultation data, using quantitative 
methods such as mean values, measures of variability, percentages.  The electronic survey file will 
also collect free text responses which will be analysed qualitatively, into themes.    
2.8 ETHICS AND CONSENT 
Individual electronic informed consent forms (Appendix C) will be provided in the invitation email. 
These will fully explain the purpose and conduct of the study. Participation in this study will be 
voluntary and participants will be informed of their right to withdraw at any moment. The 
confidentiality of the participants will be protected and data will be analysed using participant 
numbers. No monetary compensation will be provided for participants. The researchers will travel 
to the interviewees. However, if travel costs do arise (e.g. taxi) these costs will be covered by the 
project. Refreshments will be served, if appropriate. Ethical approval will be sought from the 
South African Medical Research Council, University of Stellenbosch and the University of South 
Australia Research Ethics Boards.  
2.9 ANTICIPATED BENEFITS 
Global standards in CPG development and use require that the intended end-users of guidelines 
are identified, and engaged. Barriers to guideline uptake are multi-pronged, and mean different 
things to different end-users.  Barriers to improving healthcare practices are the subject of 
considerable research, without current resolution. Common factors and barriers are listed in 
Table 2. A successfully-implemented CPG means it is consistently used without barriers. This 
Delphi survey and broad public consultation of CPG users in PHC settings will identify local 
barriers and facilitators to CPG use. This provides important formative information for the Goal 4 
of the overall SAGE project to ensure the SA CPG Manual’s capacity to influence future SA CPG 
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use is locally acceptable and feasible. 
2.10 DATA DISSEMINATION PLAN 
Study 2 will inform later steps in the overall SAGE project. We anticipate disseminating the results 
of this study in a published report in a relevant peer-reviewed journal. We will also disseminate 
the results at relevant conferences in which methodological issues regarding guidelines and 
knowledge translation are presented. Finally, if requested, we would share results in other public 
forums, particularly with those working in the field of PHC CPGs at national and provincial 
government levels. 
2.11 TIMELINES STUDY 2 
Application to ethics January/February 2014 
Recruitment (invitations for interviews and Delphi) February –March 2015 
Data collection  April – October 2015 
Data management and analysis May – November 2015 
Writing-up and communication December 2015 – January 2016 
 
3.  COLLABORATORS 
Dr Tamara Kredo, South African Cochrane Centre, South African Medical Research Council  
Prof Karen Grimmer, iCAHE, University of South Australia 
Prof Taryn Young, Centre for Evidence-based Health Care, Stellenbosch University 
Prof Quinette Louw, Department of Physiotherapy, Stellenbosch University 
Dr Karen Daniels,  Health Systems Research Unit, South African Medical Research Council 
Prof J Volmink, Stellenbosch University and South African Medical Research Council 
Dr Simon Lewin, South African Medical Research Council & Norwegian Knowledge Centre 
Amber Abrams, South African Medical Research Council 
Shingai Machingaidze, South African Medical Research Council 
 
4. BUDGET 
Refer to full Flagship proposal to MRC, included with this application 
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APPENDIX A:  
1. INFORMATION LEAFLET AND INFORMED CONSENT FORM FOR INTERVIEWS FOR 
STUDY 1 
 
TITLE OF THE RESEARCH PROJECT: 
 Mapping the role players, processes and context for clinical practice guideline (CPG) development and use 
for primary health care (PHC) conditions in South Africa (SA) 
SAMRC ETHICS REFERENCE NUMBER: EC002-2/2014 
PRINCIPAL INVESTIGATOR: Dr Tamara Kredo 
ADDRESS:  
South African Cochrane Centre 
South African Medical Research Council 
Francie van Zijl Drive, Parow Valley, 7505 
Cape Town, South Africa 
 
CONTACT NUMBER:  
+27-21-938 0508 
Email address: Tamara.kredo@mrc.ac.za 
 
Dear participant 
My name is Tamara Kredo. I would like to invite you to participate in a research project. The purpose of this 
study is to explore the needs of stakeholders involved with clinical practice guidelines in the context of the 
South African primary health care system.  
 
Background 
High quality, evidence-informed guidelines offer a way of bridging the gap between policy, best-practice, 
local contexts and patient choice. Good quality guidelines offer a ‘one stop shop’ for end-users, by 
providing comprehensive information from literature reviews regarding best practices in assessment, 
diagnosis, management and/ or monitoring of specific clinical conditions. Very little is known about the 
accessibility, quality and acceptability of guidelines used in primary health care facilities in South Africa. 
This study aims to explore the ‘landscape’ of guideline development, implementation and use by engaging 
with participants who are actively involved with guidelines in various levels of government, public health 
and private health care. 
 
Your Rights 
Should you agree to participate in this study, you will be asked to participate in an interview, lasting no 
more than an hour. The interviewer will ask you questions about who is involved in the development and 
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use of guidelines, when, where and under what circumstances guidelines are used and developed, how this 
happens and what gets included and excluded in this process. Your answers will be audio taped. This 
ensures that valuable information from this interview is not missed.  The information on the tape will be 
transcribed for analysis purposes. Your name will NOT appear on the transcription.  The research team of 
this project will do the analysis of the interviews. Your audio recording will not be released to any persons 
or entities other than the research team of this study.  The audio recording and typed transcription of the 
interview will be stored in a password protected computer file to which only the PI of this study will have 
access and will be destroyed within 12 months of your interview. The anonymous scientific data – in which 
no individuals will be named or identified – resulting from the study may be presented at meetings, used 
for Masters and/or PhD theses and published in national or international journals, for dissemination 
purposes.  
Your participation in this study is completely voluntary, choosing to or not to participate in this study will 
not have any negative repercussions. You are free to withdraw from the interview at any moment, or 
decline to answer any of the questions without penalty. The information obtained from this interview will 
be treated with strict confidentiality, the data collection forms will not contain any names and data analysis 
will be performed anonymously. You will not be paid to participate in the study, but reasonable travel or 
other related costs will be re-imbursed, and refreshments may be provided where appropriate. 
 
Important contact information for you 
This study has been approved by the South African Medical Research Council Research Ethics Committee 
and will be conducted according to accepted and applicable National and International ethical guidelines 
and principles, including those of the international Declaration of Helsinki October 2008 (updated October 
2013).  
If you have any queries related to the ethos of the project, you are invited to contact the Chair of the MRC 
Ethics Committee, Prof Danie du Toit, tel (021) 938 0687; email: adri.labuschagne@mrc.ac.za. 
If you are willing to participate in this study please sign the attached Declaration of Consent and hand it 
to the investigator /interviewer at the beginning of the interview. 
Yours sincerely 
 
Tamara Kredo 
Principal Investigator 
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Declaration by participant 
By signing below, I agree to take part in a research study entitled Mapping the role players, processes and 
context for clinical practice guideline (CPG) development and use for primary health care (PHC) conditions in 
South Africa (SA) 
 I declare that: 
 I have read the attached information leaflet and it is written in a language with which I am 
fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been adequately answered. 
 I understand that taking part in this study is voluntary and I have not been pressurised to take 
part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced in any way. 
 
 
Signed at (place) ......................…........…………….. On (date) …………....……….. 2015 
 
Participant name:  .......................................... ……………………… 
 
Signature of participant: …………………………………………..  
 
Audio taping: 
I understand and agree that the interview will be audio recorded  
 
Signature of participant: …………………………………………..  
 
Investigator name:  ........................................ ……………………… 
 
Signature of investigator: …………………………………………..  
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2.  INFORMATION LEAFLET AND INFORMED CONSENT FORM FOR FOCUS GROUPS FOR STUDY 1 
 
TITLE OF THE RESEARCH PROJECT: 
 Mapping the role players, processes and context for clinical practice guideline (CPG) development and use 
for primary health care (PHC) conditions in South Africa (SA) 
SAMRC ETHICS REFERENCE NUMBER: EC002-2/2014 
PRINCIPAL INVESTIGATOR: Dr Tamara Kredo 
ADDRESS:  
South African Cochrane Centre 
South African Medical Research Council 
Francie van Zijl Drive, Parow Valley, 7505 
Cape Town, South Africa 
 
CONTACT NUMBER:  
+27-21-938 0508 
Email address: Tamara.kredo@mrc.ac.za 
 
Dear participant 
My name is Tamara Kredo. I would like to invite you to participate in a research project. The purpose of this 
study is to explore the needs of stakeholders involved with clinical practice guidelines in the context of the 
South African primary health care system.  
Background 
High quality, evidence-informed guidelines offer a way of bridging the gap between policy, best-practice, 
local contexts and patient choice. Good quality guidelines offer a ‘one stop shop’ for end-users, by providing 
comprehensive information from literature reviews regarding best practices in assessment, diagnosis, 
management and/ or monitoring of specific clinical conditions. Very little is known about the accessibility, 
quality and acceptability of guidelines used in primary health care facilities in South Africa. This study aims 
to explore the ‘landscape’ of guideline development, implementation and use by engaging with participants 
who are actively involved with guidelines in various levels of government, public health and private health 
care. 
Your Rights 
Your participation in this study is completely voluntary, choosing to or not to participate in this study will 
not have any negative repercussions. You are free to withdraw from the focus group at any moment, or 
decline to answer any of the questions without penalty. The information obtained from this interview will 
be treated with strict confidentiality, the data collection forms will not contain any names and data analysis 
will be performed anonymously.  
Focus groups have the potential for information shared in focus groups to be shared more widely by focus 
group cohort members. We will ask all members to respect confidentiality and anonyminity, but take this 
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opportunity to remind all focus group participants that we cannot ensure that what is shared in the focus 
group will remain private or confidential. While all of our investigators have undertaken to respect 
confidentiality, and all participants have been asked to respect this, we cannot be held responsible for the 
actions of other focus group participants. 
Should you agree to participate in this study, you will be asked to participate in an focus group, lasting no 
more than an hour. The facilitator will ask you questions about who is involved in the development and use 
of guidelines, when, where and under what circumstances you make use of guidelines, how you choose the 
guidelines you use and what the barriers and facilitators are in your implementation of these guidelines. 
Your answers will be audio taped. This ensures that valuable information from this focus group is not 
missed.  The information on the tape will be transcribed for analysis purposes. Your name will NOT appear 
on the transcription.  The research team of this project will do the analysis of the focus group. Your audio 
recording will not be released to any persons or entities other than the research team of this study.  The 
audio recording and typed transcription of the focus group will be stored in a password protected 
computer file to which only the PI of this study will have access and will be destroyed within 12 months. 
The anonymous scientific data – in which no individuals will be named or identified – resulting from the 
study may be presented at meetings, used for Masters and/or PhD theses and published in national or 
international journals, for dissemination purposes.  
Anticipated risks 
The risks of participating in this form of research are anticipated to be low. As described above, where group 
discussions take place the greatest challenge is to ensure that confidential information is not shared in a 
wider audience beyond the focus group setting. We remind you that we cannot maintain control over 
information shared by other focus group members after the focus groups has ended, and encourage all 
participants to maintain confidentiality, but cannot assume responsibility for breaches of confidentiality 
beyond our research staff. The potential for information shared in focus groups to cause conflict, political 
strife or other forms of discomfort will be avoided as best as possible by constantly reminding participants 
of their right to leave the focus group at any point, and an ethical responsibility to one another to respect 
each other’s opinions and private information.   
 
Anticipated benefits 
 
Although there may be no specific benefit for individuals participating in this study, we anticipate that the 
findings of this research will allow us to understand who and what is involved with clinical guideline 
development and use in primary health care in South Africa. This will inform the larger Project on South 
African Guideline Excellence (SAGE). This project aims to improve guideline development and 
implementation of primary care guidelines to improve practices and outcomes, within South African 
primary care context.  
 
Important contact information for you 
This study has been approved by the South African Medical Research Council Research Ethics Committee 
and will be conducted according to accepted and applicable National and International ethical guidelines 
and principles, including those of the international Declaration of Helsinki October 2008 (updated October 
2013).  
If you have any queries related to the ethos of the project, you are invited to contact the Chair of the MRC 
Ethics Committee, Prof Danie du Toit, tel (021) 938 0687; email: adri.labuschagne@mrc.ac.za. 
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If you are willing to participate in this study please sign the attached Declaration of Consent and hand it to 
the investigator /facilitator at the beginning of the focus group. 
Yours sincerely 
 
 
Tamara Kredo 
Principal Investigator 
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Declaration by participant 
By signing below, I agree to take part in a research study entitled Mapping the role players, processes and 
context for clinical practice guideline (CPG) development and use for primary health care (PHC) conditions in 
South Africa (SA) 
 I declare that: 
 I have read the attached information leaflet and it is written in a language with which I am 
fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been adequately answered. 
 I understand that taking part in this study is voluntary and I have not been pressurised to take 
part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced in any way. 
 
 
Signed at (place) ......................…........…………….. On (date) …………....……….. 2015 
 
Participant name:  .............................................. ……………………… 
 
Signature of participant: …………………………………………..  
 
Audio taping: 
I understand and agree that the interview will be audio recorded  
 
Signature of participant: …………………………………………..  
 
Investigator name:  ............................................. ……………………… 
 
Signature of investigator: …………………………………………..  
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APPENDIX B:  
1. IN DEPTH INTERVIEW GUIDE FOR STUDY 1 
Introduce researchers 
This study is being organised by Tamara Kredo and colleagues who work with the South African 
Medical Research Council and Stellenbosch University.  
The study is being funded through the MRC Flagship grant for our proposal entitled: Project 
SAGE (South African Guideline Excellence) 
Explanation of consent form 
Before we begin, it is important for you to understand why the research is being done and what 
it will involve. We hope you have read the information sheet carefully.  Is anything that is not 
clear?   
You do not have to take part in this study. It is up to you to decide whether or not to take part.  
If you do decide to take part you are still free to withdraw at any time. 
Explanation of process 
The discussion will be tape-recorded and will then be typed out in an anonymous format, so 
that they can be analysed.  This typed record of the conversation will be available for you to see 
if you wish and will be stored in a secure environment. You, or any comments you make, will 
not be personally identified in our report.  
 
NOTE: Key probes for each question will be added to ensure the stated objectives are achieved 
 
Record participant name, qualifications, how long they have worked in this department, their 
position and brief description on their job: 
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
.................................................................................................................................................................. 
 
1. Who are you?  
Ask about the demographic and institutional profiles of CPG ‘players’.   
 
2. What do you think?  
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Ask them what they understand by the concept of PHC in South African context. What are the key 
PHC conditions that this project should focus on? 
Explore their views on the current processes of identifying appropriate guidelines, developing 
and/or contextualising guidelines, putting them into practice, educating others about them, using 
them to assess changes in clinical behaviours etc. 
 
 
3. What do you require?  
Assess their role, skills and resources and what their needs are with respect to CPGs for 
improving practices. 
 
4. What processes do you have in place?  
Identify existing frameworks, supports, activities that are being used. 
 
5. What is your experience of using research?  
Assess their experience in using research to inform CPG development. Ask about their 
understanding and knowledge about end-user experiences regarding putting appropriate CPG 
recommendations into practice. 
 
6. What barriers and facilitators have you considered/ experienced in implementing guidelines? 
Discuss the barriers and potential solutions, including any ‘good news’ stories for use of 
guidelines in PHC facilities in SA. 
 
7. What context are you working in?  
Explore internal and external contexts in which guidelines are formulated and implemented, 
including the drivers/ motivation for these activities.  
 
8. What networks exist already?  
Explore the contexts and networks within which South African CPGs are developed, 
implemented, used and evaluated, and who the stakeholders are in these activities.  
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2. FOCUS GROUP GUIDE FOR STUDY 1 
 
Introduce researchers 
This study is being organised by Tamara Kredo and colleagues who work with the South African 
Medical Research Council and Stellenbosch University.  
The study is being funded through the MRC Flagship grant for our proposal entitled: Project 
SAGE (South African Guideline Excellence) 
Explanation of consent form 
Before we begin, it is important for you to understand why the research is being done and what 
it will involve. We hope you have read the information sheet carefully.  Is anything that is not 
clear?   
You do not have to take part in this study. It is up to you to decide whether or not to take part.  
If you do decide to take part you are still free to withdraw at any time. 
Explanation of process 
The discussion will be tape-recorded and will then be typed out in an anonymous format, so 
that they can be analysed.  This typed record of the conversation will be available for you to see 
if you wish and will be stored in a secure environment. You, or any comments you make, will 
not be personally identified in our report. Focus groups participants should be aware that 
information you share has the potential to be more widely shared by other participants in the 
focus group. Although we do remind all participants that information shared in the group 
setting may be private and should be considered confidential, we do not have control over who 
and what the other participants will share. The potential for information shared in focus groups 
to cause conflict, political strife or other forms of discomfort will be avoided as best as possible 
by constantly reminding participants of their right to leave the focus group at any point, and 
their ethical responsibility to one another to respect each other’s opinions and private 
information.  
 
NOTE: Key probes for each question will be added to ensure the stated objectives are achieved 
 
Record participant name, qualifications, how long they have worked in this department, their 
position and brief description on their job. 
1. What guidelines do you use in your work? 
2. Can you name the ones you use . . . 
3. How often you use them? 
4. Where do you find these guidelines?  
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5. Where do you get access to them? 
6. Why do you choose these ones? What is good about them? 
7.  Which type or source of guideline is your prefered? 
8. What are some challenges you have faced in following the guidelines provided for you? 
9. What types of guidelines do not work in your job context? 
10. Experience with specific guidelines – specific guideline to be identified. 
 
Participatory Exercises: 
“Visual tools provide  . . .a rich, multilayered and mediated form of communication 
which is facilitated both by the image and by its very process of production” 
(Christensen and James, 2007: 160). Christensen and James (2007) highlight the 
importance of the drawing process, as a “routine activity”, so that the exercise of 
drawing is both a familiar (and ice-breaking) activity which would not necessarily be 
understood as a “research activity” thus avoiding responses that participants believe are 
expected of them, and adding richness to the data collected. Focus group participants 
will be asked to illustrate the usefulness of guidelines, and to describe these 
illustrations. This will work as both a ice-breaking activity and an opportunity to learn 
about people’s diverse perceptions of the usefulness of guidelines. 
 
Ranking Activity: 
 
Groups of participants will be asked to rank their preference for certain aspects within a 
guideline. These ranked lists will then be hung in the room and rankings will be tallied. 
This method allows for the focus group participants to take part in deciding what topics 
or questions will be broached in their focus group session. This method will allow the 
researchers to better understand the topics most pertinent to those involved in the 
focus group and allow these topics to guide the avenues of inquiry as the research 
moves forward, ensuring that the topics focused on are those most pertinent to the 
study cohort. 
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APPENDIX C: INFORMATION LEAFLET AND INFORMED CONSENT FORM FOR 
INTERVIEWS FOR STUDY 2 
 
TITLE OF THE RESEARCH PROJECT:  
Understanding the context-specific facilitators and barriers to guideline use we aim to conduct CPG 
stakeholder mapping to evaluate the needs of CPG users based in SA PHC facilities. 
SAMRC ETHICS REFERENCE NUMBER: EC002-2/2014 
PRINCIPAL INVESTIGATOR: Dr Tamara Kredo 
ADDRESS:  
South African Cochrane Centre 
South African Medical Research Council 
Francie van Zijl Drive, Parow Valley, 7505 
Cape Town, South Africa 
+27-21-938 0508 
Email address: Tamara.kredo@mrc.ac.za 
 
Dear participant 
 
My name is Tamara Kredo. I would like to invite you to participate in a research project. The purpose 
of this study is to explore the barriers and facilitators to implementing guidelines in the South 
African primary health care context. 
Background 
High quality, evidence-informed guidelines offer a way of bridging the gap between policy, best-
practice, local contexts and patient choice. Good quality guidelines offer a ‘one stop shop’ for end-
users, by providing comprehensive information from literature reviews regarding best practices in 
assessment, diagnosis, management and/ or monitoring of specific clinical conditions. This study 
aims to identify barriers and facilitators to getting guidelines into use in primary healthcare settings 
in South Africa. We will engage many stakeholders at various levels of government, public health 
and private health care. 
Your rights 
Should you agree to participate in this study, you will be asked to participate in Delphi process. This 
is an email based survey that aims to gain consensus through asking many individuals the same 
question and getting consensus about the answer. However, with the Delphi technique, we will 
engage you in several rounds of the survey to get to the best consensus. The process of the survey 
should not take longer than up to 30 minutes each time. 
Your answers will be recorded electronically and strictly confidentially. The anonymous data that we 
Stellenbosch University https://scholar.sun.ac.za
32 
 
collect– in which no individuals will be named or identified –may be presented at meetings, used for 
Masters and/or PhD theses and published in national or international journals, for dissemination 
purposes.  
Your participation in this study is completely voluntary, choosing to or not to participate in this study 
will not have any negative repercussions. You are free to withdraw from the interview at any 
moment, or decline to answer any of the questions without penalty.  
Important contact information for you 
This study has been approved by the South African Medical Research Council Research Ethics 
Committee and will be conducted according to accepted and applicable National and International 
ethical guidelines and principles, including those of the international Declaration of Helsinki October 
2008 (updated October 2013).  
If you have any queries related to the ethocs of the project, you are invited to contact the Chair of 
the MRC Ethics Committee, Prof Danie du Toit, tel (021) 938 0687; email: 
adri.labuschagne@mrc.ac.za. 
If you are willing to participate in this study please tick the box allocated on the electronic survey 
and add the date.  
  
Yours sincerely, 
 
Tamara Kredo 
Principal Investigator 
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Declaration by participant 
By signing below, I agree to take part in a research study entitled Mapping the role players, 
processes and context for clinical practice guideline (CPG) development and use for primary health 
care (PHC) conditions in South Africa (SA) 
 I declare that: 
 I have read the attached information leaflet and it is written in a language with which I 
am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been adequately 
answered. 
 I understand that taking part in this study is voluntary and I have not been pressurised 
to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced in 
any way. 
 
 
Signed at (place) ......................…........…………….. On (date) …………....……….. 2015 
 
Participant name:  .......................................... ……………………… 
 
Signature of participant: …………………………………………..  
 
Investigator name:  ........................................ ……………………… 
 
Signature of investigator: …………………………………………..  
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Appendix D: Photographic Consent Document 
SAGE Photographic / Media Consent Form 
TITLE OF THE RESEARCH PROJECT:  
Understanding the context-specific facilitators and barriers to guideline use we aim to conduct CPG 
stakeholder mapping to evaluate the needs of CPG users based in SA PHC facilities. 
SAMRC ETHICS REFERENCE NUMBER: EC002-2/2014 
PRINCIPAL INVESTIGATOR: Dr Tamara Kredo 
ADDRESS:  
South African Cochrane Centre 
South African Medical Research Council 
Francie van Zijl Drive, Parow Valley, 7505 
Cape Town, South Africa 
+27-21-938 0508 
Email address: Tamara.kredo@mrc.ac.za 
 
INFORMATION 
I hereby consent to the collection and use of my personal images by photography or video recording. 
I acknowledge these may be used on the SAGE website, in newsletters and in publications. I further 
acknowledge that my image may be used by the SAGE Project based at the South African Medical 
Research Council to promote the project, and disseminate its findings in the future. I understand that 
no personal information, such as names, will be used in any publications unless express consent is 
given. 
 
I also understand that my consent can be withdrawn at anytime in writing to the SAGE Principle 
investigator at the South African Cochrane Centre, South African Medical Research Council. Email: 
Tamara.kredo@mrc.ac.za ; telephone: 021 9380508 
…………………………………………………………………………………………. 
CONSENT FORM 
I ………………………………………………………………………………………………… consent to the use of my personal 
images in photographs or video footage for use on the SAGE website, in newsletters and publications 
as well as for distribution of research findings.  I consent to the use of my personal image, 
photographs or video footage being used to promote future SAGE events and programmes. 
 
I further understand that this consent may be withdrawn by me at anytime, upon written notice. 
 
Stellenbosch University https://scholar.sun.ac.za
35 
 
I give this consent voluntarily. 
 
Signed at (place) ......................…........…………….. On (date) …………....……….. 2015 
 
Participant name:  ……………………… 
 
Signature of participant: …………………………………………..  
 
Investigator name:  ……………………… 
 
Signature of investigator: …………………………………………..  
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Appendix 6: Protocol – review of primary care evidence to practice gaps in South Africa 
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Protocol  
Evidence-practice gaps: Systematic evaluation of the quality of primary care disease management 
in South Africa over the last five years  
 
Register title Prospero, submit protocol to BMJ Open 
 
Keywords: clinical guidelines, primary care, guideline adherence, evidence-practice gaps 
 
Background 
South Africa’s health system has undergone a major process of primary healthcare re-engineering 
over the past few decades (1-3). However, challenges remain, and despite the continuing 
commitment to delivering quality primary healthcare services the health outcomes relative to health 
spend are not reassuring of cost-effective health investments (2, 4).  In 2015, the South African 
government issued a White paper outlining steps to achieving a National health Insurance (NHI) 
system with the  aim of redressing persistent inequity in the country and achieving universal health 
coverage (UHC) (5).  Within universal health coverage (UHC), quality of care is one of the core 
features. UHC aims at “ensuring that all people can use the promotive, preventive, curative, 
rehabilitative and palliative health services they need, [and that these are] of sufficient quality to be 
effective, while also ensuring that the use of these services does not expose the user to financial 
hardship”(6). The World Health Organisation defines ‘quality health care’ as having six dimensions, 
these include providing health services that are 1) Effective (providing evidence-based healthcare 
services that result in improved health outcomes to individuals and the community based on needs);  
2) Safe (minimising risks and harm); 3) People-centred (providing care that responds to individual 
preferences, cultures, needs and values); 4) Accessible (delivering health care that is timely, 
geographically reasonable, and provided in a setting where skills and resources are appropriate to 
medical need; 5) Efficient (delivering health care in a manner which avoids waste and maximises 
resource use); 6) Equitable (health care services do not vary in quality due to gender, race, ethnicity, 
geographical location, or socioeconomic status) (7). 
 
To ensure delivery of the effective quality health services, we need tools to bridge the evidence base 
and clinical practice (8). Clinical practice guidelines are amongst the knowledge translation tools in 
the policy implementation armamentarium to address this evidence-practice divide. According to 
definitions of clinical guidelines, they should include evidence-informed statements that are 
intended to enhance patient care (9, 10). In the setting of UHC, clinical guidelines are intended to 
support standardised, equitable, accessible, cost effective care and are part of the planning for 
several developed or emerging national health insurance systems, such as those found in the United 
Kingdom, Japan, and Brazil (11). 
 
In South Africa, there is a large, committed community of guideline developers, and more than 250 
guidelines have been developed in the past 10 years (12, 13). However, there is very little 
coordination between these guideline groups and limited evidence of accompanying quality 
improvement initiatives to evaluate whether the guidelines are meeting their purpose of improved 
health outcomes. In trying to prioritise how and where to direct resources for quality improvement 
and guideline implementation initiates we need to consider the South African burden of disease 
(14). However, with the extent of the burden and its effect on both communicable and non-
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communicable conditions, more specific evidence is needed to guide action. Within primary care 
health services, it would be helpful to explore where there may be gaps in evidence-based health 
service delivery, so called ‘evidence-practice’ gaps.  
 
We have little systematic evidence regarding whether effective care, a key element of quality, is 
provided in health care services in South African primary care. Published evaluations conducted in 
the United Kingdom, Australia and New Zealand were able to identify stark deficiencies in what was 
desired for healthcare compared to what should be delivered (15, 16). These studies highlighted the 
gaps and informed quality improvement strategies in their countries (17, 18). 
 
To date there has been no systematic evaluation of published research on the quality of primary 
care practice against evidence-informed standards of care in South Africa. An understanding of the 
current areas of good or poor clinical effectiveness relative to local clinical guidance may inform 
future quality improvement endeavours. 
 
In the proposed research we aim to describe and summarise published evaluations of the quality of 
South African primary care disease management in order to report on the any gaps between 
standards of care that should be delivered and what in fact is delivered. 
 
Methods  
Study eligibility:  
Study designs: 
 We will include both analytical and cross-sectional, descriptive studies which have evaluated the 
quality of disease management in primary care settings. Surveys of self-reported behaviour will be 
excluded. we anticipate three kinds of studies:  
1) descriptive studies that asses quality of healthcare delivery 
2) evaluations of audit programmes where we can use pre-feedback baseline data 
3) intervention studies where the baseline or control data will be used. 
 
Population: 
Reports should provide data on patients attending primary healthcare services in South Africa. This 
may include public or private sector health services.  
 
Outcomes of interest: 
We are interested in clinical outcomes, relative to evidence-based standards. That is, reports on 
delivery of clinical primary healthcare services for which primary care guidelines are available in 
South Africa within the Essential Medicine List or PC101 guidelines specifically developed for and 
disseminated within primary care. Standards of care will be based on the available clinical practice 
guidelines for South African primary care, matched for the timing of the publication we find. We will 
not include process outcomes. (e.g. for a report on asthma care, we want to extract whether those 
with mild persistent asthma were prescribed a bronchodilator and a steroid inhaler (Asthma 
guidelines/ Essential Drug List standard treatment guidelines - EDL); or patients who have had a 
heart attack are prescribed aspirin and a beta-blocker (EDL)). 
 
Search methods  
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We will include all published data providing baseline information about quality performance 
standards. The standards should be explicitly provided by authors of documents else, standards will 
be derived from evidence-based sources, including available primary care clinical guidelines. Where 
standards are not provided, we will consider national guidelines available at the time of the 
publication. 
 
We will search three online databases: PubMed, Embase and Cochrane’s trial registry. Search terms 
will include: family practice or general practice, primary care, primary health care, quality of health 
care, audit, clinical competence, guideline adherence, quality improvement, health care quality 
indicators, and health care quality assurance, amongst others.  
 
A detailed search strategy will be developed in collaboration with an information specialist. 
 
In addition, we will review local Southern African medical journals (e.g. African Journal of Primary 
Care and Family Medicine; South African Family Practice, South African Medical Journal). We will 
search reference lists of reviews or related studies. We will contact authors in the field. We will 
review relevant conference lists (e.g. Family Practice, Perinatal Care Conference proceedings). 
Where necessary, authors will be contacted to clarify or complete missing information.  Titles and 
abstracts of all documents will be independently evaluated for possible inclusion using an agreed 
eligibility form. Where necessary, full texts will be required to finalise eligibility and disagreements 
will be resolved by consensus. Reasons for exclusion of full texts will be captured and reported in a 
table of excluded studies. 
 
Data collection and management: 
A standardised, pre-piloted data extraction form will be used to extract data from the included 
studies for assessment of study quality and evidence synthesis.  
 
We will extract the following:  
study design, sampling strategy and size, setting (private, public, urban, peri-urban, rural), clinical 
condition, quality of care attained for each condition compared with explicit standards from 
evidence sources, date of data collection.  
 
Two review authors will extract data independently, discrepancies will be identified and resolved 
through discussion (with a third author where necessary). Missing data will be requested from study 
authors if needed.  Descriptions of included studies will be captured in a table of ‘characteristics of 
included studies’ table. 
 
Analysis approach 
We will provide a narrative synthesis of the findings from the included studies, structured around 
the diseases condition, population characteristics, type of clinical outcome and intervention content. 
Where feasible, we will report summaries of outcomes using percentage relative to standard. That 
is, for each outcome, we will have an agreed standard (e.g. 100% of people with moderate asthma 
should be prescribed an inhaler); and we will capture the actual percentage of the outcome (e.g. 
40% of people with asthma received an inhaler) [see table 1]. We anticipate that there will be 
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limited scope for meta-analysis because of the range of diseases conditions and outcomes measured 
across the varying study designs.  
 
Quality assessment of included studies:  
We will assess study quality to consider issues of bias that may arise from inclusion of different study 
designs. A modified Newcastle-Ottawa tool for assessing risk of bias will be used considering the 
different non-randomised studies that will be included. Some elements will include sample selection 
and consideration of confounders in the design, conduct or analysis of the included study. 
 
The following criteria will be systematically collected: study design, sample size (number of 
practices/ clinics and patients), whether random methods for sampling were used or not, whether 
potential confounders were specified and addressed in the design or analysis of the data. 
 
As we are only reporting on single arms of any intervention studies, full risk of bias assessment for 
intervention studies will not be undertaken.  
 
Presentation the results  
We anticipate identifying data from cross-sectional descriptive studies, national and provincial 
audits, and various types of analytical studies. The summary of results will include the condition; 
number of studies, setting, criteria (e.g. management of blood pressure or use of aspirin post 
myocardial infarction), and target of the standard, based on evidence base, source of evidence base, 
including national guideline or a clinical trial. 
 
Table 1. Example of presentation of results: 
Condition # of studies Setting  Criteria  Target 
standard 
Percentage 
meeting the 
standard 
Source of 
standards 
e.g. 
asthma 
10 urban 
and 
peri-
urban 
use of 
steroid 
inhaler 
100% in 
moderate 
asthma 
55% met 
target 
SA Asthma 
guideline, 
2005, SAMJ 
 
Dissemination plan 
We plan to publish the results in relevant journal, share results in relevant conferences and events. 
Depending on findings, there may be specific stakeholders who would benefit from direct 
communication of results, this will be determined after the analysis. 
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